assays_ss_d,assays_src_d,assays_ss_cll_tp,assays_cnfdnc_scr,assays_ss_rgnsm,assays_ss_tst_tp,assays_ss_ctgr,assays_ss_tx_d,assays_tss_d,assays_cll_d,assays_dscrptn,assays_ss_tss,assays_vrnt_d,assays_src_ss_d,assays_ss_sbclllr_frctn,assays_b_frmt,assays_td,assays_rltnshp_tp,assays_crtd_b,assays_chmbl_d
7524,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618647
7525,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618648
7526,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618649
7527,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618650
7528,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618651
7529,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876497
7530,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618652
7531,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618653
7532,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618654
7533,1,,1,Rattus norvegicus,,,10116.0,,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618655
7534,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for solubility in water,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618656
7535,1,,0,,,,,,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,,,,BAO_0000100,22229,U,Intermediate,CHEMBL618657
7536,1,,1,Rattus norvegicus,,,10116.0,,,Solubility was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618658
7537,1,,1,Rattus norvegicus,,,10116.0,,,solubility in water (ug/mL) at 37 degree C.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618659
7538,1,,1,Rattus norvegicus,,,10116.0,,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618660
7539,1,,1,Rattus norvegicus,,,10116.0,,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618661
7540,1,,1,Rattus norvegicus,,,10116.0,,,Half life in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873807
7541,1,,1,Rattus norvegicus,,,10116.0,,,Half life in Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618662
7542,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period after 3 mg/kg iv administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618663
7543,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period after 3 mg/kg iv administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618664
7544,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period after 3 mg/kg iv administration in the rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618665
7545,1,,1,Rattus norvegicus,,,10116.0,,,Half life period in female Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876498
7546,1,,1,Rattus norvegicus,,,10116.0,,,Half life period in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618666
7547,1,,1,Rattus norvegicus,,,10116.0,,,Half-life in rats was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620440
7548,1,,1,Rattus norvegicus,,,10116.0,,,Half-life in rats with metabolic oxidation,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620441
7549,1,,1,Rattus norvegicus,,,10116.0,,,Half-life in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620442
7550,1,,1,Rattus norvegicus,In vivo,,10116.0,,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620443
7551,1,,1,Rattus norvegicus,In vivo,,10116.0,,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620444
7552,1,,1,Rattus norvegicus,In vivo,,10116.0,,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620445
7553,1,,1,Rattus norvegicus,In vivo,,10116.0,,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620446
7554,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Biological half-life measured in plasma of rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620447
7555,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Biological half-life measured in plasma of rat; 22-25,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621129
7556,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Biological half-life measured in plasma of rat; 9-16,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621130
7557,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for its half life when administered intravenously in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873808
7558,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876598
7559,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621131
7560,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life (T1/2) after oral administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621132
7561,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life of compound after iv administration of 20 mg/kg dose in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621133
7562,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Expert,CHEMBL621312
7563,1,,1,Rattus norvegicus,,,10116.0,,,Half life of compound was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621313
7564,1,,1,Rattus norvegicus,,,10116.0,178.0,,Half life of compound was determined in rat blood,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621314
7565,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life at 1 mg/kg was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621315
7566,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life at 10 mg/kg was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621316
7567,1,,1,Rattus norvegicus,,,10116.0,,,Half life in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621317
7568,1,,1,Rattus norvegicus,,,10116.0,,,Half life in rats in hours,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621318
7569,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621319
7570,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621377
7571,1,,1,Rattus norvegicus,,,10116.0,,,Half life was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621378
7572,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life after i.v. administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876599
7573,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621379
7574,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life in rat plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621380
7575,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life in rat plasma; Not detected,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621381
7576,1,,1,Rattus norvegicus,,,10116.0,,,Half life in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618515
7577,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period of compound was determined after peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618516
7578,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618517
7579,1,,1,Rattus norvegicus,,,10116.0,,,Half life period in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618518
7580,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618519
7581,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618698
7582,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618862
7583,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618863
7584,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618864
7585,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life time in rat the dose of 2 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618865
7586,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life 24 hr after 10 mg/kg iv administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618866
7587,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life 24 hr after 2 mg/kg iv administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618867
7588,1,,1,Rattus norvegicus,,,10116.0,,,Half-life consistent with the observed metabolic steady state in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875828
7589,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618868
7590,1,,1,Rattus norvegicus,,,10116.0,,,Half-life for oxidative metabolic stability was determined using male human,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618869
7591,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618870
7592,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half-life in rat plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618871
7593,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half-life in rat plasma was determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618872
7594,1,,1,Rattus norvegicus,,,10116.0,,,Half-life in rats was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873816
7595,1,,0,,,,,,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL618873
7596,1,,0,,,,,,,Area under curve after oral dose of 0.1 mg//kg,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL621602
7597,1,,0,,,,,,,Area under curve after oral dose of 0.3 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621603
7598,1,,0,,,,,,,Area under curve after oral dose of 1 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621604
7599,1,,0,,,,,,,Area under curve after oral dose of 10 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621605
7600,1,,0,,,,,,,Area under curve after oral dose of 23.4 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621606
7601,1,,0,,,,,,,Area under curve after oral dose of 3 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621607
7602,1,,0,,,,,,,Area under curve after oral dose of 3.87 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621608
7603,1,,0,,,,,,,Area under curve was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL621609
7604,1,,0,,,,,,,Area under curve at a dose of 10 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621610
7605,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined; ND=No data,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621611
7606,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621612
7607,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622308
7608,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622309
7609,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622310
7610,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622311
7611,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622312
7612,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622931
7613,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622932
7614,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622736
7615,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622737
7616,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622738
7617,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622739
7618,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622740
7619,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622741
7620,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622742
7621,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622743
7622,1,,1,Mus musculus,,,10090.0,1969.0,,AUC in mice,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622744
7623,1,,0,,,,,,,Area under curve was measured from the graph obtained from concentration Vs time,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624134
7624,1,,0,,,,,,,Area under curve value of compound per hour after oral administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624135
7625,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined after oral administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624136
7626,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined after oral administration in rats; No data,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624137
7627,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined after oral administration in rats;No data,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624320
7628,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624321
7629,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624322
7630,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined for the compound after iv dose of 5.06 in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624323
7631,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624324
7632,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624325
7633,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624326
7634,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624327
7635,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624328
7636,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve was determined in Dogs after peroral administration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627848
7637,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined in Rats after peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627849
7638,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined in carotid blood of rat when administered intradermally,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627850
7639,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined in portal blood of rat when administered intradermally,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627851
7640,1,,1,Mus musculus,,,10090.0,,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627852
7641,1,,1,Mus musculus,,,10090.0,,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627853
7642,1,,1,Mus musculus,,,10090.0,,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627854
7643,1,,1,Mus musculus,,,10090.0,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627855
7644,1,,1,Mus musculus,,,10090.0,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627856
7645,1,,1,Mus musculus,,,10090.0,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL875339
7646,1,,1,Mus musculus,,,10090.0,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627857
7647,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627858
7648,1,,1,Rattus norvegicus,,,10116.0,178.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627859
7649,1,,1,Rattus norvegicus,,,10116.0,955.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627860
7650,1,,1,Rattus norvegicus,,,10116.0,948.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627019
7651,1,,1,Rattus norvegicus,,,10116.0,2107.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627020
7652,1,,1,Rattus norvegicus,,,10116.0,2048.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627021
7653,1,,1,Rattus norvegicus,,,10116.0,2385.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627022
7654,1,,1,Rattus norvegicus,,,10116.0,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627023
7655,1,,1,Rattus norvegicus,,,10116.0,2106.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627024
7656,1,,1,Rattus norvegicus,,,10116.0,2046.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627025
7657,1,,1,Rattus norvegicus,,,10116.0,2113.0,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627026
7658,1,,1,Rattus norvegicus,,,10116.0,178.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627027
7659,1,,1,Rattus norvegicus,,,10116.0,955.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627028
7660,1,,1,Rattus norvegicus,,,10116.0,948.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627029
7661,1,,1,Rattus norvegicus,,,10116.0,2113.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627030
7662,1,,1,Rattus norvegicus,,,10116.0,2107.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627031
7663,1,,1,Rattus norvegicus,,,10116.0,2048.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627032
7664,1,,1,Rattus norvegicus,,,10116.0,2385.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627033
7665,1,,1,Rattus norvegicus,,,10116.0,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627034
7666,1,,1,Rattus norvegicus,,,10116.0,2106.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627035
7667,1,,1,Rattus norvegicus,,,10116.0,2046.0,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627036
7668,1,,1,Rattus norvegicus,,,10116.0,178.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875340
7669,1,,1,Rattus norvegicus,,,10116.0,948.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627037
7670,1,,1,Rattus norvegicus,,,10116.0,2113.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627038
7671,1,,1,Rattus norvegicus,,,10116.0,2107.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627039
7672,1,,1,Rattus norvegicus,,,10116.0,2385.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627040
7673,1,,1,Rattus norvegicus,,,10116.0,2106.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624663
7674,1,,1,Rattus norvegicus,,,10116.0,2046.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625963
7675,1,,1,Rattus norvegicus,,,10116.0,955.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876799
7676,1,,1,Rattus norvegicus,,,10116.0,2048.0,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626133
7677,1,,1,Rattus norvegicus,,,10116.0,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626134
7678,1,,1,Rattus norvegicus,,,10116.0,,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626135
7679,1,,1,Rattus norvegicus,,,10116.0,,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626136
7680,1,,1,Rattus norvegicus,,,10116.0,,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626137
7681,1,,1,Rattus norvegicus,,,10116.0,,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626138
7682,1,,1,Rattus norvegicus,,,10116.0,,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626139
7683,1,,1,Rattus norvegicus,In vivo,,10116.0,,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626140
7684,1,,1,Rattus norvegicus,In vivo,,10116.0,,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626141
7685,1,,1,Rattus norvegicus,,,10116.0,,,C24h in rat p.o. at 20 mg/kg concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626142
7686,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627930
7687,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627931
7688,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627932
7689,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627933
7690,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627934
7691,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627935
7692,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627936
7693,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627937
7694,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627938
7695,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627939
7696,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627940
7697,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627941
7698,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876800
7699,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627942
7700,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627943
7701,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627944
7702,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627945
7703,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628584
7704,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628585
7705,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628586
7706,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628587
7707,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628588
7708,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628589
7709,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625304
7710,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625305
7711,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625306
7712,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625307
7713,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625308
7714,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627740
7715,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627741
7716,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627742
7717,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627743
7718,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627744
7719,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627745
7720,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627746
7721,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627747
7722,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876810
7723,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627748
7724,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627749
7725,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627750
7726,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618728
7727,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618729
7728,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618730
7729,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618731
7730,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618732
7731,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618733
7732,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618734
7733,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618735
7734,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876602
7735,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618736
7736,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618737
7737,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618738
7738,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618739
7739,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618740
7740,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618741
7741,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618742
7742,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618743
7743,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Half-life from rat plasma at a single oral dose of 25 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618744
7744,1,,1,Rattus norvegicus,,,10116.0,,,Half-life in male rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618745
7745,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life in rat after peroral administration at 10 mg/kg concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620479
7746,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life in rat after peroral administration at 5 mg/kg concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620480
7747,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life in rat at a dose of 3 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620481
7748,1,,1,Rattus norvegicus,,,10116.0,,,Half-life was evaluated in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620482
7749,1,,1,Rattus norvegicus,,,10116.0,,,Half-life was measured in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876603
7750,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life period for the compound was determined in rats at 50 mg/kg dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620483
7751,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life period in rats after intravenous administration at 5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620484
7752,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life period in rat at 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620485
7753,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620486
7754,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620487
7755,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620488
7756,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life time in rat the dose of 2 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620489
7757,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620490
7758,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620491
7759,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876604
7760,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral half life was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620492
7761,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620493
7762,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (t1/2) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620494
7763,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Plasma elimination half-life was determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620495
7764,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620496
7765,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Plasma half life was observed after intravenous administration in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620497
7766,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Plasma half-life was determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620498
7767,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Plasma half-life following oral administration in Fisher rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620499
7768,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Plasma half-life in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620500
7769,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Plasmatic Half-life after intravenous administration to rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873809
7770,1,,1,Rattus norvegicus,In vivo,,10116.0,,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620501
7771,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Terminal half life after intravenous administration (1 mg/kg) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620502
7772,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Terminal half life in Rat at a oral dose of 5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620503
7773,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620504
7774,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876605
7775,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620505
7776,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,plasma half life was observed after intravenous administration in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873811
7777,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Expert,CHEMBL624016
7778,1,,1,Rattus norvegicus,,,10116.0,,,Half life of compound determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624017
7779,1,,1,Rattus norvegicus,,,10116.0,,,Mean residence time determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624018
7780,1,,1,Rattus norvegicus,,,10116.0,,,Plasma half life determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624019
7781,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624020
7782,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for pharmacokinetic parameter maximum time period,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624201
7783,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL872528
7784,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624202
7785,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624203
7786,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624350
7787,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621320
7788,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621321
7789,1,,1,Rattus norvegicus,,,10116.0,,,Maximum time (Tmax) required to reach Cmax in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621322
7790,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621323
7791,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum time of clearance of compound in rats after peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621324
7792,1,,1,Rattus norvegicus,,,10116.0,,,Maximum time at the dose of 2 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621325
7793,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875837
7794,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621326
7795,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax in Guinea pig (PO dose),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621327
7796,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621328
7797,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter (Tmax) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621329
7798,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter (Tmax) was estimated,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621330
7799,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (Tmax) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621331
7800,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621332
7801,1,,1,Rattus norvegicus,In vivo,,10116.0,,,T max in Rat at a oral dose of 5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621333
7802,1,,1,Rattus norvegicus,In vivo,,10116.0,,,T max was determined at 10 mg/kg po dose in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621334
7803,1,,1,Mus musculus,,,10090.0,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL621335
7804,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL621336
7805,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621337
7806,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve was measured after i.v. administration into Beagle dog.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL621338
7807,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve was measured after iv administration into Beagle dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL875838
7808,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve was measured after po administration into Beagle dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL621339
7809,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve was measured after po administration into Beagle dog.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL621340
7810,1,,0,,,,,,,Area under curve was measured at peroral dose of 3 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621341
7811,1,,0,,,,,,,Area under curve was measured by using concentration Vs time,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL621342
7812,1,,0,,,,,,,Area under curve was measured by using concentration Vs time; not tested,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL621343
7813,1,,1,Mus musculus,,,10090.0,,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL621344
7814,1,,1,Mus musculus,,,10090.0,,,Area under curve(AUC) was measured in mice after oral administration.,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL621345
7815,1,,0,,,,,,,Area under curve(AUC) value of the compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL621346
7816,1,,0,,,,,,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621347
7817,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL621348
7818,1,,0,,,,,178.0,,Area under curve(carotid artery) was determined by the availability in blood,Blood,,,,BAO_0000019,22224,U,Autocuration,CHEMBL621349
7819,1,,0,,,,,178.0,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,Blood,,,,BAO_0000019,22224,U,Autocuration,CHEMBL621350
7820,1,,0,,,,,178.0,,Area under curve(carotid artery) was determined by the availability in blood; No data,Blood,,,,BAO_0000019,22224,U,Autocuration,CHEMBL875839
7821,1,,0,,,,,178.0,,Area under curve(portal vein) was determined by the availability in blood,Blood,,,,BAO_0000019,22224,U,Autocuration,CHEMBL620211
7822,1,,0,,,,,178.0,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,Blood,,,,BAO_0000019,22224,U,Autocuration,CHEMBL620212
7823,1,,0,,,,,178.0,,Area under curve(portal vein) was determined by the availability in blood; No data,Blood,,,,BAO_0000019,22224,U,Autocuration,CHEMBL620213
7824,1,,1,Macaca mulatta,,,9544.0,1969.0,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Plasma,,,,BAO_0000218,50797,N,Intermediate,CHEMBL620214
7825,1,,1,Macaca mulatta,,,9544.0,1969.0,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Plasma,,,,BAO_0000218,50797,N,Intermediate,CHEMBL620215
7826,1,,1,Macaca mulatta,,,9544.0,1969.0,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,Plasma,,,,BAO_0000218,50797,N,Intermediate,CHEMBL620216
7827,1,,1,Canis lupus familiaris,,,9615.0,1969.0,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL620888
7828,1,,1,Canis lupus familiaris,,,9615.0,1969.0,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL620889
7829,1,,0,,,,,1969.0,,Area under plasma concentration vs time curve observed in rats for 0-3 h,Plasma,,,,BAO_0000019,22224,U,Autocuration,CHEMBL620890
7830,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Area under plasma time curve determined in male rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620891
7831,1,,0,,,,,,,Area under the MAP curve measured over 5 min.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL620892
7832,1,,1,Mus musculus,,,10090.0,,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL621079
7833,1,,1,Mus musculus,,,10090.0,,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL621080
7834,1,,1,Canis lupus familiaris,,,9615.0,,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL621081
7835,1,,1,Cricetinae,,,10026.0,,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,,,,BAO_0000218,100712,N,Intermediate,CHEMBL621082
7836,1,,1,Rattus norvegicus,,,10116.0,,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621083
7837,1,,1,Canis lupus familiaris,,,9615.0,,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL621084
7838,1,,1,Canis lupus familiaris,,,9615.0,,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL621085
7839,1,,1,Canis lupus familiaris,,,9615.0,,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL621086
7840,1,,1,Canis lupus familiaris,,,9615.0,,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL621087
7841,1,,1,Canis lupus familiaris,,,9615.0,,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622607
7842,1,,1,Canis lupus familiaris,,,9615.0,,,Serum AUC in marmosets (IV dose),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622608
7843,1,,0,,,,,,,Area under the curve after intravenous administration at a dose of 10 umol/kg,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624481
7844,1,,0,,,,,,,Area under the curve after intravenous administration at a dose of 2 umol/kg,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624482
7845,1,,0,,,,,,,Area under the curve after intravenous administration at a dose of 4 umol/kg,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624483
7846,1,,0,,,,,,,Area under the curve after intravenous administration at a dose of 40 umol/kg,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624484
7847,1,,0,,,,,,,Area under the curve after intravenous administration at a dose of 5 umol/kg,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624485
7848,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve for fumarate salt was evaluated in F344 Rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624486
7849,1,,0,,,,,,,Area under the curve for the compound was calculated.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624487
7850,1,,0,,,,,,,Area under the curve in concentration/ time,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624488
7851,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve administered intraintestinal in rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624489
7852,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve administered intravenously in rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625184
7853,1,,0,,,,,,,Area under the curve during intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625185
7854,1,,0,,,,,,,Area under the curve during intravenous administration; Not determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL875954
7855,1,,0,,,,,,,Area under the curve during systemic administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625186
7856,1,,0,,,,,,,Area under the curve during systemic administration; Not determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625187
7857,1,,0,,,,,,,Area under the curve was calculated for the compound.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625188
7858,1,,1,Canis lupus familiaris,,,9615.0,,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625189
7859,1,,1,Canis lupus familiaris,,,9615.0,,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625190
7860,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621733
7861,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621734
7862,1,,1,Rattus norvegicus,,,10116.0,,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621735
7863,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Clearance of the drug was measured in the plasma of rat; No data,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621736
7864,1,,1,Rattus norvegicus,,,10116.0,1969.0,,The pharmacokinetic parameter plasma clearance in vivo in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621737
7865,1,,1,Rattus norvegicus,,,10116.0,,,Plasma clearance at the dose of 2 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621738
7866,1,,1,Rattus norvegicus,In vivo,,10116.0,,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622806
7867,1,,1,Rattus norvegicus,In vivo,,10116.0,,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623519
7868,1,,1,Rattus norvegicus,In vivo,,10116.0,,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623520
7869,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623521
7870,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623522
7871,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance rate in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623523
7872,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance rate in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623690
7873,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623691
7874,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623692
7875,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623693
7876,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623694
7877,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance of compound after iv administration of 20 mg/kg dose in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623695
7878,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623696
7879,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623697
7880,1,,0,Macaca mulatta,In vivo,,9544.0,1969.0,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Plasma,,,,BAO_0000218,22224,U,Intermediate,CHEMBL623698
7881,1,,0,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,Plasma,,,,BAO_0000218,22224,U,Intermediate,CHEMBL623699
7882,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Mean (%CV) PK parameters for CL(mL/min/kg).,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623700
7883,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623701
7884,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623702
7885,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623703
7886,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623704
7887,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat after administration of 2 mg/kg iv,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623705
7888,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat after administration of 2 mg/kg iv,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623706
7889,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623707
7890,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623708
7891,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623709
7892,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat by iv administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623710
7893,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623711
7894,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat p.o.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623712
7895,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623713
7896,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was determined; ND denotes no data,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623714
7897,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was determined; ND denotes not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623715
7898,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623716
7899,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622980
7900,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma administration to rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622981
7901,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance of the compound in female Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622982
7902,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was observed after intravenous administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622983
7903,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622984
7904,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622985
7905,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,plasma clearance was observed after intravenous administration in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623631
7906,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo CL/F determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623632
7907,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623633
7908,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623634
7909,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was tested for the lower blood clearance in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623635
7910,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Evaluated for the low clearance in rat (in vivo),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621195
7911,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (CLb)of the compound was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621196
7912,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Rapid clearance after intravenous administration in rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875287
7913,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance measured in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621197
7914,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was evaluated for plasma clearance in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621198
7915,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Low plasma clearance was calculated in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621199
7916,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (Clp) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621200
7917,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621201
7918,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621202
7919,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621203
7920,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance after IV dosing at 1 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621204
7921,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621205
7922,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621206
7923,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621207
7924,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621208
7925,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621209
7926,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876484
7927,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621210
7928,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621211
7929,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621212
7930,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621213
7931,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621214
7932,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621215
7933,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621216
7934,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621217
7935,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621218
7936,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621219
7937,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621220
7938,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621221
7939,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621222
7940,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621223
7941,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876485
7942,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621224
7943,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621225
7944,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621226
7945,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621227
7946,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621228
7947,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621229
7948,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621230
7949,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621231
7950,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621232
7951,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621233
7952,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621234
7953,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621235
7954,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621236
7955,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621237
7956,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876486
7957,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622436
7958,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622437
7959,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622438
7960,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622439
7961,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622440
7962,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622441
7963,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622442
7964,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622443
7965,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622444
7966,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622445
7967,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622446
7968,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622447
7969,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622448
7970,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622449
7971,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622450
7972,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622451
7973,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622452
7974,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622453
7975,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622454
7976,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622455
7977,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876024
7978,1,,1,Rattus norvegicus,In vivo,,10116.0,,,T max was determined at 3 mg/kg po dose in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622456
7979,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622457
7980,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622458
7981,1,,1,Rattus norvegicus,,,10116.0,,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622459
7982,1,,1,Rattus norvegicus,,,10116.0,,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873343
7983,1,,1,Rattus norvegicus,,,10116.0,,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622460
7984,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Time for maximum plasma concentration determined in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622461
7985,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622462
7986,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622463
7987,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622464
7988,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622465
7989,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622466
7990,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622467
7991,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Time of maximum plasma concentration in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622468
7992,1,,1,Rattus norvegicus,,,10116.0,1969.0,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876025
7993,1,,1,Rattus norvegicus,,,10116.0,1969.0,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622469
7994,1,,1,Rattus norvegicus,,,10116.0,1969.0,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622470
7995,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time required to reach maximum concentration (Cmax) after oral administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622471
7996,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Time required to reach maximum concentration in rat plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622472
7997,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622473
7998,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624282
7999,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624283
8000,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624284
8001,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624285
8002,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time to reach Cmax after oral administration to rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624286
8003,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624287
8004,1,,1,Rattus norvegicus,,,10116.0,,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624288
8005,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624289
8006,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873344
8007,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax after peroral administration (10 mg/kg) was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619623
8008,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Expert,CHEMBL621399
8009,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621400
8010,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621401
8011,1,,1,Rattus norvegicus,,,10116.0,,,Tmax was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621402
8012,1,,1,Rattus norvegicus,,,10116.0,,,Tmax was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621403
8013,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax after oral administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621121
8014,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax after peroral administration in rats at 2.4 uM/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL872525
8015,1,,1,Rattus norvegicus,,,10116.0,,,Tmax in male rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621122
8016,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax in rat at 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621123
8017,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax in rat by po administration at a dose of 40 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621124
8018,1,,1,Rattus norvegicus,,,10116.0,,,Tmax in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621125
8019,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax was measured in rats after peroral administration at 5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621126
8020,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621127
8021,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax value after administration of 20 mg/Kg oral dose in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621128
8022,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax value at a dose of 10 mg/kg in male SD rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618263
8023,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax value at a dose of 100 mg/kg in male SD rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618264
8024,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax value at a dose of 50 mg/kg in male SD rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618265
8025,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618266
8026,1,,1,Rattus norvegicus,In vivo,,10116.0,,,time required to reach maximum concentration (Cmax) after oral administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618267
8027,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618450
8028,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618451
8029,1,,1,Rattus norvegicus,,,10116.0,,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618452
8030,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618453
8031,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618454
8032,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618455
8033,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618456
8034,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound distribution in rat tissues was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618457
8035,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution was evaluated in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618458
8036,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618459
8037,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876733
8038,1,,1,Canis lupus familiaris,,,9615.0,,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL618460
8039,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618461
8040,1,,0,,,,,,,Area under the curve was determined after oral administration (300 uM/Kg),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL618462
8041,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618463
8042,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618464
8043,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618465
8044,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618466
8045,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618467
8046,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618468
8047,1,,1,Canis lupus familiaris,,,9615.0,1969.0,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL618469
8048,1,,1,Canis lupus familiaris,,,9615.0,1969.0,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL618470
8049,1,,0,,,,,,,Plasma drug AUC in rat (PO dose),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL618471
8050,1,,1,Mus musculus,,,10090.0,,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618472
8051,1,,0,,,,,,,Area under was determined at a dose of 30 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL618473
8052,1,,1,Mustela putorius furo,,,9669.0,,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,,,,BAO_0000218,50506,N,Intermediate,CHEMBL621699
8053,1,,1,Rattus norvegicus,,,10116.0,,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621700
8054,1,,1,Rattus norvegicus,,,10116.0,,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621701
8055,1,,1,Mustela putorius furo,,,9669.0,,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,,,,BAO_0000218,50506,N,Intermediate,CHEMBL621702
8056,1,,1,Canis lupus familiaris,,,9615.0,,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL621703
8057,1,,1,Canis lupus familiaris,,,9615.0,,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL621704
8058,1,,1,Rattus norvegicus,,,10116.0,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624259
8059,1,,1,Rattus norvegicus,,,10116.0,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624260
8060,1,,1,Rattus norvegicus,,,10116.0,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624430
8061,1,,1,Rattus norvegicus,,,10116.0,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624431
8062,1,,1,Rattus norvegicus,,,10116.0,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624432
8063,1,,1,Rattus norvegicus,,,10116.0,,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624433
8064,1,,1,Rattus norvegicus,,,10116.0,,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624434
8065,1,,1,Rattus norvegicus,,,10116.0,,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624435
8066,1,,1,Mus musculus,,,10090.0,,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618570
8067,1,,1,Mus musculus,,,10090.0,,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618571
8068,1,,1,Mus musculus,,,10090.0,,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618572
8069,1,,1,Mus musculus,,,10090.0,,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618573
8070,1,,1,Mus musculus,,,10090.0,,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL619267
8071,1,,1,Mus musculus,,,10090.0,,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL619431
8072,1,,1,Mus musculus,,,10090.0,,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL619432
8073,1,,1,Mus musculus,,,10090.0,,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL619433
8074,1,,0,,,,,1969.0,,AUC in mice after oral dose (50 mg/kg),Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL619434
8075,1,,1,Mus musculus,,,10090.0,1977.0,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,Serum,,,,BAO_0000218,50594,N,Intermediate,CHEMBL619435
8076,1,,0,,,,,1969.0,,AUC (0-4 hr) ug/ml/h,Plasma,,,,BAO_0000019,22224,U,Autocuration,CHEMBL619436
8077,1,,1,Rattus norvegicus,,,10116.0,,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619437
8078,1,,0,,,,,,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL619438
8079,1,,1,Mus musculus,,,10090.0,,,Compound was evaluated for Area under curve in mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL619439
8080,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619440
8081,1,,0,,,,,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL619441
8082,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619442
8083,1,,0,,,,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL875156
8084,1,,0,,,,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL619443
8085,1,,0,,,,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL619444
8086,1,,0,,,,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623464
8087,1,,1,Mus musculus,,,10090.0,,,Compound was evaluated for area under curve when administered through oral route in mouse,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623465
8088,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623466
8089,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623467
8090,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623468
8091,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622660
8092,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance rate in Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622661
8093,1,,1,Rattus norvegicus,In vivo,,10116.0,,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622662
8094,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (total body clearance) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622663
8095,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622664
8096,1,,1,Rattus norvegicus,,,10116.0,,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622665
8097,1,,1,Rattus norvegicus,,,10116.0,,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622666
8098,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cl in rat i.v. at 2 mg/kg concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621615
8099,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance of compound after intravenous administration in rats at 24 uM/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621616
8100,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621617
8101,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance by intravenous administration of 3.4 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621618
8102,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621619
8103,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance rate after i.v. administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621620
8104,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621786
8105,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621787
8106,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621788
8107,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance (Cl) after oral administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621789
8108,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621790
8109,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was tested for plasma clearance in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621791
8110,1,,1,Rattus norvegicus,In vitro,,10116.0,,,In vitro microsome metabolism clearance in rat was determined,,,,Microsomes,BAO_0000218,50597,N,Intermediate,CHEMBL621792
8111,1,,1,Rattus norvegicus,In vitro,,10116.0,,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,,,,Microsomes,BAO_0000218,50597,N,Intermediate,CHEMBL621793
8112,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621794
8113,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,In vivo plasma clearance was determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621795
8114,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621796
8115,1,Hepatocyte,1,Rattus norvegicus,In vivo,,10116.0,2107.0,401.0,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621797
8116,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (Plasma clearance) was measured in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621798
8117,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (clearance) in rat i.v.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621799
8118,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Plasma Clearance was evaluated in rats, iv",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621800
8119,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance (in vivo) in rats was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621801
8120,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621802
8121,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618596
8122,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618597
8123,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618598
8124,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618599
8125,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance rate determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618600
8126,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618601
8127,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618602
8128,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance value in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618603
8129,1,,1,Rattus norvegicus,Ex vivo,,10116.0,2107.0,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618604
8130,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618605
8131,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Total body clearance in rat i.v. at 2 mg/kg concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618606
8132,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance of compound in rats after intravenous administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618607
8133,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance after iv administration to rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618608
8134,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618609
8135,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618610
8136,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618611
8137,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618612
8138,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618613
8139,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621076
8140,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621077
8141,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621078
8142,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621251
8143,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance in rat after oral administration at 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621252
8144,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance in rat.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621253
8145,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance rate following an oral dose of 20 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621254
8146,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621255
8147,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621256
8148,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621257
8149,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621258
8150,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621259
8151,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621260
8152,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876494
8153,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621261
8154,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621262
8155,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621263
8156,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621264
8157,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621265
8158,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621266
8159,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621267
8160,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621268
8161,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621269
8162,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621270
8163,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621271
8164,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621272
8165,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621273
8166,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621274
8167,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876495
8168,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621275
8169,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621276
8170,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621277
8171,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621278
8172,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621279
8173,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621280
8174,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621281
8175,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621282
8176,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621283
8177,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621284
8178,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621285
8179,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621286
8180,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623220
8181,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623221
8182,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876029
8183,1,,1,Rattus norvegicus,In vivo,,10116.0,945.0,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623222
8184,1,,1,Rattus norvegicus,In vivo,,10116.0,945.0,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623223
8185,1,,1,Rattus norvegicus,In vivo,,10116.0,945.0,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621445
8186,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621446
8187,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621447
8188,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619681
8189,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619682
8190,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619683
8191,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619684
8192,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619685
8193,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619686
8194,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619687
8195,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619688
8196,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619689
8197,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619690
8198,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619691
8199,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619692
8200,1,,1,Rattus norvegicus,,,10116.0,,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Expert,CHEMBL619693
8201,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Vc value after IV dose at a dose of 5 mg/kg in rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619694
8202,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619695
8203,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for pharmacokinetic parameter volume of distribution,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619696
8204,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for volume of distribution in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619697
8205,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Steady state volume distribution was determined; steady state(ss),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619698
8206,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Steady state volume of distribution after iv administration to rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619699
8207,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Steady state volume of distribution dosing at 3 mg/kg iv,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619700
8208,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The compound was evaluated for volume of distribution in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619701
8209,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The compound was tested for volume of distribution in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619702
8210,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620335
8211,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution (VD) after oral administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620336
8212,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620337
8213,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620520
8214,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620521
8215,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution in rat after peroral administration at 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875825
8216,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution in rat after peroral administration at 5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620522
8217,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620523
8218,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution in rat.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620524
8219,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620525
8220,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620526
8221,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution in rat by iv administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620527
8222,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620528
8223,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620529
8224,1,,1,Rattus norvegicus,,,10116.0,,,Volume distribution at the dose of 2 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620530
8225,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Steady state volume of distribution was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620531
8226,1,,0,Macaca mulatta,In vivo,,9544.0,,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,,,,BAO_0000218,22224,U,Intermediate,CHEMBL620532
8227,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,,,,BAO_0000218,22224,U,Intermediate,CHEMBL620533
8228,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,,,,BAO_0000218,22224,U,Intermediate,CHEMBL620534
8229,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Mean (%CV) PK parameters for Vdss(mL/kg).,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620535
8230,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875826
8231,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620536
8232,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620537
8233,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618526
8234,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618527
8235,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (Vdss) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618528
8236,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (vdss) was measured in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618529
8237,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618530
8238,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618531
8239,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The pharmacokinetic parameter volume of distribution in vivo in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618532
8240,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618533
8241,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Vdss in rat i.v. at 2 mg/kg concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618534
8242,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution after intravenous administration (1 mg/kg) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618535
8243,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618536
8244,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618537
8245,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution at a dose of 10 uM/kg in rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618538
8246,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618539
8247,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution was calculated in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618540
8248,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618541
8249,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution after intravenous administration was evaluated in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618542
8250,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622544
8251,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622545
8252,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622546
8253,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622547
8254,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution in steady state was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622548
8255,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622549
8256,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622550
8257,1,,1,Mus musculus,,,10090.0,,,Compound was evaluated for area under curve when administered through oral route to mouse,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622551
8258,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622552
8259,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622553
8260,1,,0,,In vivo,,,,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622554
8261,1,,1,Canis lupus familiaris,,,9615.0,,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622555
8262,1,,1,Mus musculus,,,10090.0,,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622556
8263,1,,1,Mus musculus,,,10090.0,,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622557
8264,1,,1,Mus musculus,,,10090.0,178.0,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622558
8265,1,,1,Mus musculus,,,10090.0,178.0,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622559
8266,1,,1,Canis lupus familiaris,,,9615.0,,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622560
8267,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622561
8268,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622562
8269,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622563
8270,1,,0,,,,,,,Concentration of compound in Central nervous system,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622564
8271,1,,0,,,,,,,Concentration of compound in Central nervous system; Not detectable,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622565
8272,1,,1,Mus musculus,,,10090.0,,,"Concentration of diester in the blood, following oral administration in mice",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622566
8273,1,,1,Mus musculus,,,10090.0,,,"Concentration of monoester in the blood, following oral administration in mice",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624515
8274,1,,1,Mus musculus,,,10090.0,,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624516
8275,1,,0,,,,,,,Evaluated for Pharmacokinetic property: Area under the curve,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624517
8276,1,,1,Mus musculus,,,10090.0,,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624518
8277,1,,1,Macaca fascicularis,,,9541.0,,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL624519
8278,1,,1,Macaca fascicularis,,,9541.0,,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL624520
8279,1,,1,Macaca fascicularis,,,9541.0,,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL624521
8280,1,,1,Macaca fascicularis,,,9541.0,,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL624522
8281,1,,1,Macaca fascicularis,,,9541.0,,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL624523
8282,1,,1,Macaca fascicularis,,,9541.0,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,,,BAO_0000218,100710,N,Intermediate,CHEMBL624409
8283,1,,1,Macaca fascicularis,,,9541.0,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,,,,BAO_0000218,100710,N,Intermediate,CHEMBL624410
8284,1,,1,Macaca fascicularis,,,9541.0,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,,,BAO_0000218,100710,N,Intermediate,CHEMBL624411
8285,1,,1,Macaca fascicularis,,,9541.0,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,,,,BAO_0000218,100710,N,Intermediate,CHEMBL623531
8286,1,,1,Macaca fascicularis,,,9541.0,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,,,,BAO_0000218,100710,N,Intermediate,CHEMBL623532
8287,1,,1,Macaca fascicularis,,,9541.0,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,,,,BAO_0000218,100710,N,Intermediate,CHEMBL623533
8288,1,,1,Macaca fascicularis,,,9541.0,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,,,BAO_0000218,100710,N,Intermediate,CHEMBL623534
8289,1,,1,Mus musculus,,,10090.0,,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623535
8290,1,,1,Mus musculus,,,10090.0,,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623536
8291,1,,1,Mus musculus,,,10090.0,,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623537
8292,1,,1,Mus musculus,,,10090.0,,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623538
8293,1,,1,Mus musculus,,,10090.0,,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623539
8294,1,,1,Mus musculus,,,10090.0,,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623540
8295,1,,1,Mus musculus,,,10090.0,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623541
8296,1,,1,Mus musculus,,,10090.0,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623542
8297,1,,1,Mus musculus,,,10090.0,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623543
8298,1,,1,Mus musculus,,,10090.0,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623544
8299,1,,1,Mus musculus,,,10090.0,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623545
8300,1,,1,Mus musculus,,,10090.0,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623546
8301,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623547
8302,1,,1,Rattus norvegicus,In vivo,,10116.0,,,High i.v. clearance in Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623548
8303,1,,1,Rattus norvegicus,In vitro,,10116.0,2107.0,,In vitro clearance in rat liver microsomes,Liver,,,Microsomes,BAO_0000218,50597,N,Intermediate,CHEMBL623549
8304,1,,1,Rattus norvegicus,In vitro,,10116.0,2107.0,,Intrinsic clearance in rat liver microsomes was determined,Liver,,,Microsomes,BAO_0000218,50597,N,Intermediate,CHEMBL623550
8305,1,Hepatocyte,1,Rattus norvegicus,In vitro,,10116.0,2107.0,401.0,Intrinsic clearance in rat hepatocytes was determined,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875276
8306,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma Clearance was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621872
8307,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621873
8308,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621874
8309,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621875
8310,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621876
8311,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621877
8312,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was measured in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621878
8313,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621879
8314,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621880
8315,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621881
8316,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621882
8317,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Total clearance at 1 mg/kg was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875283
8318,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Total clearance at 10 mg/kg was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621883
8319,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621884
8320,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance rate determined in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621885
8321,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance of compound in rat was evaluated,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621886
8322,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621887
8323,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (blood clearance) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621888
8324,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621889
8325,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621890
8326,1,,1,Rattus norvegicus,In vitro,,10116.0,2107.0,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Liver,,,Microsomes,BAO_0000218,50597,N,Intermediate,CHEMBL621891
8327,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance in Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621892
8328,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621893
8329,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621894
8330,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance rat; Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621895
8331,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875284
8332,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618699
8333,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618700
8334,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618701
8335,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876600
8336,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance of compound in rat after 1 mg/kg i.v. administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618702
8337,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for Hepatic clearance in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618703
8338,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo clearance after 5 mg/kg dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618704
8339,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was tested for plasma clearance in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618705
8340,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Hepatic clearance after intravenous administration was evaluated in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618706
8341,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Lower clearance in rat (i.v.) at 0.5 mpk,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618707
8342,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Pharmacokinetic parameter expressed as plasma clearance in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618708
8343,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (Clp) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618709
8344,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618710
8345,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance (Clp) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618711
8346,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618712
8347,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618713
8348,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance after intravenous administration of 1 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618714
8349,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618715
8350,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618716
8351,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance measured in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876601
8352,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was calculated in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618717
8353,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618718
8354,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618719
8355,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618720
8356,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618721
8357,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621477
8358,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621478
8359,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was evaluated in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621479
8360,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was evaluated in rat; Not tested,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621480
8361,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance rate was determined for the compound in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621481
8362,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621482
8363,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621483
8364,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621484
8365,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621485
8366,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621486
8367,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621487
8368,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621488
8369,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621489
8370,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621490
8371,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621491
8372,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621492
8373,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621493
8374,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621494
8375,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621495
8376,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621496
8377,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621497
8378,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621498
8379,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621499
8380,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618634
8381,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618635
8382,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618636
8383,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619737
8384,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619738
8385,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624329
8386,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624330
8387,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624331
8388,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624332
8389,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624333
8390,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624334
8391,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624335
8392,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620016
8393,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620169
8394,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620170
8395,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620171
8396,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620172
8397,1,,1,Rattus norvegicus,In vivo,,10116.0,945.0,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620173
8398,1,,1,Rattus norvegicus,In vivo,,10116.0,945.0,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620174
8399,1,,1,Rattus norvegicus,In vivo,,10116.0,945.0,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620175
8400,1,,1,Rattus norvegicus,In vivo,,10116.0,945.0,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620176
8401,1,,1,Rattus norvegicus,In vivo,,10116.0,945.0,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620177
8402,1,,1,Rattus norvegicus,,,10116.0,2037.0,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620178
8403,1,,1,Rattus norvegicus,,,10116.0,2037.0,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620179
8404,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620180
8405,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620181
8406,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution of compound in rats after intravenous administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620182
8407,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620183
8408,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620184
8409,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620185
8410,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620186
8411,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution was determined in Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620187
8412,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620188
8413,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution was reported in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620189
8414,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volumes of distribution in rat after peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620190
8415,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volumes of distribution in rat after po administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620191
8416,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volumes of distribution in rat after po administration; Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620192
8417,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (Volume) in rat i.v.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620193
8418,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620194
8419,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876730
8420,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution in rat after oral administration at 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620195
8421,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620196
8422,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620197
8423,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620198
8424,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620199
8425,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620200
8426,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620201
8427,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620202
8428,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620203
8429,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620204
8430,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620205
8431,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter (Vss) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624664
8432,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (Volume) in rat i.v.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624665
8433,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic property (Vss) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624666
8434,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624667
8435,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624668
8436,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624669
8437,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624670
8438,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624671
8439,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Steady state volume distribution in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624672
8440,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624673
8441,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Steady state volume of distribution determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624674
8442,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624675
8443,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621728
8444,1,,1,Rattus norvegicus,,,10116.0,,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621729
8445,1,,1,Rattus norvegicus,,,10116.0,,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621730
8446,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution in rat after administration of 2 mg/kg iv,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621731
8447,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution in rat after administration of 2 mg/kg iv,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621732
8448,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume in steady state distribution value was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621908
8449,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume in steady state distribution value was determined; ND denotes no data,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875347
8450,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume in steady state distribution value was determined; ND denotes not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621909
8451,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621910
8452,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution at steady state was evaluated in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621911
8453,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution at steady state was observed after intravenous administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621912
8454,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution in steady state was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621913
8455,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution in steady state was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621914
8456,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution after i.v. administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621915
8457,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621916
8458,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL621917
8459,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL621918
8460,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,Biodistribution of compound (oxidized form) in spleen tissue,Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL621919
8461,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL621920
8462,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL621921
8463,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622401
8464,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL875348
8465,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622402
8466,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622403
8467,1,,1,Mus musculus,In vivo,,10090.0,178.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622404
8468,1,,1,Mus musculus,In vivo,,10090.0,955.0,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622405
8469,1,,1,Mus musculus,In vivo,,10090.0,955.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622406
8470,1,,1,Mus musculus,In vivo,,10090.0,955.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622407
8471,1,,1,Mus musculus,In vivo,,10090.0,948.0,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,Heart,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622408
8472,1,,1,Mus musculus,In vivo,,10090.0,948.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Heart,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622409
8473,1,,1,Mus musculus,In vivo,,10090.0,948.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Heart,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622410
8474,1,,1,Mus musculus,In vivo,,10090.0,2113.0,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622411
8475,1,,1,Mus musculus,In vivo,,10090.0,2113.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627864
8476,1,,1,Mus musculus,In vivo,,10090.0,2113.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627865
8477,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627866
8478,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627751
8479,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627752
8480,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627753
8481,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627754
8482,1,,1,Mus musculus,,,10090.0,,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627755
8483,1,,1,Mus musculus,In vivo,,10090.0,955.0,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627756
8484,1,,1,Mus musculus,In vivo,,10090.0,955.0,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627757
8485,1,,1,Mus musculus,In vivo,,10090.0,955.0,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627758
8486,1,,1,Mus musculus,In vivo,,10090.0,955.0,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627759
8487,1,,1,Mus musculus,In vivo,,10090.0,955.0,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627760
8488,1,,1,Mus musculus,In vivo,,10090.0,955.0,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627761
8489,1,,1,Mus musculus,In vivo,,10090.0,948.0,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),Heart,,,,BAO_0000218,50594,N,Intermediate,CHEMBL876811
8490,1,,1,Mus musculus,In vivo,,10090.0,948.0,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),Heart,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627762
8491,1,,1,Mus musculus,In vivo,,10090.0,948.0,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),Heart,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627763
8492,1,,1,Mus musculus,In vivo,,10090.0,948.0,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),Heart,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627764
8493,1,,1,Mus musculus,In vivo,,10090.0,948.0,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),Heart,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627765
8494,1,,1,Mus musculus,In vivo,,10090.0,948.0,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),Heart,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627766
8495,1,,1,Mus musculus,In vivo,,10090.0,2113.0,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627767
8496,1,,1,Mus musculus,In vivo,,10090.0,2113.0,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627768
8497,1,,1,Mus musculus,In vivo,,10090.0,2113.0,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628422
8498,1,,1,Mus musculus,In vivo,,10090.0,2113.0,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628423
8499,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628424
8500,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628425
8501,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628426
8502,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628427
8503,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626938
8504,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626939
8505,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626940
8506,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626941
8507,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was reported in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626942
8508,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance after intravenous administration (1 mg/kg) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876812
8509,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance of compound in rats was evaluated,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626943
8510,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626944
8511,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626945
8512,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626946
8513,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance rate in Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626856
8514,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626857
8515,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,The compound was evaluated for plasma clearance in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626858
8516,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Total plasma clearance in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627018
8517,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625331
8518,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625332
8519,1,,1,Rattus norvegicus,In vivo,,10116.0,,,C max was determined at 10 mg/kg po dose in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877590
8520,1,,1,Rattus norvegicus,In vivo,,10116.0,,,C max was determined at 3 mg/kg po dose in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625333
8521,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625334
8522,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax after single intravenous bolus of 1 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625335
8523,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax of compound at 5 mg/kg after po administration was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625336
8524,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax 24 hr after 10 mg/kg oral administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625337
8525,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax 24 hr after 2 mg/kg oral administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625338
8526,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625339
8527,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rat after administration of 2 mg/kg iv,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625340
8528,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rat after administration of 2 mg/kg iv,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625341
8529,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622687
8530,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622688
8531,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622689
8532,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620295
8533,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax after 10 mg/kg oral administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620296
8534,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620297
8535,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax after IV dosing at 1 mg/kg in rat; no data,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620298
8536,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax after oral administration at 20 mpk in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620299
8537,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax after oral administration at 20 mpk in rats; Not performed.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620300
8538,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax after oral administration at 20 mpk in rats d; Not performed.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620301
8539,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax after oral administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620302
8540,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax after oral administration at a dose of 2 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620303
8541,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax after oral administration at a dose of 4 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620304
8542,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rats after 20 mg/kg oral dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620305
8543,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax after peroral administration in rats at 2.4 uM/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620306
8544,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax at the dose of 2 mg/Kg administered perorally in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620307
8545,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax at the dose of 5 mg/Kg administered perorally in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620308
8546,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax by administering at 20 mg/kg p.o. in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620309
8547,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in male rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620310
8548,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620311
8549,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620312
8550,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620313
8551,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rat at 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620314
8552,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rat at the dose of 1 mg/kg i.v.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620315
8553,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rat by po administration at a dose of 40 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620316
8554,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rat p.o. at 20 mg/kg concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620317
8555,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620318
8556,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620319
8557,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax was evaluated after 20 uM/kg of peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620320
8558,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax was measured in rats after peroral administration at 3 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620321
8559,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620322
8560,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620323
8561,1,,1,Rattus norvegicus,,,10116.0,1870.0,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Frontal cortex,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620324
8562,1,,1,Rattus norvegicus,,,10116.0,1870.0,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Frontal cortex,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620325
8563,1,,1,Rattus norvegicus,,,10116.0,10000000.0,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620326
8564,1,,1,Rattus norvegicus,,,10116.0,10000000.0,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620327
8565,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620328
8566,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620329
8567,1,,1,Rattus norvegicus,,,10116.0,1891.0,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,Midbrain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620330
8568,1,,1,Rattus norvegicus,,,10116.0,1891.0,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,Midbrain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875286
8569,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620331
8570,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620332
8571,1,,1,Rattus norvegicus,,,10116.0,2435.0,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620333
8572,1,,1,Rattus norvegicus,,,10116.0,2435.0,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620334
8573,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621015
8574,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621016
8575,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621191
8576,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621192
8577,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621193
8578,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621194
8579,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624204
8580,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624205
8581,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624206
8582,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624207
8583,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624208
8584,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624209
8585,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624210
8586,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624211
8587,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624212
8588,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624213
8589,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876611
8590,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624214
8591,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624215
8592,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624216
8593,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624217
8594,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624218
8595,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624219
8596,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624220
8597,1,,1,Rattus norvegicus,,,10116.0,178.0,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624221
8598,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624222
8599,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624223
8600,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624224
8601,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624225
8602,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622420
8603,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of steady state distribution after i.v. administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622421
8604,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622422
8605,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622423
8606,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Vss was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622424
8607,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Vss in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622425
8608,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Vss was evaluated after 10 uM/kg of intra arterial administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876612
8609,1,,1,Rattus norvegicus,In vivo,,10116.0,,,volume of distribution at steady state was observed after intravenous administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622426
8610,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622427
8611,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic (PK) parameter Vz in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622428
8612,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume distribution in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622429
8613,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution in rat; No data,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622430
8614,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622431
8615,1,,1,Rattus norvegicus,,,10116.0,2116.0,,% absorption predicted from in vitro rat ileum transport studies,Ileum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622432
8616,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622433
8617,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622434
8618,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622435
8619,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618748
8620,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618749
8621,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618750
8622,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618751
8623,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618752
8624,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618753
8625,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618754
8626,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618755
8627,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618756
8628,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618757
8629,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618758
8630,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 30 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621088
8631,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic property (cLogP) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621089
8632,1,,1,Rattus norvegicus,,,10116.0,178.0,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621090
8633,1,,1,Rattus norvegicus,,,10116.0,178.0,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621091
8634,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance in rat.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876731
8635,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for its clearance when administered intravenously in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621092
8636,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621093
8637,1,,1,Rattus norvegicus,,,10116.0,,,Blood: Brain distribution ratio is determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621094
8638,1,,1,Rattus norvegicus,,,10116.0,,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621095
8639,1,,1,Rattus norvegicus,,,10116.0,,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621096
8640,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621097
8641,1,,1,Rattus norvegicus,,,10116.0,,,Percent dose excreted in 0-48 hours administered ip to male rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621098
8642,1,,1,Rattus norvegicus,,,10116.0,2037.0,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621099
8643,1,,1,Rattus norvegicus,,,10116.0,2037.0,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621100
8644,1,,1,Rattus norvegicus,,,10116.0,2037.0,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621101
8645,1,,1,Rattus norvegicus,,,10116.0,2037.0,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621102
8646,1,,1,Rattus norvegicus,,,10116.0,2037.0,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876732
8647,1,,1,Rattus norvegicus,,,10116.0,,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621103
8648,1,,1,Rattus norvegicus,,,10116.0,,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621104
8649,1,,1,Rattus norvegicus,,,10116.0,,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621105
8650,1,,1,Rattus norvegicus,,,10116.0,,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621106
8651,1,,1,Rattus norvegicus,,,10116.0,,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621107
8652,1,,1,Rattus norvegicus,,,10116.0,,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621108
8653,1,,1,Rattus norvegicus,,,10116.0,,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621109
8654,1,,1,Mus musculus,In vivo,,10090.0,2113.0,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL621110
8655,1,,1,Mus musculus,In vivo,,10090.0,2113.0,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL621111
8656,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622541
8657,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622542
8658,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622543
8659,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624412
8660,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624413
8661,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624414
8662,1,,1,Mus musculus,In vivo,,10090.0,2048.0,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),Lung,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624415
8663,1,,1,Mus musculus,In vivo,,10090.0,2048.0,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),Lung,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624416
8664,1,,1,Mus musculus,In vivo,,10090.0,2048.0,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),Lung,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624417
8665,1,,1,Mus musculus,In vivo,,10090.0,2048.0,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),Lung,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624418
8666,1,,1,Mus musculus,In vivo,,10090.0,2048.0,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),Lung,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624419
8667,1,,1,Mus musculus,In vivo,,10090.0,2048.0,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),Lung,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624420
8668,1,,1,Mus musculus,In vivo,,10090.0,2385.0,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),Muscle tissue,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624421
8669,1,,1,Mus musculus,In vivo,,10090.0,2385.0,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),Muscle tissue,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624422
8670,1,,1,Mus musculus,In vivo,,10090.0,2385.0,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),Muscle tissue,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624423
8671,1,,1,Mus musculus,In vivo,,10090.0,2385.0,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),Muscle tissue,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625123
8672,1,,1,Mus musculus,In vivo,,10090.0,2385.0,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),Muscle tissue,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625124
8673,1,,1,Mus musculus,In vivo,,10090.0,2385.0,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),Muscle tissue,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625125
8674,1,,1,Mus musculus,In vivo,,10090.0,14.0,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),Zone of skin,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625126
8675,1,,1,Mus musculus,In vivo,,10090.0,14.0,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),Zone of skin,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626947
8676,1,,1,Mus musculus,In vivo,,10090.0,14.0,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),Zone of skin,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626948
8677,1,,1,Mus musculus,In vivo,,10090.0,14.0,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),Zone of skin,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626949
8678,1,,1,Mus musculus,In vivo,,10090.0,14.0,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),Zone of skin,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626950
8679,1,,1,Mus musculus,In vivo,,10090.0,14.0,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),Zone of skin,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626951
8680,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626952
8681,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626953
8682,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626954
8683,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626955
8684,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626956
8685,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626957
8686,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626958
8687,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626959
8688,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626960
8689,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626961
8690,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627589
8691,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627590
8692,1,,1,Mus musculus,,,10090.0,,,Time taken for EC90 was determined when tested in mouse,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627591
8693,1,,1,Mus musculus,,,10090.0,,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627592
8694,1,,1,Mus musculus,In vivo,,10090.0,,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627593
8695,1,,1,Mus musculus,,,10090.0,,,Half life in mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627594
8696,1,,1,Mus musculus,In vivo,,10090.0,,,Half life period in mouse after 10 mg/Kg dose,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL876813
8697,1,,1,Mus musculus,In vivo,,10090.0,,,Half life period in mouse after 10 mg/kg dose,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627595
8698,1,,1,Mus musculus,In vivo,,10090.0,,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627596
8699,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value at 5 mg/kg po was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627597
8700,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value evaluated in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627598
8701,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627599
8702,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value after administration of 20 mg/Kg oral dose in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627600
8703,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value at 1 mg/kg po in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627601
8704,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value at 5 mg/kg po in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627776
8705,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value at a dose of 10 mg/kg in male SD rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627777
8706,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value at a dose of 100 mg/kg in male SD rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627778
8707,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value at a dose of 50 mg/kg in male SD rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627779
8708,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value in rats at 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876814
8709,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value was evaluated in rats at a dose of 20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627780
8710,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value was determined after peroral administration of 20 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627781
8711,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627782
8712,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627783
8713,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627784
8714,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627785
8715,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627786
8716,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627787
8717,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627788
8718,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626579
8719,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626580
8720,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876815
8721,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626581
8722,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626582
8723,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626583
8724,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626205
8725,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626206
8726,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626207
8727,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623882
8728,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623883
8729,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623884
8730,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623885
8731,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623886
8732,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximal concentration in rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623887
8733,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximal concentration after i.v. administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623888
8734,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623889
8735,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623890
8736,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Cmax in rat plasma after oral dose (50 mg/Kg),Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623891
8737,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximal plasma concentration was determined.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623892
8738,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximal plasma drug concentration was determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623893
8739,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximal concentration in rats after peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877616
8740,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration in rat after 2 mg/kg peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623894
8741,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623895
8742,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration of compound in rat was evaluated.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623896
8743,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623897
8744,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623898
8745,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623899
8746,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623900
8747,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623901
8748,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration was evaluated in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623902
8749,1,,1,Rattus norvegicus,In vivo,,10116.0,1359.0,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,Cerebrospinal fluid,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623903
8750,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623904
8751,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877617
8752,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623905
8753,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623906
8754,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623907
8755,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623908
8756,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623909
8757,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623910
8758,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623911
8759,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623912
8760,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624616
8761,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624617
8762,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624618
8763,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624619
8764,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624794
8765,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624795
8766,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623921
8767,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623922
8768,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623923
8769,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623924
8770,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623925
8771,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623926
8772,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623927
8773,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623928
8774,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623929
8775,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623930
8776,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623931
8777,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622165
8778,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621249
8779,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621250
8780,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621448
8781,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621449
8782,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621450
8783,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621451
8784,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621452
8785,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621453
8786,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621454
8787,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621455
8788,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621456
8789,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625145
8790,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875847
8791,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625146
8792,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625147
8793,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625148
8794,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625149
8795,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625150
8796,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625151
8797,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625152
8798,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625153
8799,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625154
8800,1,,1,Rattus norvegicus,,,10116.0,955.0,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625155
8801,1,,1,Rattus norvegicus,,,10116.0,,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625156
8802,1,,1,Rattus norvegicus,,,10116.0,,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624354
8803,1,,1,Rattus norvegicus,,,10116.0,10000000.0,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624355
8804,1,,1,Rattus norvegicus,,,10116.0,10000000.0,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624356
8805,1,,1,Rattus norvegicus,,,10116.0,10000000.0,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624357
8806,1,,1,Rattus norvegicus,,,10116.0,10000000.0,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624358
8807,1,,1,Rattus norvegicus,,,10116.0,2435.0,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624359
8808,1,,1,Rattus norvegicus,,,10116.0,2435.0,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624360
8809,1,,1,Rattus norvegicus,,,10116.0,2435.0,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624361
8810,1,,1,Rattus norvegicus,,,10116.0,2435.0,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624362
8811,1,,1,Rattus norvegicus,,,10116.0,2435.0,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624363
8812,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624364
8813,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624365
8814,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624366
8815,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624367
8816,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624368
8817,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624369
8818,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624370
8819,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625069
8820,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625070
8821,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626051
8822,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626052
8823,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626053
8824,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626054
8825,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626055
8826,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626056
8827,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626057
8828,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625193
8829,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625194
8830,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625195
8831,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625196
8832,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625197
8833,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625198
8834,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627929
8835,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627074
8836,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627075
8837,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627076
8838,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627077
8839,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627078
8840,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627079
8841,1,,1,Mus musculus,In vivo,,10090.0,,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL873824
8842,1,,1,Mus musculus,In vivo,,10090.0,1969.0,,Half life in mouse plasma was determined at dose 25 mg/kg,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627080
8843,1,,1,Mus musculus,,,10090.0,,,Half life was determined,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627081
8844,1,,1,Mus musculus,In vivo,,10090.0,,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627082
8845,1,,1,Mus musculus,In vivo,,10090.0,,,Half-life in male mice after 1 mg/kg intravenous dose,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627083
8847,1,,1,Mus musculus,,,10090.0,1969.0,,Half life in mice plasma,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627085
8848,1,,1,Mus musculus,,,10090.0,,,Half life in mouse,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627086
8849,1,,1,Mus musculus,In vivo,,10090.0,1969.0,,Half life in mouse plasma at dose 25 mg/kg,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627087
8850,1,,1,Mus musculus,In vivo,,10090.0,,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627088
8851,1,,1,Mus musculus,In vivo,,10090.0,,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627089
8852,1,,1,Mus musculus,In vivo,,10090.0,,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627090
8853,1,,1,Mus musculus,In vivo,,10090.0,,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627091
8854,1,,1,Mus musculus,In vivo,,10090.0,,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627092
8855,1,,1,Mus musculus,In vivo,,10090.0,,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL876785
8856,1,,1,Mus musculus,In vivo,,10090.0,,,Half-life by iv administration in mouse,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627093
8857,1,,1,Mus musculus,In vivo,,10090.0,,,Half-life by oral administration in mouse,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627094
8858,1,,1,Mus musculus,,,10090.0,,,Half-life in mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627095
8859,1,,1,Mus musculus,,,10090.0,955.0,,Half-life using mouse brain homogenate,Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627096
8860,1,,1,Mus musculus,,,10090.0,,,Half-life was measured in mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627097
8861,1,,1,Mus musculus,In vivo,,10090.0,,,Half-life was measured in mouse after an iv dose of 1 mg/kg,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627098
8862,1,,1,Mus musculus,,,10090.0,178.0,,Half-life period was determined in mouse blood,Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627099
8863,1,,1,Mus musculus,,,10090.0,955.0,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627100
8864,1,,1,Mus musculus,,,10090.0,1969.0,,Plasma half life in mouse,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627101
8865,1,,1,Mus musculus,,,10090.0,,,Stability of the peptide in the presence of mouse serum,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627102
8866,1,,1,Mus musculus,,,10090.0,,,Terminal half life of compound was determined in mouse,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627103
8867,1,,1,Mus musculus,In vivo,,10090.0,,,Terminal half life was evaluated in mice after intravenous administration,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627104
8868,1,,1,Mus musculus,In vivo,,10090.0,,,Terminal half life was evaluated in mice after oral administration,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627105
8869,1,,1,Mus musculus,,,10090.0,,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL876786
8870,1,,1,Mus musculus,,,10090.0,,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL873825
8871,1,,1,Mus musculus,,,10090.0,,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627106
8872,1,,1,Mus musculus,In vivo,,10090.0,,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626336
8873,1,,1,Mus musculus,In vivo,,10090.0,,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL877462
8874,1,,1,Mus musculus,In vivo,,10090.0,,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626337
8875,1,,1,Mus musculus,,,10090.0,,,Half life after intraperitoneal administration of 100 mg/kg in mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626338
8876,1,,1,Mus musculus,In vivo,,10090.0,,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626339
8877,1,,1,Mus musculus,In vivo,,10090.0,,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626340
8878,1,,1,Mus musculus,In vivo,,10090.0,,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625377
8879,1,,1,Mus musculus,In vivo,,10090.0,,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625378
8880,1,,1,Mus musculus,In vivo,,10090.0,,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625379
8881,1,,0,Sus scrofa,,,9823.0,,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),,,,Microsomes,BAO_0000251,22224,U,Autocuration,CHEMBL625380
8882,1,,0,Sus scrofa,,,9823.0,,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),,,,Microsomes,BAO_0000251,22224,U,Autocuration,CHEMBL625381
8883,1,,0,Sus scrofa,,,9823.0,,,Stability to porcine renal DHP-I,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625382
8884,1,,0,Sus scrofa,In vivo,,9823.0,,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL873828
8885,1,,0,Sus scrofa,In vivo,,9823.0,,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625383
8886,1,,0,Sus scrofa,,,9823.0,,,Half-life of the parent prodrug in porcine esterase solution,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625384
8887,1,,0,Sus scrofa,,,9823.0,,,"First order rate constant, k was determined in in pig liver Esterase",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625385
8888,1,,0,Sus scrofa,,,9823.0,2107.0,,Half life of the in pig liver Esterase,Liver,,,,BAO_0000221,22224,U,Autocuration,CHEMBL625386
8889,1,,0,Sus scrofa,,,9823.0,2107.0,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,Liver,,,,BAO_0000221,22224,U,Autocuration,CHEMBL623571
8890,1,,0,Sus scrofa,,,9823.0,2107.0,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,Liver,,,,BAO_0000221,22224,U,Autocuration,CHEMBL623572
8891,1,,0,Sus scrofa,,,9823.0,2107.0,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,Liver,,,,BAO_0000221,22224,U,Autocuration,CHEMBL623573
8892,1,,0,Sus scrofa,,,9823.0,2107.0,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,Liver,,,,BAO_0000221,22224,U,Autocuration,CHEMBL623574
8893,1,,0,Sus scrofa,,,9823.0,2107.0,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,Liver,,,,BAO_0000221,22224,U,Autocuration,CHEMBL623575
8894,1,,0,Sus scrofa,,,9823.0,2107.0,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,Liver,,,,BAO_0000221,22224,U,Autocuration,CHEMBL623749
8895,1,,0,Sus scrofa,,,9823.0,2107.0,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,Liver,,,,BAO_0000221,22224,U,Autocuration,CHEMBL623750
8896,1,,0,Sus scrofa,In vitro,,9823.0,2107.0,,Half-life in vitro in pig liver,Liver,,,,BAO_0000221,22224,U,Autocuration,CHEMBL623751
8897,1,,0,Sus scrofa,,,9823.0,2107.0,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,Liver,,,,BAO_0000221,22224,U,Autocuration,CHEMBL623752
8898,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623753
8899,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623754
8900,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration in rat plasma was determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623755
8901,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623756
8902,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration in rats at 1-2 hours,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623757
8903,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623758
8904,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623759
8905,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration at the dose of 2 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623760
8906,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration was evaluated in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623761
8907,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623762
8908,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877594
8909,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623763
8910,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623764
8911,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623765
8912,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623766
8913,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623767
8914,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623768
8915,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623769
8916,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623770
8917,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623771
8918,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623772
8919,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623773
8920,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623774
8921,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623775
8922,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rat (PO dose),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623776
8923,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622191
8924,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622192
8925,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration determined in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622193
8926,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622194
8927,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622195
8928,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622196
8929,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622197
8930,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622198
8931,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622199
8932,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration of compound was measured in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622200
8933,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration after 20 mg/kg oral administration in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622201
8934,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration after oral administration to rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623990
8935,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623991
8936,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623992
8937,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623993
8938,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623994
8939,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623995
8940,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623996
8941,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623997
8942,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration dosed orally in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623998
8943,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration dosed orally in rats after 6 hours,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623999
8944,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624000
8945,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624001
8946,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration in rat after po administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624002
8947,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624003
8948,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624004
8949,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624005
8950,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624006
8951,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624007
8952,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624008
8953,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624009
8954,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874387
8955,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624010
8956,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624011
8957,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624012
8958,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624013
8959,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624736
8960,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624737
8961,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624738
8962,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624739
8963,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624740
8964,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624896
8965,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624897
8966,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624108
8967,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624109
8968,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624110
8969,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624111
8970,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624112
8971,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624113
8972,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619709
8973,1,,1,Rattus norvegicus,,,10116.0,948.0,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619710
8974,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619711
8975,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619712
8976,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619713
8977,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619714
8978,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619715
8979,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619716
8980,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619717
8981,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619718
8982,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619719
8983,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875329
8984,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619720
8985,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619721
8986,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619722
8987,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619723
8988,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619724
8989,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619725
8990,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619726
8991,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619727
8992,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619728
8993,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619729
8994,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619730
8995,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619731
8996,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619732
8997,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619733
8998,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619734
8999,1,,1,Rattus norvegicus,In vivo,,10116.0,14.0,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Zone of skin,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619735
9000,1,,1,Rattus norvegicus,In vivo,,10116.0,14.0,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Zone of skin,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875330
9001,1,,1,Rattus norvegicus,In vivo,,10116.0,14.0,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Zone of skin,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628465
9002,1,,1,Rattus norvegicus,In vivo,,10116.0,14.0,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Zone of skin,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628466
9003,1,,1,Rattus norvegicus,In vivo,,10116.0,14.0,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Zone of skin,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628467
9004,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628468
9005,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628469
9006,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628470
9007,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628471
9008,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628472
9009,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625191
9010,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625192
9011,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875337
9012,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626341
9013,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626342
9014,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621943
9015,1,,1,Rattus norvegicus,,,10116.0,,,Half life in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621944
9016,1,,1,Rattus norvegicus,,,10116.0,,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621945
9017,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621946
9018,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621947
9019,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621948
9020,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621949
9021,1,,1,Rattus norvegicus,,,10116.0,,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621950
9022,1,,1,Rattus norvegicus,,,10116.0,,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621951
9023,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621952
9024,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Stability (%) in rat liver microsomes,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621953
9025,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was calculated after intravenous administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621954
9026,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was calculated after iv administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621955
9027,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was calculated in rat after peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621956
9028,1,,1,Rattus norvegicus,,,10116.0,,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621957
9029,1,,1,Rattus norvegicus,,,10116.0,,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621958
9030,1,,1,Rattus norvegicus,,,10116.0,,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621959
9031,1,,1,Rattus norvegicus,,,10116.0,,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621960
9032,1,,1,Rattus norvegicus,,,10116.0,,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621961
9033,1,,1,Rattus norvegicus,,,10116.0,,,p value of the compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621962
9034,1,,1,Rattus norvegicus,,,10116.0,,,p value of the compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876787
9035,1,,1,Rattus norvegicus,,,10116.0,,,p value of the compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621963
9036,1,,1,Rattus norvegicus,,,10116.0,945.0,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622637
9037,1,,1,Rattus norvegicus,,,10116.0,945.0,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622638
9038,1,,1,Rattus norvegicus,,,10116.0,945.0,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626561
9039,1,,0,Oryctolagus cuniculus,,,9986.0,,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626562
9040,1,,0,Oryctolagus cuniculus,,,9986.0,,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626563
9041,1,,0,Oryctolagus cuniculus,,,9986.0,,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626564
9042,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626565
9043,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626566
9044,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,Clearance rate in rabbits,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626567
9045,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626568
9046,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626569
9047,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626570
9048,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626571
9049,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626572
9050,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,1969.0,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626573
9051,1,,0,Oryctolagus cuniculus,,,9986.0,2107.0,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Liver,,,Microsomes,BAO_0000251,22224,U,Autocuration,CHEMBL626574
9052,1,,0,Oryctolagus cuniculus,,,9986.0,2107.0,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Liver,,,Microsomes,BAO_0000251,22224,U,Autocuration,CHEMBL626575
9053,1,,0,Oryctolagus cuniculus,,,9986.0,,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626576
9054,1,,0,Oryctolagus cuniculus,,,9986.0,,,Dose at which bioavailability of perorally administered compound was tested in rabbit,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626577
9055,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,The compound was tested for its bioavailability in rabbit (by oral dosage).,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626578
9056,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625263
9057,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625264
9058,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625265
9059,1,,0,Oryctolagus cuniculus,,,9986.0,,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),,,,Microsomes,BAO_0000251,22224,U,Autocuration,CHEMBL625266
9060,1,,0,Oryctolagus cuniculus,,,9986.0,,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),,,,Microsomes,BAO_0000251,22224,U,Autocuration,CHEMBL876796
9061,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625267
9062,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,1969.0,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625268
9063,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,1969.0,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625269
9064,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,1969.0,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624689
9065,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624690
9066,1,,0,Oryctolagus cuniculus,,,9986.0,1088.0,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624691
9067,1,,0,Oryctolagus cuniculus,,,9986.0,1088.0,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624692
9068,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624693
9069,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624694
9070,1,,0,Oryctolagus cuniculus,In vitro,,9986.0,,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,,,,BAO_0000221,22224,U,Autocuration,CHEMBL877596
9071,1,,0,Oryctolagus cuniculus,,,9986.0,,,Time within which only 10% of the drug was degraded,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624695
9072,1,,0,Oryctolagus cuniculus,,,9986.0,2107.0,,Half life period in rabbit liver homogenate,Liver,,,,BAO_0000221,22224,U,Autocuration,CHEMBL624696
9073,1,,0,Oryctolagus cuniculus,,,9986.0,,,Half life value in rabbits,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624697
9074,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,178.0,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624698
9075,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,178.0,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624699
9076,1,,0,Oryctolagus cuniculus,In vivo,,9986.0,,,Half-life period in rabbits following intravenous administration at 2 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624700
9077,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC 0-8 hr value in rats at 10 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622903
9078,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC after administration at 2000 mg/kg/day in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622904
9079,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622905
9080,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622906
9081,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622907
9082,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC in rat after oral administration at 10.5 mg/kg dose,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622908
9083,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC in rat after oral administration at 11.2 mg/kg dose,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622909
9084,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC in rat after oral administration at 9.7 mg/kg dose,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622910
9085,1,,1,Rattus norvegicus,,,10116.0,955.0,,AUC in rat brain after oral administration at 10 mg/kg,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622911
9086,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC in rat p.o.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622912
9087,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC in rat p.o. at 20 mg/kg concentration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622913
9088,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC in rat plasma after oral administration at 10 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622914
9089,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622915
9090,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC value after IV dose at a dose of 5 mg/kg in rats.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622916
9091,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC value after oral dose at a dose of 10 mg/kg in rats.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622917
9092,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622918
9093,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622919
9094,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration was evaluated in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622920
9095,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622921
9096,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622922
9097,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622923
9098,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877604
9099,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622924
9100,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622925
9101,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622926
9102,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623625
9103,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,Plasma,,,,BAO_0000218,50597,N,Expert,CHEMBL623626
9104,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma drug concentration was determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623627
9105,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623628
9106,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Mean peak plasma concentration was observed after intravenous administration in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623629
9107,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Mean peak plasma concentration was observed after oral administration in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623630
9108,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623804
9109,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623805
9110,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Peak oral plasma concentration was determined in rats by oral administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623806
9111,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Peak plasma concentration (Cmax) was determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623807
9112,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623808
9113,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Peak plasma concentration (Cmax) in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623809
9114,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Peak plasma concentration at 1 mg/kg peroral administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623810
9115,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Peak plasma concentration in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623811
9116,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623812
9117,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877605
9118,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (Cmax) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623813
9119,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623814
9120,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rat after 3mg/kg oral dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623815
9121,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623816
9122,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rats after 20 mg/kg oral dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623145
9123,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Cmax in rat plasma after 30mg/kg oral dose,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623146
9124,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Plasma concentration after oral administration of 100 mg/kg to rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623147
9125,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623042
9126,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tested for the Cmax in rat at 10 mg/kg per orally,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623043
9127,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623044
9128,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623045
9129,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability as oral Cmax in rats at 30 mins,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623046
9130,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability as oral Cmax in rats at 6hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623226
9131,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The maximum concentration of compound was measured at the dose of 100 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623227
9132,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The maximum concentration of compound was measured at the dose of 300 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623228
9133,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The maximum concentration of compound was measured at the dose of 30 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623229
9134,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,The maximum plasma levels for the compounds were determined by LC-MS.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623230
9135,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,mean peak plasma concentration was observed after intravenous administration in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623231
9136,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,mean peak plasma concentration was observed after oral administration in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623232
9137,1,,1,Rattus norvegicus,,,10116.0,,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623233
9138,1,,1,Rattus norvegicus,,,10116.0,,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623234
9139,1,,1,Rattus norvegicus,,,10116.0,,,Concentration in plasma (portal) following oral dose in rats at 1 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623235
9140,1,,1,Rattus norvegicus,,,10116.0,,,Concentration in plasma (portal) following oral dose in rats at 2 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623236
9141,1,,1,Rattus norvegicus,,,10116.0,,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623237
9142,1,,1,Rattus norvegicus,,,10116.0,,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623238
9143,1,,1,Rattus norvegicus,,,10116.0,,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623239
9144,1,,0,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,Plasma,,,,BAO_0000218,22224,U,Intermediate,CHEMBL623240
9145,1,,1,Rattus norvegicus,,,10116.0,1898.0,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",Hypothalamus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623241
9146,1,,1,Rattus norvegicus,,,10116.0,1898.0,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",Hypothalamus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623242
9147,1,,1,Rattus norvegicus,,,10116.0,,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874394
9148,1,,1,Rattus norvegicus,,,10116.0,,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623243
9149,1,,1,Rattus norvegicus,,,10116.0,,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623244
9150,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623245
9151,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623246
9152,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623247
9153,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623248
9154,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623249
9155,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625072
9156,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625073
9157,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625074
9158,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625075
9159,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625076
9160,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625077
9161,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625078
9162,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874395
9163,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625079
9164,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625080
9165,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625081
9166,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625082
9167,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625083
9168,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625084
9169,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625085
9170,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625086
9171,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625087
9172,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625088
9173,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622205
9174,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622206
9175,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622207
9176,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622366
9177,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622367
9178,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875331
9179,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622368
9180,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622369
9181,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622370
9182,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622371
9183,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622372
9184,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622373
9185,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622374
9186,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622375
9187,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622376
9188,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622377
9189,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622378
9190,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622379
9191,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622380
9192,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622381
9193,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622382
9194,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622383
9195,1,,1,Rattus norvegicus,,,10116.0,945.0,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875332
9196,1,,1,Rattus norvegicus,,,10116.0,945.0,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622384
9197,1,,1,Rattus norvegicus,,,10116.0,945.0,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622385
9198,1,,1,Rattus norvegicus,,,10116.0,945.0,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622386
9199,1,,1,Rattus norvegicus,,,10116.0,,,The compound was tested for the plasma binding in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622387
9200,1,,1,Rattus norvegicus,,,10116.0,,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622388
9201,1,,1,Rattus norvegicus,,,10116.0,,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622389
9202,1,,1,Rattus norvegicus,,,10116.0,,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622390
9203,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622391
9204,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622392
9205,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622393
9206,1,,1,Rattus norvegicus,,,10116.0,,,Plasma level at 2 hr after administration of the compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622394
9207,1,,1,Rattus norvegicus,,,10116.0,,,plasma level at 2 hr after administration of the compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622395
9208,1,,1,Rattus norvegicus,,,10116.0,1977.0,,Stability in rat serum measured as % recovery at 1 min,Serum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622396
9209,1,,1,Rattus norvegicus,,,10116.0,1977.0,,Stability in rat serum measured as % recovery at 10 min,Serum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624894
9210,1,,1,Rattus norvegicus,,,10116.0,1977.0,,Stability in rat serum measured as % recovery at 10 mins,Serum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624895
9211,1,,1,Rattus norvegicus,,,10116.0,1977.0,,Stability in rat serum measured as % recovery at 2 hr,Serum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624058
9212,1,,1,Rattus norvegicus,,,10116.0,1977.0,,Stability in rat serum measured as % recovery at 3 min,Serum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624059
9213,1,,1,Rattus norvegicus,,,10116.0,1977.0,,Stability in rat serum measured as % recovery at 3 mins,Serum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624060
9214,1,,1,Rattus norvegicus,,,10116.0,1977.0,,Stability in rat serum measured as % recovery at 5 min,Serum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624061
9215,1,,1,Rattus norvegicus,,,10116.0,1977.0,,Stability in rat serum measured as % recovery at 5 mins,Serum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624062
9216,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624063
9217,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624064
9218,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624065
9219,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624066
9220,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life tested in mature male rat at a dose of 30 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877490
9221,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life after intravenous administration of 1 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874442
9222,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period after administration (30 mg/kg) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626890
9223,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period in rat after 5 mg/Kg dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626891
9224,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period in rat after 5 mg/kg dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626892
9225,1,,1,Rattus norvegicus,,,10116.0,,,Half life period was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626893
9226,1,,1,Rattus norvegicus,,,10116.0,,,Half life period was evaluated in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626894
9227,1,,1,Rattus norvegicus,,,10116.0,,,Half life period was evaluated in rat; 0.5-1.0,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626895
9228,1,,1,Rattus norvegicus,,,10116.0,,,Half life period was evaluated in rat; 5.9-7.5,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626896
9229,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half-life in rat plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626897
9230,1,,1,Rattus norvegicus,,,10116.0,,,Half-life time in rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626898
9231,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Terminal half-life after iv administration to rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626899
9232,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626900
9233,1,,1,Rattus norvegicus,,,10116.0,,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626901
9234,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626902
9235,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626903
9236,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874443
9237,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626904
9238,1,,1,Rattus norvegicus,,,10116.0,,,Half life in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626905
9239,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873830
9240,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626906
9241,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631076
9242,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Biological half-life was measured in plasma of rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631077
9243,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631078
9244,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631079
9245,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631080
9246,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631081
9247,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631239
9248,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Compound was evaluated for plasma half life in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631240
9249,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC value at a dose of 5 mg/kg (p.o.) in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631241
9250,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC value after administration of 20 mg/Kg oral dose in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631242
9251,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631243
9252,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC0-96 after administration at 50 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874444
9253,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631244
9254,1,,1,Rattus norvegicus,,,10116.0,,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631245
9255,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627162
9256,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627163
9257,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627164
9258,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627165
9259,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627166
9260,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627167
9261,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve (AUC) at a dose of 30 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627822
9262,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627823
9263,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627824
9264,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627825
9265,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627826
9266,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve (Pharmacokinetic property) was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627827
9267,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve (Pharmacokinetic property) of the compound; Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627828
9268,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve after intravenous administration (1 mg/kg) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627829
9269,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627830
9270,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627831
9271,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve in male SD rats was observed after oral administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627832
9272,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627833
9273,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Expert,CHEMBL627834
9274,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Expert,CHEMBL628004
9275,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve at 5 mg/kg po was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628005
9276,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve in Rat at a oral dose of 5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628006
9277,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628007
9278,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625676
9279,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631309
9280,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve after intravenous administration at 3 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631310
9281,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631311
9282,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve at 4 hr in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631312
9283,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve at a dose of 30 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631313
9284,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631314
9285,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631315
9286,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve for a 2-mpk po dose in SD rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631316
9287,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve in SD rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631317
9288,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve in rat after oral administration at 13 mg/kg dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874471
9289,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve in rat by po administration at 0-24 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631318
9290,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Area under curve in rat plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631319
9291,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631320
9292,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631321
9293,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631322
9294,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631323
9295,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve value in rat at a dose of 5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631324
9296,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined after oral administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631325
9297,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631326
9298,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined after peroral administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631327
9299,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined at a dose 30 mpk administered orally.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631328
9300,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631329
9301,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627217
9302,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined in male rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626352
9303,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined in rat after PO administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626353
9304,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined in rat after a 3 mg/kg of oral dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626354
9305,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626355
9306,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626356
9307,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626357
9308,1,,1,Rattus norvegicus,,,10116.0,,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626358
9309,1,,1,Rattus norvegicus,,,10116.0,,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626359
9310,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Peak plasma concentration in rat at a dose of 3 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626360
9311,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration at 2 hr in rats was evaluated.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626361
9312,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration at 2 hr in rats was evaluated; Not available,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626362
9313,1,,1,Rattus norvegicus,,,10116.0,,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626363
9314,1,,1,Rattus norvegicus,,,10116.0,,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626970
9315,1,,1,Rattus norvegicus,,,10116.0,,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626971
9316,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626972
9317,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626973
9318,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626974
9319,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874592
9320,1,,1,Rattus norvegicus,,,10116.0,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626975
9321,1,,1,Rattus norvegicus,,,10116.0,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626976
9322,1,,1,Rattus norvegicus,,,10116.0,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626977
9323,1,,1,Rattus norvegicus,,,10116.0,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626978
9324,1,,1,Rattus norvegicus,,,10116.0,,,PK study was carried to determine the relative absorption ranking in rat.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626979
9325,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626980
9326,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626981
9327,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626982
9328,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626983
9329,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622522
9330,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622523
9331,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622524
9332,1,,1,Rattus norvegicus,,,10116.0,955.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622525
9333,1,,1,Rattus norvegicus,,,10116.0,955.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622526
9334,1,,1,Rattus norvegicus,,,10116.0,955.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619849
9335,1,,1,Rattus norvegicus,,,10116.0,955.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619850
9336,1,,1,Rattus norvegicus,,,10116.0,955.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623864
9337,1,,1,Rattus norvegicus,,,10116.0,955.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623865
9338,1,,1,Rattus norvegicus,,,10116.0,948.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623866
9339,1,,1,Rattus norvegicus,,,10116.0,948.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623867
9340,1,,1,Rattus norvegicus,,,10116.0,948.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877615
9341,1,,1,Rattus norvegicus,,,10116.0,948.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623868
9342,1,,1,Rattus norvegicus,,,10116.0,948.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623869
9343,1,,1,Rattus norvegicus,,,10116.0,948.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623870
9344,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623871
9345,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623872
9346,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622129
9347,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622130
9348,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622131
9349,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622132
9350,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622133
9351,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622134
9352,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622135
9353,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622136
9354,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622137
9355,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622138
9356,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623017
9357,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623018
9358,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623019
9359,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623020
9360,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623021
9361,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623022
9362,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623023
9363,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623024
9364,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623025
9365,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620545
9366,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620546
9367,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620547
9368,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620548
9369,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620549
9370,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620550
9371,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620551
9372,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620552
9373,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620553
9374,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620554
9375,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875845
9376,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620555
9377,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620556
9378,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620557
9379,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620558
9380,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620559
9381,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622939
9382,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622940
9383,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622941
9384,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622942
9385,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622943
9386,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622944
9387,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622945
9388,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622946
9389,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for terminal half life in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622947
9390,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622948
9391,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622949
9392,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for its half life in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622950
9393,1,,0,Macaca mulatta,In vivo,,9544.0,1969.0,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,Plasma,,,,BAO_0000218,22224,U,Intermediate,CHEMBL622951
9394,1,,0,Rattus norvegicus,,,10116.0,1969.0,,Compound was tested for its plasma half life in Sprague Dawley rats,Plasma,,,,BAO_0000366,22224,U,Intermediate,CHEMBL622952
9395,1,,0,Rattus norvegicus,,,10116.0,1969.0,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,Plasma,,,,BAO_0000366,22224,U,Intermediate,CHEMBL622953
9396,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Compound was tested for plasma half-life period in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873818
9397,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Elimination half life after i.v. administration of compound in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622954
9398,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622955
9399,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Elimination half-life after IV dosing at 1 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875229
9400,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622956
9401,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622957
9402,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622958
9403,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622959
9404,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622960
9405,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622961
9406,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Evaluated for the half life in rat (in vivo),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622962
9407,1,,1,Rattus norvegicus,,,10116.0,,,Hafl life in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622963
9408,1,,1,Rattus norvegicus,,,10116.0,,,Hafl life rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622964
9409,1,,1,Rattus norvegicus,,,10116.0,,,Hafl life rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622965
9410,1,,1,Rattus norvegicus,,,10116.0,,,Hafl life rat; Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622966
9411,1,,1,Rattus norvegicus,,,10116.0,,,Hafl life rat; Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622967
9412,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622968
9413,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622969
9414,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875327
9415,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life in rat after 1 mg/kg i.v. administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628638
9416,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life in rat after 2 mg/kg peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628639
9417,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625840
9418,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life of 10 mg/kg oral dose determined in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625841
9419,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625842
9420,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625843
9421,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625844
9422,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873822
9423,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625845
9424,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627059
9425,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627060
9426,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627061
9427,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life of compound at 5 mg/kg after po administration was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627709
9428,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life of compound determined after intravenous administration to rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627710
9429,1,,1,Rattus norvegicus,,,10116.0,,,Half life of compound was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627711
9430,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627712
9431,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627713
9432,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627714
9433,1,,0,Macaca fascicularis,In vivo,,9541.0,,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,,,,BAO_0000218,22224,U,Intermediate,CHEMBL627889
9434,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Half life determined in rat by intravenous administration,,,,,BAO_0000218,22224,U,Intermediate,CHEMBL627890
9435,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life determined in rats after iv administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627891
9436,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Half life in rat plasma after administration of 2 mg/kg iv,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627892
9437,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Half life in rat plasma after administration of 2 mg/kg iv,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627893
9438,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life in rat plasma was determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627894
9439,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life in rat plasma was determined; NA means not applicable,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627895
9440,1,,1,Rattus norvegicus,,,10116.0,,,Half life in rat was tested,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627896
9441,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life measured in rat plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627897
9442,1,,1,Rattus norvegicus,,,10116.0,,,Half life recorded in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627898
9443,1,,1,Rattus norvegicus,,,10116.0,,,Half life was calculated,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627899
9444,1,,1,Rattus norvegicus,,,10116.0,,,Half life was calculated in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873823
9445,1,,1,Rattus norvegicus,,,10116.0,,,Half life was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627900
9446,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life after 10 mg/kg oral administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627901
9447,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627902
9448,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life after administering orally a dose of 30 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627903
9449,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627904
9450,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627905
9451,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627906
9452,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627907
9453,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876783
9454,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627908
9455,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627909
9456,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627910
9457,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627911
9458,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627912
9459,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627913
9460,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627914
9461,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627915
9462,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was evaluated after 20 uM/kg of peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627916
9463,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627917
9464,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627918
9465,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627919
9466,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627920
9467,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve was evaluated at an oral dose of 30 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627921
9468,1,,1,Rattus norvegicus,,,10116.0,,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627922
9469,1,,1,Rattus norvegicus,,,10116.0,,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876784
9470,1,,1,Rattus norvegicus,,,10116.0,,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627923
9471,1,,1,Rattus norvegicus,,,10116.0,,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626208
9472,1,,1,Rattus norvegicus,,,10116.0,,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626209
9473,1,,1,Rattus norvegicus,,,10116.0,,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626210
9474,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627994
9475,1,,1,Rattus norvegicus,,,10116.0,,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627995
9476,1,,1,Rattus norvegicus,,,10116.0,,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627996
9477,1,,1,Rattus norvegicus,,,10116.0,,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627997
9478,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627998
9479,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628640
9480,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628641
9481,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628642
9482,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for area under the curve expressed as (h*ug/ml),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628643
9483,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for area under curve in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628644
9484,1,,1,Rattus norvegicus,,,10116.0,,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628645
9485,1,,1,Rattus norvegicus,,,10116.0,,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628646
9486,1,,1,Rattus norvegicus,,,10116.0,,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628647
9487,1,,1,Rattus norvegicus,,,10116.0,,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628648
9488,1,,1,Rattus norvegicus,,,10116.0,,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625358
9489,1,,1,Rattus norvegicus,,,10116.0,,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625359
9490,1,,1,Rattus norvegicus,,,10116.0,,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625360
9491,1,,1,Rattus norvegicus,,,10116.0,,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625361
9492,1,,1,Rattus norvegicus,,,10116.0,,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625362
9493,1,,1,Rattus norvegicus,,,10116.0,,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625363
9494,1,,1,Rattus norvegicus,,,10116.0,,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625364
9495,1,,1,Rattus norvegicus,,,10116.0,,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625365
9496,1,,1,Rattus norvegicus,,,10116.0,,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625366
9497,1,,1,Rattus norvegicus,,,10116.0,,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625367
9498,1,,1,Rattus norvegicus,,,10116.0,2113.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625368
9499,1,,1,Rattus norvegicus,,,10116.0,2113.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625369
9500,1,,1,Rattus norvegicus,,,10116.0,2113.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625370
9501,1,,1,Rattus norvegicus,,,10116.0,2113.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625371
9502,1,,1,Rattus norvegicus,,,10116.0,2113.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625372
9503,1,,1,Rattus norvegicus,,,10116.0,2113.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625373
9504,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625374
9505,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877593
9506,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625375
9507,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625376
9508,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621973
9509,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621974
9510,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621975
9511,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622166
9512,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622167
9513,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622168
9514,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622169
9515,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622170
9516,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622171
9517,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622172
9518,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622173
9519,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622174
9520,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622175
9521,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622176
9522,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622177
9523,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622178
9524,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622179
9525,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622180
9526,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622181
9527,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622182
9528,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622183
9529,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622184
9530,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622185
9531,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622186
9532,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622187
9533,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625002
9534,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622090
9535,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622091
9536,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622092
9537,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622093
9538,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622094
9539,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622095
9540,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622264
9541,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622265
9542,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622266
9543,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622267
9544,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622268
9545,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622269
9546,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625071
9547,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621621
9548,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621622
9549,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621623
9550,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621624
9551,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621625
9552,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621626
9553,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621627
9554,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621628
9555,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875328
9556,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621629
9557,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621630
9558,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621631
9559,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621632
9560,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621633
9561,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621634
9562,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621635
9563,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621636
9564,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621637
9565,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621638
9566,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618883
9567,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618884
9568,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628627
9569,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628628
9570,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628629
9571,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life after administering orally a dose of 3 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628630
9572,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628631
9573,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life after administering intravenously a dose of 1 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628632
9574,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life after oral dosing in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628633
9575,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628634
9576,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life by intravenous administration of 3.4 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627789
9577,1,,1,Rattus norvegicus,,,10116.0,,,Half life in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627790
9578,1,,1,Rattus norvegicus,,,10116.0,,,Half life in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627791
9579,1,,1,Rattus norvegicus,,,10116.0,,,Half life in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627792
9580,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life in rat after intravenous administration of the compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627793
9581,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627794
9582,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life in rat after po administration of the compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627795
9583,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life in rat after po administration of the compound; ND means Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627796
9584,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875335
9585,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627797
9586,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life in rat i.v.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627798
9587,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life in rat i.v. at 2 mg/kg concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627799
9588,1,,1,Rattus norvegicus,,,10116.0,,,Half life in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627800
9589,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life in rats after intravenous administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627801
9590,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life in rats at the dose of 1.0 mpk by i.v. administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627802
9591,1,,1,Rattus norvegicus,,,10116.0,,,Half life in rat,,,,,BAO_0000218,50597,N,Expert,CHEMBL627803
9592,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life was evaluated after intravenous administration to rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873820
9593,1,,1,Rattus norvegicus,,,10116.0,,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627804
9594,1,,1,Rattus norvegicus,,,10116.0,,,Half life was evaluated in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627805
9595,1,,1,Rattus norvegicus,,,10116.0,,,Half life was evaluated in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627806
9596,1,,1,Rattus norvegicus,,,10116.0,,,Half life was evaluated in rat; Not tested,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627107
9597,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627108
9598,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627109
9599,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627110
9600,1,,0,Primates,In vivo,,9443.0,,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,,,,BAO_0000218,22224,U,Intermediate,CHEMBL627111
9601,1,,0,Primates,In vivo,,9443.0,,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,,,,BAO_0000218,22224,U,Intermediate,CHEMBL627112
9602,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Half life was measured in rat at dose of 30 mg/kg by iv administration,,,,,BAO_0000218,22224,U,Intermediate,CHEMBL627113
9603,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Half life was measured in rat at dose of 30 mg/kg by po administration,,,,,BAO_0000218,22224,U,Intermediate,CHEMBL627114
9604,1,,1,Rattus norvegicus,,,10116.0,,,Half life (t1/2) was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627115
9605,1,,1,Rattus norvegicus,,,10116.0,,,Half life period at a dose of 10 uM/kg in rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627116
9606,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627117
9607,1,,1,Rattus norvegicus,,,10116.0,,,Half life period was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627118
9608,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period after intravenous administration at 20 mpk in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627119
9609,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627120
9610,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period after intravenous administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626922
9611,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626923
9612,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626924
9613,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life period in 80% rat plasma at 37 degree Centigrade,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626925
9614,1,,1,Rattus norvegicus,,,10116.0,,,Half life period in SD rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626926
9615,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626927
9616,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626928
9617,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626929
9618,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626930
9619,1,,1,Rattus norvegicus,,,10116.0,,,Half life period in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626931
9620,1,,1,Rattus norvegicus,,,10116.0,,,Half life period in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626932
9621,1,,1,Rattus norvegicus,,,10116.0,,,Half life period in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626933
9622,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period in rat after oral administration at 10.5 mg/kg dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873826
9623,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period in rat after oral administration at 11.2 mg/kg dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626934
9624,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period in rat after oral administration at 13 mg/kg dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626935
9625,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period in rat after oral administration at 9.7 mg/kg dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626936
9626,1,,1,Rattus norvegicus,,,10116.0,,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626937
9627,1,,1,Rattus norvegicus,,,10116.0,,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625906
9628,1,,1,Rattus norvegicus,,,10116.0,,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625907
9629,1,,1,Rattus norvegicus,,,10116.0,,,PK study was carried to determine AUC (area under curve) value in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625908
9630,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter AUC after intravenous administration to rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625909
9631,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter AUC after oral administration to rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625910
9632,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625911
9633,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625912
9634,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626538
9635,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876794
9636,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626539
9637,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626540
9638,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626541
9639,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626542
9640,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626543
9641,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626544
9642,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626545
9643,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626546
9644,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter area under curve was reported,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626547
9645,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic property (AUC) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626548
9646,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626549
9647,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626550
9648,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626551
9649,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic property was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623777
9650,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623778
9651,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623779
9652,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623780
9653,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622015
9654,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622016
9655,1,,1,Rattus norvegicus,,,10116.0,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622017
9656,1,,1,Rattus norvegicus,,,10116.0,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622018
9657,1,,1,Rattus norvegicus,,,10116.0,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622019
9658,1,,1,Rattus norvegicus,,,10116.0,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622020
9659,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622021
9660,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622022
9661,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622023
9662,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622024
9663,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622693
9664,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622694
9665,1,,1,Rattus norvegicus,,,10116.0,,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622695
9666,1,,1,Rattus norvegicus,,,10116.0,,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622696
9667,1,,1,Rattus norvegicus,,,10116.0,,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622697
9668,1,,1,Rattus norvegicus,,,10116.0,,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622874
9669,1,,1,Rattus norvegicus,,,10116.0,,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622875
9670,1,,1,Rattus norvegicus,,,10116.0,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622876
9671,1,,1,Rattus norvegicus,,,10116.0,,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622877
9672,1,,1,Rattus norvegicus,,,10116.0,,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622878
9673,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622879
9674,1,,1,Rattus norvegicus,,,10116.0,,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877602
9675,1,,1,Rattus norvegicus,,,10116.0,,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622880
9676,1,,1,Rattus norvegicus,,,10116.0,,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622881
9677,1,,1,Rattus norvegicus,,,10116.0,,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622882
9678,1,,1,Rattus norvegicus,,,10116.0,,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622883
9679,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622884
9680,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622885
9681,1,,1,Rattus norvegicus,,,10116.0,,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622886
9682,1,,1,Rattus norvegicus,,,10116.0,,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622887
9683,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622888
9684,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622889
9685,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622890
9686,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622891
9687,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877603
9688,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622892
9689,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622893
9690,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622894
9691,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622895
9692,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622896
9693,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622897
9694,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622898
9695,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622899
9696,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622900
9697,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624114
9698,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624115
9699,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624116
9700,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624117
9701,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624118
9702,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624119
9703,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624120
9704,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624121
9705,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624122
9706,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624123
9707,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624124
9708,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624125
9709,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624126
9710,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624127
9711,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624128
9712,1,,1,Rattus norvegicus,In vivo,,10116.0,14.0,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Zone of skin,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624129
9713,1,,1,Rattus norvegicus,In vivo,,10116.0,14.0,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Zone of skin,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624130
9714,1,,1,Rattus norvegicus,In vivo,,10116.0,14.0,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Zone of skin,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622340
9715,1,,1,Rattus norvegicus,In vivo,,10116.0,14.0,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Zone of skin,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622341
9716,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622342
9717,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622343
9718,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622344
9719,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622345
9720,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622346
9721,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622347
9722,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622348
9723,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622349
9724,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622350
9725,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622351
9726,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622352
9727,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622353
9728,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622354
9729,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622355
9730,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622356
9731,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622357
9732,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622358
9733,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622359
9734,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874393
9735,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622872
9736,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622873
9737,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623047
9738,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623048
9739,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623049
9740,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623050
9741,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623051
9742,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623052
9743,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626343
9744,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626344
9745,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626345
9746,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626346
9747,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626347
9748,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626348
9749,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626349
9750,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626350
9751,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626351
9752,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627650
9753,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627651
9754,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627652
9755,1,,1,Rattus norvegicus,,,10116.0,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627653
9756,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627654
9757,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627835
9758,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627836
9759,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627837
9760,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627838
9761,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875338
9762,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627839
9763,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627840
9764,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627841
9765,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627842
9766,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627843
9767,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627844
9768,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627845
9769,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period in rat by iv administration at a dose of 3 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627846
9770,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627847
9771,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873821
9772,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626079
9773,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626080
9774,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life period was evaluated in rat plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626081
9775,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life period was evaluated in rat plasma; Not tested,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875344
9776,1,,1,Rattus norvegicus,,,10116.0,,,Half life period was evaluated in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626082
9777,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Half life period was evaluated in rats, iv",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626250
9778,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period after intravenous administration at 5 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626251
9779,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626252
9780,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626253
9781,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life stability of compound was evaluated in rat plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626254
9782,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626255
9783,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626256
9784,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626257
9785,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626258
9786,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626259
9787,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half in rat i.v.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626260
9788,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half period in rat after intravenous administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875345
9789,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626261
9790,1,,1,Rattus norvegicus,In vitro,,10116.0,2107.0,,Half-life measured in in vitro Cathepsin B assay in rat liver,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626262
9791,1,,1,Rattus norvegicus,,,10116.0,,,Half-life of compound was determined in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626263
9792,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life at 10 mg/kg in rat upon intravenous administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625270
9793,1,,1,Rattus norvegicus,,,10116.0,,,Half-life determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625271
9794,1,,1,Rattus norvegicus,,,10116.0,,,Half-life determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625272
9795,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625273
9796,1,,1,Rattus norvegicus,,,10116.0,1969.0,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625274
9797,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625275
9798,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625276
9799,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half-life in rat plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625277
9800,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half-life in rat plasma was determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625278
9801,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half-life in rat plasma; Not tested,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625279
9802,1,,1,Rattus norvegicus,,,10116.0,1977.0,,Half-life in rat serum,Serum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625280
9803,1,,1,Rattus norvegicus,,,10116.0,1977.0,,Half-life in rat serum; na is not available,Serum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876797
9804,1,,1,Rattus norvegicus,,,10116.0,,,Half-life was calculated in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625281
9805,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half-life was calculated in rat plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873827
9806,1,,1,Rattus norvegicus,,,10116.0,,,Half-life was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625282
9807,1,,1,Rattus norvegicus,,,10116.0,,,Half-life was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625283
9808,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life after administration of 20 mg/Kg oral dose in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625284
9809,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life after administration of 3.2 mg/kg intravenously in male rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625285
9810,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life after intravenous administration in female rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625286
9811,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life after intravenous administration in male rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625287
9812,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life after intravenous dose in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625288
9813,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Half-life in a rat liver homogenate preparation,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625289
9814,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half-life in plasma of rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625290
9815,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half-life in plasma of rat at dose of 3-10 mgkg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876798
9816,1,,1,Rattus norvegicus,,,10116.0,,,Half-life in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625291
9817,1,,1,Rattus norvegicus,,,10116.0,,,Half-life in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625292
9818,1,,1,Rattus norvegicus,,,10116.0,,,Half-life in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625293
9819,1,,1,Rattus norvegicus,,,10116.0,,,Half-life in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622832
9820,1,,1,Rattus norvegicus,,,10116.0,,,Half-life in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622833
9821,1,,1,Rattus norvegicus,,,10116.0,,,Half-life in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622834
9822,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life in rat after oral administration at 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622835
9823,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life in rat after po administration at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622836
9824,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622837
9825,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life in rat at 3 mg/kg dose administered intravenously,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622838
9826,1,,1,Rattus norvegicus,,,10116.0,955.0,,Half-life in rat brain homogenate,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622839
9827,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half-life in rat plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622840
9828,1,,1,Rattus norvegicus,,,10116.0,,,Half-life in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622841
9829,1,,1,Rattus norvegicus,,,10116.0,,,Half-life in Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622842
9830,1,,1,Rattus norvegicus,In vitro,,10116.0,1969.0,,Half-life in vitro in rat plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622843
9831,1,,1,Rattus norvegicus,In vitro,,10116.0,1969.0,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622844
9832,1,,1,Rattus norvegicus,,,10116.0,,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622845
9833,1,,1,Rattus norvegicus,,,10116.0,,,The area under the curve of compound was measured at the dose of 100 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622846
9834,1,,1,Rattus norvegicus,,,10116.0,,,The area under the curve of compound was measured at the dose of 300 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622847
9835,1,,1,Rattus norvegicus,,,10116.0,,,The area under the curve of compound was measured at the dose of 30 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622848
9836,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability as oral AUC in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622849
9837,1,,1,Rattus norvegicus,,,10116.0,1969.0,,The plasma concentration versus time curve (AUC) was determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622850
9838,1,,1,Rattus norvegicus,,,10116.0,,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876807
9839,1,,1,Rattus norvegicus,,,10116.0,,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622851
9840,1,,1,Rattus norvegicus,,,10116.0,,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622852
9841,1,,1,Rattus norvegicus,,,10116.0,,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622853
9842,1,,1,Rattus norvegicus,,,10116.0,,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622854
9843,1,,1,Rattus norvegicus,,,10116.0,,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622855
9844,1,,1,Rattus norvegicus,,,10116.0,1969.0,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622856
9845,1,,1,Rattus norvegicus,,,10116.0,1969.0,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622857
9846,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC in rat after po administration at a dose of 10 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622858
9847,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622859
9848,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622860
9849,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622861
9850,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622862
9851,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622863
9852,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve value 6 hr after po administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623817
9853,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623818
9854,1,,1,Rattus norvegicus,,,10116.0,,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623819
9855,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623820
9856,1,,1,Rattus norvegicus,,,10116.0,,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623821
9857,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC normalized for dose (AUCN) in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623822
9858,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve in rat after p.o. administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623823
9859,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve in rat after p.o. administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623824
9860,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve in rat after p.o. administration; Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623825
9861,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve in rat after peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622070
9862,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve (carotid artery) value of the compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622071
9863,1,,1,Rattus norvegicus,,,10116.0,,,Bioavailability expressed as the area under curve of rat carotid artery,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622072
9864,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve in male SD rats was observed after intravenous administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622073
9865,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve of the compound was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622074
9866,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622075
9867,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622076
9868,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622077
9869,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve (portal vein) value of the compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622078
9870,1,,1,Rattus norvegicus,,,10116.0,,,Bioavailability expressed as the area under curve of rat portal vein,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622079
9871,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Area Under plasma concentration time curve in rat upon peroral administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622080
9872,1,,1,Rattus norvegicus,,,10116.0,,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877612
9873,1,,1,Rattus norvegicus,,,10116.0,,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622081
9874,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for oral bioavailability in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622082
9875,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for oral bioavailability in rats after iv administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622083
9876,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for oral bioavailability in rats; 30-80,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622084
9877,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for oral bioavailability in rats; 50-60,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622085
9878,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for oral bioavailability in rats; no data,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622086
9879,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for oral bioavailability in rats; peptide,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622087
9880,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622088
9881,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622089
9882,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623685
9883,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623686
9884,1,,1,Rattus norvegicus,In vivo,,10116.0,945.0,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623687
9885,1,,1,Rattus norvegicus,In vivo,,10116.0,945.0,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623688
9886,1,,1,Rattus norvegicus,In vivo,,10116.0,945.0,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623689
9887,1,,1,Rattus norvegicus,In vivo,,10116.0,945.0,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Stomach,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622485
9888,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622486
9889,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877613
9890,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622487
9891,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622488
9892,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622489
9893,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622490
9894,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622491
9895,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622492
9896,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622493
9897,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622494
9898,1,,1,Rattus norvegicus,,,10116.0,2385.0,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622495
9899,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622496
9900,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622497
9901,1,,1,Rattus norvegicus,,,10116.0,,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622498
9902,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624918
9903,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624919
9904,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of compound in rat blood after 5 min of administration,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624920
9905,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of compound in rat blood after 5 min of administration.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624921
9906,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of compound in rat brain after 5 min of administration,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624922
9907,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of compound in rat heart after 5 min of administration,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624923
9908,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of compound in rat heart after 5 min of administration.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624924
9909,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of compound in rat kidney after 5 min of administration,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624925
9910,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of compound in rat kidney after 5 min of administration.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624926
9911,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of compound in rat liver after 5 min of administration,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624927
9912,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of compound in rat liver after 5 min of administration.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874402
9913,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of compound in rat lung after 5 min of administration,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624928
9914,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of compound in rat lung after 5 min of administration.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624929
9915,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of compound in rat muscle after 5 min of administration,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624930
9916,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of compound in rat muscle after 5 min of administration.,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624931
9917,1,,1,Rattus norvegicus,,,10116.0,948.0,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624932
9918,1,,1,Rattus norvegicus,,,10116.0,948.0,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624933
9919,1,,1,Rattus norvegicus,,,10116.0,2107.0,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624934
9920,1,,1,Rattus norvegicus,,,10116.0,2107.0,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624935
9921,1,,1,Rattus norvegicus,,,10116.0,,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624936
9922,1,,1,Rattus norvegicus,,,10116.0,,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624937
9923,1,,1,Rattus norvegicus,,,10116.0,2106.0,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624938
9924,1,,1,Rattus norvegicus,,,10116.0,2106.0,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624939
9925,1,,1,Rattus norvegicus,,,10116.0,,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624940
9926,1,,1,Rattus norvegicus,,,10116.0,,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874403
9927,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624941
9928,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624942
9929,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624943
9930,1,,1,Rattus norvegicus,In vivo,,10116.0,,,% Bioavailability after 1 day of the drug administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624944
9931,1,,1,Rattus norvegicus,In vivo,,10116.0,,,% Bioavailability after 4 day of the drug administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624945
9932,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Absolute bioavailability was evaluated in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624946
9933,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624947
9934,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624948
9935,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624949
9936,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622025
9937,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622026
9938,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622027
9939,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622028
9940,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622029
9941,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622208
9942,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622209
9943,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622210
9944,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622211
9945,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622212
9946,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622213
9947,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874404
9948,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620452
9949,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620453
9950,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620454
9951,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624067
9952,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624068
9953,1,,1,Rattus norvegicus,,,10116.0,992.0,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,Female gonad,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624069
9954,1,,1,Rattus norvegicus,,,10116.0,992.0,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,Female gonad,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624070
9955,1,,1,Rattus norvegicus,,,10116.0,992.0,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,Female gonad,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624071
9956,1,,1,Rattus norvegicus,,,10116.0,995.0,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624072
9957,1,,1,Rattus norvegicus,,,10116.0,995.0,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624073
9958,1,,1,Rattus norvegicus,,,10116.0,995.0,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624788
9959,1,,1,Rattus norvegicus,,,10116.0,995.0,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624789
9960,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624790
9961,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624791
9962,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624792
9963,1,,1,Rattus norvegicus,,,10116.0,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624793
9964,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877491
9965,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624957
9966,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624958
9967,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624959
9968,1,,1,Rattus norvegicus,,,10116.0,,,Dissociation constant was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624960
9969,1,,1,Rattus norvegicus,,,10116.0,,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624961
9970,1,,1,Rattus norvegicus,,,10116.0,,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624962
9971,1,,1,Rattus norvegicus,,,10116.0,,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624963
9972,1,,1,Rattus norvegicus,,,10116.0,,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624964
9973,1,,1,Rattus norvegicus,,,10116.0,,,LogP value was evaluated in the in situ rat gut perfusion assay,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624965
9974,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624966
9975,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624967
9976,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624968
9977,1,,1,Rattus norvegicus,,,10116.0,,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624969
9978,1,,1,Rattus norvegicus,,,10116.0,,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,,,,BAO_0000218,50597,N,Expert,CHEMBL624970
9979,1,,1,Rattus norvegicus,,,10116.0,,,Half-life was evaluated after 10 uM/kg of intra arterial administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624971
9980,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life was evaluated after 20 uM/kg of peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624972
9981,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624973
9982,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half-life was evaluated in plasma of rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624974
9983,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624975
9984,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877492
9985,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life was measured in rat after an iv dose of 1 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624976
9986,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life period of compound in rats after peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624977
9987,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half-life period of compound was measured in rat plasma.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626848
9988,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half-life period of compound was measured in rat plasma; ND is not determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626849
9989,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half-life period of compound was measured in rat plasma; not determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626850
9990,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626851
9991,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life period in rat by iv administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626852
9992,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life period in rats following intravenous administration at 2 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626853
9993,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626854
9994,1,,1,Rattus norvegicus,,,10116.0,,,Half-life period was determined for the compound in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627486
9995,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627487
9996,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627488
9997,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627489
9998,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627490
9999,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873829
10000,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life was determined in rat at a dose of 1 mpk i.v.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627655
10001,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625994
10002,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625995
10003,1,,1,Rattus norvegicus,,,10116.0,,,Half-life in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625996
10004,1,,1,Rattus norvegicus,In vitro,,10116.0,1969.0,,In vitro half life in rat plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625850
10005,1,,1,Rattus norvegicus,In vitro,,10116.0,1969.0,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625851
10006,1,,1,Rattus norvegicus,In vitro,,10116.0,,,In vitro half life in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625852
10007,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo half life period after intravenous administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625853
10008,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625854
10009,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874450
10010,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625855
10011,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625856
10012,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625857
10013,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873831
10014,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Longer half-life in rat (i.v.) at 0.5 mpk,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625858
10015,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Longer half-life in rat (p.o.) at 2.0 mpk,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625859
10016,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic property (half life) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625860
10017,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625861
10018,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625862
10019,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625863
10020,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625864
10021,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625865
10022,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic half time was determined intravenously in rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625866
10023,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625867
10024,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Plasma half life of hydrolysis of the compound,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625868
10025,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625869
10026,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Plasma half life period was calculated in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874451
10027,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Plasma half-life in Sprague-Dawley rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625870
10028,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Plasma half-life in Sprague-Dawley rats; Not determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625871
10029,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Plasma half-life in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625872
10030,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Plasma half-life in rats; <MQL,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625873
10031,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Plasma half-life period (0-8 h) was determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625874
10032,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625875
10033,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625876
10034,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631258
10035,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631259
10036,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631260
10037,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631261
10038,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631262
10039,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631263
10040,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631264
10041,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631265
10042,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631266
10043,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631267
10044,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631268
10045,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631269
10046,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631270
10047,1,,1,Rattus norvegicus,,,10116.0,948.0,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631271
10048,1,,1,Rattus norvegicus,,,10116.0,948.0,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631272
10049,1,,1,Rattus norvegicus,,,10116.0,948.0,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631273
10050,1,,1,Rattus norvegicus,,,10116.0,948.0,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631274
10051,1,,1,Rattus norvegicus,,,10116.0,948.0,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631275
10052,1,,1,Rattus norvegicus,,,10116.0,948.0,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626984
10053,1,,1,Rattus norvegicus,,,10116.0,948.0,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626985
10054,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626986
10055,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626987
10056,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626988
10057,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626989
10058,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626990
10059,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626991
10060,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626992
10061,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626993
10062,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874593
10063,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626994
10064,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626995
10065,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626190
10066,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626191
10067,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626364
10068,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626365
10069,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626366
10070,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626367
10071,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626368
10072,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626369
10073,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626370
10074,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626371
10075,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626372
10076,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability after a dose of 10 mg/kg p.o.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626373
10077,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626374
10078,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626375
10079,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626376
10080,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat po was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626377
10081,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability of compound at 10 mg/kg in rat after oral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626378
10082,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626379
10083,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626380
10084,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626381
10085,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626382
10086,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (Sprague-Dawley) (female),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626383
10087,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874652
10088,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626384
10089,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626385
10090,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat at an oral dose of 2 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626386
10091,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626387
10092,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626388
10093,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626389
10094,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626390
10095,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626391
10096,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626392
10097,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626393
10098,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623026
10099,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623027
10100,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623028
10101,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat after 1 day dosing,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623029
10102,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat after 4 day dosing,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623030
10103,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623031
10104,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623032
10105,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623033
10106,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623034
10107,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623035
10108,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623036
10109,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623037
10110,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623038
10111,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874385
10112,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (Fisher) (fasted),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623039
10113,1,,0,Primates,In vivo,,9443.0,,,Bioavailability in monkey after po administration of 10 mg/kg dose,,,,,BAO_0000218,22224,U,Intermediate,CHEMBL623040
10114,1,,0,Primates,In vivo,,9443.0,,,Oral bioavailability in monkey (dose 10 mg/kg),,,,,BAO_0000218,22224,U,Intermediate,CHEMBL623041
10115,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623741
10116,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623742
10117,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623743
10118,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623744
10119,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 2.0 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623745
10120,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623746
10121,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 5 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623747
10122,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat after po administration of 30 mg/kg dose,,,,,BAO_0000218,22224,U,Intermediate,CHEMBL623748
10123,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat after po administration of 30 mg/kg dose,,,,,BAO_0000218,22224,U,Intermediate,CHEMBL623916
10124,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623917
10125,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 2 mg/kg i.v.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623918
10126,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874386
10127,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Bioavailability in rat; Only traces detected in rat plasma,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623919
10128,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623920
10129,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability upon oral administration of compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623148
10130,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623149
10131,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623150
10132,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623151
10133,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623152
10134,1,,1,Rattus norvegicus,,,10116.0,,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,,,,BAO_0000218,50597,N,Expert,CHEMBL623153
10135,1,,1,Rattus norvegicus,,,10116.0,,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,,,,BAO_0000218,50597,N,Expert,CHEMBL623154
10136,1,,1,Rattus norvegicus,,,10116.0,,,In vitro and metabolic stability was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623155
10137,1,,1,Rattus norvegicus,,,10116.0,,,In vitro metabolic stability in rat hepatocytes,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623156
10138,1,,1,Rattus norvegicus,,,10116.0,,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623157
10139,1,Hepatocyte,1,Rattus norvegicus,In vitro,,10116.0,2107.0,401.0,Metabolic rate for compound was observed in rat hepatocytes,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623158
10140,1,,1,Rattus norvegicus,,,10116.0,,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623159
10141,1,,1,Rattus norvegicus,,,10116.0,,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874390
10142,1,,1,Rattus norvegicus,,,10116.0,,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623160
10143,1,,1,Rattus norvegicus,,,10116.0,,,Metabolism of compound in rat S9 microsomes; Trace,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623161
10144,1,,1,Rattus norvegicus,,,10116.0,,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623162
10145,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623163
10146,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623164
10147,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623165
10148,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623166
10149,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624983
10150,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624984
10151,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624985
10152,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622970
10153,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622971
10154,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622972
10155,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622973
10156,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622974
10157,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622975
10158,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622976
10159,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622977
10160,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624351
10161,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624352
10162,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624353
10163,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622397
10164,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622398
10165,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622399
10166,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622400
10167,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628428
10168,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628590
10169,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628591
10170,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628592
10171,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628593
10172,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875333
10173,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628594
10174,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628595
10175,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Stability in rat plasma was determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628596
10176,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Stability in rat plasma was determined; ND= no data,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628597
10177,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Tested for plasma half life period in rat (0-8 hr),Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628598
10178,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Tested for plasma half life period in rat (0-8 hr); Not determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628599
10179,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628600
10180,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628601
10181,1,,1,Rattus norvegicus,,,10116.0,,,Tested for the half life in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628602
10182,1,,1,Rattus norvegicus,In vitro,,10116.0,,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628603
10183,1,,1,Rattus norvegicus,In vitro,,10116.0,,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628604
10184,1,,1,Rattus norvegicus,In vitro,,10116.0,,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628605
10185,1,,1,Rattus norvegicus,In vitro,,10116.0,,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628606
10186,1,,1,Rattus norvegicus,In vitro,,10116.0,,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628607
10187,1,,1,Rattus norvegicus,,,10116.0,,,The biological half life the compound was measured at the dose of 100 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628608
10188,1,,1,Rattus norvegicus,,,10116.0,,,The biological half life the compound was measured at the dose of 30 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628609
10189,1,,1,Rattus norvegicus,,,10116.0,1969.0,,The compound was evaluated for plasma half life period in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628610
10190,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL873819
10191,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628611
10192,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The pharmacokinetic parameter half-life period in vivo in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628612
10193,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"The pharmacokinetic property, Half-life was determined",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628613
10194,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"The pharmacokinetic property, Half-life in rat in vivo",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628614
10195,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628615
10196,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628616
10197,1,,1,Rattus norvegicus,,,10116.0,1969.0,,The plasma half life period in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627924
10198,1,,1,Rattus norvegicus,,,10116.0,2107.0,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627925
10199,1,,1,Rattus norvegicus,In vivo,,10116.0,,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627926
10200,1,,1,Rattus norvegicus,,,10116.0,,,t1/2 (apparent elimination)of the compound was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627927
10201,1,,1,Rattus norvegicus,,,10116.0,,,t1/2 value in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627928
10202,1,,1,Rattus norvegicus,,,10116.0,,,Half life in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627539
10203,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876790
10204,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL858186
10205,1,,1,Rattus norvegicus,,,10116.0,,,Half-life period in fasted rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627540
10206,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627541
10207,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627715
10208,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627716
10209,1,,1,Rattus norvegicus,,,10116.0,,,Maximum time required to achieve Cmax was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627717
10210,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627718
10211,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627719
10212,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627720
10213,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627721
10214,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627722
10215,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627723
10216,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626058
10217,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626059
10218,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626060
10219,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626061
10220,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876791
10221,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626062
10222,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax at the dose of 2 mg/Kg administered perorally in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626063
10223,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tmax at the dose of 5 mg/Kg administered perorally in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626064
10224,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626065
10225,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626066
10226,1,,1,Rattus norvegicus,In vivo,,10116.0,,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626067
10227,1,,1,Rattus norvegicus,,,10116.0,,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626068
10228,1,,1,Rattus norvegicus,,,10116.0,,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626069
10229,1,,1,Rattus norvegicus,,,10116.0,,,Percent total excretion of 3-methoxyacetaminophen glucuronide,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626070
10230,1,,1,Rattus norvegicus,,,10116.0,,,Percent total excretion of N-methoxyacetaminophen glucuronide,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626071
10231,1,,1,Rattus norvegicus,,,10116.0,,,Percent total excretion of N-methoxyacetaminophen sulfate,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626072
10232,1,,1,Rattus norvegicus,,,10116.0,,,Percent total excretion of acetaminophen,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626073
10233,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626741
10234,1,,1,Rattus norvegicus,,,10116.0,,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626742
10235,1,,1,Rattus norvegicus,,,10116.0,,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626743
10236,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876792
10237,1,,1,Rattus norvegicus,,,10116.0,,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626744
10238,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for antidiuretic activity in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626745
10239,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,AUC in rat after 3mg/kg oral dose,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626746
10240,1,,1,Rattus norvegicus,,,10116.0,,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626747
10241,1,,1,Rattus norvegicus,,,10116.0,,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626748
10242,1,,1,Rattus norvegicus,,,10116.0,,,Bioavailability administered orally at a dose of 10 mg/kg to rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626749
10243,1,,1,Rattus norvegicus,,,10116.0,,,Oral Bioavailability was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626750
10244,1,,1,Rattus norvegicus,,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626751
10245,1,,1,Rattus norvegicus,,,10116.0,,,Oral bioavailability in rat; Not performed.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626913
10246,1,,1,Rattus norvegicus,,,10116.0,,,Bioavailability,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626914
10247,1,,1,Rattus norvegicus,,,10116.0,,,Bioavailability was determined; ND denotes no data,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626915
10248,1,,1,Rattus norvegicus,,,10116.0,,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626916
10249,1,,1,Rattus norvegicus,,,10116.0,,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626917
10250,1,,1,Rattus norvegicus,,,10116.0,,,Binding towards rat plasma protein at 10 uM,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626918
10251,1,,1,Rattus norvegicus,,,10116.0,,,Binding towards rat plasma protein at 100 uM,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626919
10252,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 20 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626920
10253,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621976
10254,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat after 5 mg/kg oral gavage,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877599
10255,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621977
10256,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 1 mg/kg i.v.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621978
10257,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 3 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621979
10258,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621980
10259,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability of the compound in rats after administration of 30 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621981
10260,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability after administration of 10 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621982
10261,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability after administration of 2 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL882953
10262,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621983
10263,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in dogs was determined; high,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621984
10264,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in monkey after intravenous administration at 1 mpk,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621985
10265,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in monkey after peroral administration at 10 mpk,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621986
10266,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat after intravenous administration at 1 mpk,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621987
10267,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat after intravenous administration at 2 mpk,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877600
10268,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat after peroral administration at 30 mpk,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621988
10269,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat after peroral administration at at 100 mpk,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621989
10270,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rats was evaluated,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621990
10271,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621991
10272,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621992
10273,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621993
10274,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621994
10275,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621995
10276,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621996
10277,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 10 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621997
10278,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621998
10279,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621999
10280,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622000
10281,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was measured in rat after oral administration; 2-4,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622001
10282,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was measured in rat after oral administration; 3-7,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622002
10283,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (intraduodenal administration),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622003
10284,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (intraduodenal administration),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877601
10285,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624871
10286,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622004
10287,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL882954
10288,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622005
10289,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622006
10290,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was measured in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622007
10291,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was reported,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622008
10292,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622009
10293,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622010
10294,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622011
10295,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622012
10296,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622013
10297,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622014
10298,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was determined at 3 mg/kg po dose in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624749
10299,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 2 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624750
10300,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624751
10301,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624752
10302,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624753
10303,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624754
10304,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624755
10305,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624756
10306,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624757
10307,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624758
10308,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622270
10309,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (Sprague-Dawley),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622271
10310,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat at the dose of 2 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622272
10311,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622273
10312,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (cannulated) (dose 2 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622274
10313,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability value of compound in rats was determined after peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622275
10314,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 20 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622276
10315,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622277
10316,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 5 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622278
10317,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622279
10318,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622280
10319,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for oral bioavailability in rats; 15-27 %,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624083
10320,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624084
10321,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624085
10322,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was tested for bioavailability in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624086
10323,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624087
10324,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624088
10325,1,,0,Macaca mulatta,In vivo,,9544.0,,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,,,,BAO_0000218,22224,U,Intermediate,CHEMBL624089
10326,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,,,BAO_0000218,22224,U,Intermediate,CHEMBL624090
10327,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Evaluated for the bioavailability in rat (in vivo),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624091
10328,1,,1,Rattus norvegicus,In vivo,,10116.0,,,F value of compound in rats was determined after peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624092
10329,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624093
10330,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624094
10331,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624095
10332,1,,1,Rattus norvegicus,In vivo,,10116.0,,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624096
10333,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624097
10334,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum fall in carotid flow in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624098
10335,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874392
10336,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 5 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624099
10337,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624100
10338,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624101
10339,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (male Wistar),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624102
10340,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability after administration (30 mg/kg) in rat; good,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624103
10341,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability at the dose of 2 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624104
10342,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability determined in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624105
10343,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624106
10344,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose single 10 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624107
10345,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose single 10 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623943
10346,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623944
10347,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623945
10348,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623946
10349,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623947
10350,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623948
10351,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623949
10352,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623950
10353,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874398
10354,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623951
10355,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623952
10356,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623953
10357,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623954
10358,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623955
10359,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623956
10360,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627807
10361,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627808
10362,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627809
10363,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627810
10364,1,,1,Rattus norvegicus,,,10116.0,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627811
10365,1,,1,Rattus norvegicus,,,10116.0,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627812
10366,1,,1,Rattus norvegicus,,,10116.0,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627813
10367,1,,1,Rattus norvegicus,,,10116.0,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627814
10368,1,,1,Rattus norvegicus,,,10116.0,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875336
10369,1,,1,Rattus norvegicus,,,10116.0,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627815
10370,1,,1,Rattus norvegicus,,,10116.0,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627816
10371,1,,1,Rattus norvegicus,,,10116.0,,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627817
10372,1,,1,Rattus norvegicus,,,10116.0,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627818
10373,1,,1,Rattus norvegicus,,,10116.0,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627819
10374,1,,1,Rattus norvegicus,,,10116.0,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627820
10375,1,,1,Rattus norvegicus,,,10116.0,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627821
10376,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628464
10377,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626239
10378,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626240
10379,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626241
10380,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626242
10381,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626243
10382,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626244
10383,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626907
10384,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626908
10385,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626909
10386,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626910
10387,1,,1,Rattus norvegicus,,,10116.0,,,Percent total excretion of acetaminophen cysteine conjugate,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875342
10388,1,,1,Rattus norvegicus,,,10116.0,,,Percent total excretion of acetaminophen glucuronide,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626911
10389,1,,1,Rattus norvegicus,,,10116.0,,,Percent total excretion of acetaminophen sulfate,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626912
10390,1,,1,Rattus norvegicus,,,10116.0,,,Percent total excretion of acetaminophen-mercapturic acid,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627065
10391,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627066
10392,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627067
10393,1,,0,ratrat,In vivo,,8656.0,2385.0,,Biodistribution of compound in rat muscle after 5 min of administration,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627068
10394,1,,0,ratrat,In vivo,,8656.0,2385.0,,Biodistribution of compound in rat muscle after 5 min of administration.,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627069
10395,1,,0,Ovis aries,In vivo,,9940.0,,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627070
10396,1,,0,Ovis aries,In vivo,,9940.0,,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627071
10397,1,,0,Ovis aries,In vivo,,9940.0,,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627072
10398,1,,0,Ovis aries,In vivo,,9940.0,,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627073
10399,1,,0,Ovis aries,In vivo,,9940.0,,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625387
10400,1,,0,Ovis aries,In vivo,,9940.0,,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625388
10401,1,,0,Ovis aries,In vivo,,9940.0,1969.0,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625389
10402,1,,0,Ovis aries,In vivo,,9940.0,1969.0,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL875343
10403,1,,1,Serpentes,,,8570.0,,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,,,,BAO_0000218,50497,N,Intermediate,CHEMBL876795
10404,1,,1,Serpentes,,,8570.0,,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,,,,BAO_0000218,50497,N,Intermediate,CHEMBL626552
10405,1,,1,Serpentes,,,8570.0,,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,,,,BAO_0000218,50497,N,Intermediate,CHEMBL626553
10406,1,,0,Homo sapiens,,,9606.0,1969.0,,The human biological plasma half life of the compound,Plasma,,,,BAO_0000366,22224,U,Autocuration,CHEMBL626554
10407,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626555
10408,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626556
10409,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626557
10410,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626558
10411,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626559
10412,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626560
10413,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876803
10414,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627964
10415,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627965
10416,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627966
10417,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627967
10418,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627968
10419,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627969
10420,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627970
10421,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627971
10422,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627972
10423,1,,9,Homo sapiens,,,9606.0,,,Dissociation constant against binding to human cyclophilin A,,,,,BAO_0000357,180,D,Expert,CHEMBL856029
10424,1,,8,Bos taurus,,,9913.0,,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,,,,BAO_0000019,11591,H,Expert,CHEMBL627973
10425,1,,0,,,,,,,-Log C was determined by performing the electroshock minimum test,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627974
10426,1,,0,,,,,,,-Log C was determined by performing the foot shock test,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627975
10427,1,,0,,,,,,,-Log C was determined by performing the incl screen test,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627976
10428,1,,0,,,,,,,-Log C was determined by performing the maximum electroshock test,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627977
10429,1,,0,,,,,,,-Log C was determined by performing the pentylenetetrazole test,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627978
10430,1,,0,,,,,,,Tested for experimental arotinoid inhibitory dose,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627979
10431,1,,0,,,,,,,Negative log transformed activity,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL876804
10432,1,,0,,,,,,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627980
10433,1,,1,Cavia porcellus,,,10141.0,,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,,,,BAO_0000218,50512,N,Intermediate,CHEMBL627981
10434,1,,1,Cavia porcellus,,,10141.0,,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,,,,BAO_0000218,50512,N,Intermediate,CHEMBL627982
10435,1,,1,Cavia porcellus,,,10141.0,,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,,,,BAO_0000218,50512,N,Intermediate,CHEMBL627983
10436,1,,1,Cavia porcellus,,,10141.0,2116.0,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,Ileum,,,,BAO_0000218,50512,N,Intermediate,CHEMBL627984
10437,1,,0,,,,,,,Solubility in water was determined; values expressed as -log,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL627985
10438,1,,0,,,,,,,Ratio of Kcat to that of Km was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627986
10439,1,,0,,,,,,,Observed first order rate constant,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627987
10440,1,,0,,,,,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627988
10441,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627989
10442,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627990
10443,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral Bioavailability after administration of 10 mg/kg in male rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876805
10444,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627991
10445,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627992
10446,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627993
10447,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability at 1 mg/kg was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622817
10448,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability at 10 mg/kg was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622818
10449,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622819
10450,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL872267
10451,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622820
10452,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622821
10453,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622822
10454,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622823
10455,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622824
10456,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat at a dose of 3 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622825
10457,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat after oral administration at 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622901
10458,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622902
10459,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621844
10460,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621845
10461,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621846
10462,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 30 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621847
10463,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877609
10464,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 3 mg/kg i.v.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621848
10465,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621849
10466,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622030
10467,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Percent oral bioavailability determined in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622031
10468,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622032
10469,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The compound was evaluated for bioavailability in rats; 32-51,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622033
10470,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 20 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622034
10471,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622035
10472,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability percent in rat at the dose of 2 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL882966
10473,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was evaluated after 20 uM/kg of peroral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622036
10474,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622037
10475,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622038
10476,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622039
10477,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622040
10478,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622041
10479,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622042
10480,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622043
10481,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622044
10482,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622045
10483,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622046
10484,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622047
10485,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877610
10486,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622048
10487,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622049
10488,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622050
10489,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622051
10490,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622052
10491,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622053
10492,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622054
10493,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622055
10494,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rats was determined; High,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622056
10495,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in the rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622057
10496,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628008
10497,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622058
10498,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622059
10499,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622060
10500,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622061
10501,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622062
10502,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622063
10503,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Expert,CHEMBL877611
10504,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability of compound in Sprague Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622064
10505,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability of compound in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622065
10506,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 2 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622066
10507,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability of compound in rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622067
10508,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability of compound in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622068
10509,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability of compound was determined in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622069
10510,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability at a dose of 30 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624796
10511,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 10 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624797
10512,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 10 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623053
10513,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability evaluated in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623054
10514,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in fasted rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623055
10515,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in fed rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623056
10516,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623057
10517,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623058
10518,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623059
10519,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat after administration of 10 mg/kg po,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623060
10520,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623061
10521,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623062
10522,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623063
10523,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623064
10524,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in ratrs,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623065
10525,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623066
10526,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623067
10527,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rats was determined; High,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623068
10528,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623069
10529,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623070
10530,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability was calculated in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623071
10531,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623072
10532,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623073
10533,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623074
10534,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623075
10535,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability after i.v. administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623076
10536,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623077
10537,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623078
10538,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623079
10539,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623080
10540,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623081
10541,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623082
10542,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in fasted rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874400
10543,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in fed rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623083
10544,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623084
10545,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623085
10546,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623086
10547,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623087
10548,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623088
10549,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623089
10550,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623090
10551,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623091
10552,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623092
10553,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623093
10554,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874401
10555,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623094
10556,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623095
10557,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat after peroral administration at 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623096
10558,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat after peroral administration at 5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624913
10559,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624914
10560,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624915
10561,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat; Not measured,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624916
10562,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624917
10563,1,,1,Rattus norvegicus,,,10116.0,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625157
10564,1,,1,Rattus norvegicus,,,10116.0,2107.0,,In vitro metabolic potential in rat liver microsomes,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625158
10565,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625159
10566,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625160
10567,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625161
10568,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625162
10569,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625163
10570,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rats at 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625164
10571,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625165
10572,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625166
10573,1,,1,Rattus norvegicus,,,10116.0,,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625167
10574,1,,1,Rattus norvegicus,,,10116.0,,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625168
10575,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance of the compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625169
10576,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626264
10577,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626265
10578,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,The compound was tested for plasma clearance in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626266
10579,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626267
10580,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration upon oral administration of 1 mg/Kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626268
10581,1,,1,Rattus norvegicus,,,10116.0,,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626269
10582,1,,1,Rattus norvegicus,,,10116.0,,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626270
10583,1,,1,Rattus norvegicus,,,10116.0,,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626271
10584,1,,1,Rattus norvegicus,,,10116.0,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626272
10585,1,,1,Rattus norvegicus,,,10116.0,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626273
10586,1,,1,Rattus norvegicus,,,10116.0,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875346
10587,1,,1,Rattus norvegicus,,,10116.0,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626274
10588,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for protein binding in rat plasma,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626275
10589,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624646
10590,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624647
10591,1,,1,Rattus norvegicus,,,10116.0,2107.0,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624648
10592,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve ratio was determined (po/iv) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624649
10593,1,,1,Rattus norvegicus,,,10116.0,,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624650
10594,1,,1,Rattus norvegicus,,,10116.0,,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624651
10595,1,,1,Rattus norvegicus,,,10116.0,,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624652
10596,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624653
10597,1,,1,Rattus norvegicus,,,10116.0,,,Ratio of AUCbrain to AUCplasma,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624654
10598,1,,1,Rattus norvegicus,,,10116.0,,,Ratio of brain to plasma,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624655
10599,1,,1,Rattus norvegicus,,,10116.0,,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624656
10600,1,,1,Rattus norvegicus,,,10116.0,,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624657
10601,1,,1,Rattus norvegicus,,,10116.0,,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624658
10602,1,,1,Rattus norvegicus,,,10116.0,,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624659
10603,1,,1,Rattus norvegicus,,,10116.0,,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624660
10604,1,,1,Rattus norvegicus,,,10116.0,,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624661
10605,1,,1,Rattus norvegicus,,,10116.0,,,Steady state brain :blood ratio was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624662
10606,1,,1,Rattus norvegicus,,,10116.0,,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625199
10607,1,,1,Rattus norvegicus,,,10116.0,,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625200
10608,1,,1,Rattus norvegicus,,,10116.0,,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625201
10609,1,,1,Rattus norvegicus,,,10116.0,,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625202
10610,1,,1,Rattus norvegicus,,,10116.0,,,Percentage recovery after 3h incubation with rat hapatocytes was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625203
10611,1,,1,Rattus norvegicus,,,10116.0,,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625204
10612,1,,1,Rattus norvegicus,,,10116.0,,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625205
10613,1,,1,Rattus norvegicus,,,10116.0,,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625206
10614,1,,0,,,,,,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625207
10615,1,,0,,,,,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625208
10616,1,Caco-2,1,Homo sapiens,,,9606.0,,495.0,In vivo absorption in Caco-2 cell line monolayers was determined,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL625209
10617,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625210
10618,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determine after peroral administration at 10 mpk in Rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625211
10619,1,,1,Macaca mulatta,,,9544.0,,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,,,,BAO_0000218,50797,N,Intermediate,CHEMBL625212
10620,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determine after peroral administration at 160 mpk in Rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625213
10621,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determine after peroral administration at 20 mpk in Rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625214
10622,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve was determine after peroral administration at 50 mpk in Rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874542
10623,1,,0,,,,,,,Calculated partition coefficient (clogP) (AlogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625215
10624,1,,0,,,,,,,Activated partial thromboplastin time measured,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625216
10625,1,,0,,,,,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,,,,BAO_0000100,22224,U,Autocuration,CHEMBL625217
10626,1,,0,,,,,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,,,,BAO_0000100,22224,U,Autocuration,CHEMBL625218
10627,1,,1,Canis lupus familiaris,,,9615.0,1969.0,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622864
10628,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622865
10629,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622866
10630,1,,1,Canis lupus familiaris,,,9615.0,1969.0,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622867
10631,1,,1,Cavia porcellus,,,10141.0,1969.0,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,Plasma,,,,BAO_0000218,50512,N,Intermediate,CHEMBL876808
10632,1,,0,,,,,955.0,,AUC in brain,Brain,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627725
10633,1,,0,,,,,1977.0,,AUC in serum,Serum,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627726
10634,1,,0,,,,,1969.0,,AUC was determined,Plasma,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627727
10635,1,,0,,,,,1969.0,,AUC of the compound.,Plasma,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627728
10636,1,,0,,,,,1969.0,,AUC value (0-4 hr),Plasma,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627729
10637,1,,0,,,,,1969.0,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",Plasma,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627730
10638,1,,0,,,,,1969.0,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,Plasma,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627731
10639,1,,0,,,,,1969.0,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",Plasma,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627732
10640,1,,0,,,,,1969.0,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",Plasma,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627733
10641,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC(area under curve) was determined after intravenous administration in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627734
10642,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC(area under curve) was determined after oral administration in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627735
10643,1,,1,Cavia porcellus,,,10141.0,1969.0,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,Plasma,,,,BAO_0000218,50512,N,Intermediate,CHEMBL627736
10644,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876809
10645,1,,0,,,,,,,Area Under Curve after oral dosing of 100 uM/Kg,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627737
10646,1,,0,,,,,,,Area Under Curve after oral dosing of 30 uM/Kg,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627738
10647,1,,0,,,,,,,Area Under Curve was measured by ploting the graph between concentration verses time,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627739
10648,1,,1,Canis lupus familiaris,,,9615.0,,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626143
10649,1,,0,Simiiformes,,,314293.0,,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626144
10650,1,,1,Oryctolagus cuniculus,,,9986.0,,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,,,,BAO_0000218,50592,N,Intermediate,CHEMBL626145
10651,1,,1,Rattus norvegicus,,,10116.0,,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626146
10652,1,,1,Rattus norvegicus,,,10116.0,178.0,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626147
10653,1,,0,,,,,,,Area under curve (AUC) was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626148
10654,1,,0,,,,,,,Area under curve (AUC) following ip administration at 1 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626149
10655,1,,0,,,,,,,Area under curve (AUC) was determined; ND is Not determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626150
10656,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626151
10657,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626152
10658,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626153
10659,1,,0,,,,,,,Area under curve (AUR) was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626154
10660,1,,0,,,,,,,Area under curve at 1 uM/dg administered intravenously,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626155
10661,1,,0,,,,,,,Area under curve at 10 uM/dg administered perorally,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626156
10662,1,,0,,,,,,,Area under curve at 2 uM/dg administered intravenously,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626157
10663,1,,0,,,,,,,Area under curve at 20 uM/dg administered perorally,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626158
10664,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve at a peroral dose of 3 mg/kg in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626159
10665,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve at a peroral dose of 3 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626160
10666,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve at an iv dose of 1 mg/kg in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626161
10667,1,,1,Rattus norvegicus,,,10116.0,,,Area under curve at an iv dose of 1 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626162
10668,1,,0,,,,,,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626163
10669,1,,0,,,,,,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626164
10670,1,,1,Mus musculus,,,10090.0,,,Area under curve measured as conc vs time after intravenous administration to mice.,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626165
10671,1,,1,Mus musculus,,,10090.0,,,Area under curve measured as conc vs time after peroral administration to mice.,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626166
10672,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626167
10673,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626168
10674,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL877463
10675,1,,1,Canis lupus familiaris,,,9615.0,,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626169
10676,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626170
10677,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626171
10678,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626172
10679,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626173
10680,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626174
10681,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626175
10682,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626176
10683,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626177
10684,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622499
10685,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622500
10686,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622501
10687,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622502
10688,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622503
10689,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877614
10690,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624839
10691,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624840
10692,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624841
10693,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624842
10694,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624843
10695,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624844
10696,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624845
10697,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621904
10698,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621905
10699,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874382
10700,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621906
10701,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621907
10702,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622096
10703,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622097
10704,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622098
10705,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622099
10706,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622100
10707,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622101
10708,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622102
10709,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622103
10710,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622104
10711,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622105
10712,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622106
10713,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622107
10714,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622108
10715,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622109
10716,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622110
10717,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622111
10718,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874383
10719,1,,1,Rattus norvegicus,In vivo,,10116.0,14.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,Zone of skin,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622112
10720,1,,1,Rattus norvegicus,In vivo,,10116.0,14.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,Zone of skin,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622113
10721,1,,1,Rattus norvegicus,In vivo,,10116.0,14.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,Zone of skin,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622114
10722,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622115
10723,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622116
10724,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622117
10725,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622118
10726,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rats at 6 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622119
10727,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 6 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622120
10728,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622121
10729,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622122
10730,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622123
10731,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622124
10732,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622125
10733,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622126
10734,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620455
10735,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620456
10736,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620457
10737,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability was evaluated; Not tested,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620458
10738,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620459
10739,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat by oral dosing,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620460
10740,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620461
10741,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620462
10742,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620463
10743,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620464
10744,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620465
10745,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620466
10746,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620467
10747,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620468
10748,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620469
10749,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620470
10750,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620471
10751,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620472
10752,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620473
10753,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620474
10754,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620475
10755,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620476
10756,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620477
10757,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620478
10758,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618768
10759,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618769
10760,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618770
10761,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability (dose 20 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618771
10762,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618772
10763,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat at 10 mg/kg of the compound,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618773
10764,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875842
10765,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 3 mg/kg i.v.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618774
10766,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618775
10767,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618776
10768,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Percent bioavailability (F) in rats after iv administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618777
10769,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618778
10770,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 5 uM/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618779
10771,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618780
10772,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 2 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618781
10773,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618782
10774,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 20 mg/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618783
10775,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618784
10776,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Percent oral bioavailability evaluated in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618785
10777,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618786
10778,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Percent oral bioavailability in rat; Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618787
10779,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618788
10780,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618789
10781,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618790
10782,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618791
10783,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875843
10784,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 20 mg/kg p.o.),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL618792
10785,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax at a dose of 30 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623395
10786,1,,0,Simiiformes,In vivo,,314293.0,,,Cmax in monkeys at a dose of 1 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623396
10787,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623397
10788,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rats at a dose of 1 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623398
10789,1,,1,Mus musculus,In vivo,,10090.0,,,Cmax was measured in mice after an oral dose of 50 mg/kg.,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623399
10790,1,,0,,In vivo,,,,,"Cmax value at a dose of 12.7 uM/kg, po",,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623400
10791,1,,0,,In vivo,,,,,"Cmax value at a dose of 6.3 uM/kg, iv",,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623401
10792,1,,0,,In vivo,,,,,"Cmax value at a dose of 7.1 uM/kg, iv",,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623402
10793,1,,0,,In vivo,,,,,Cmax value of compound was determined after 1 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623403
10794,1,,0,,In vivo,,,,,Cmax value of the compound,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623404
10795,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value administered intraintestinal in rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625997
10796,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value administered perorally was determined in rat; Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625998
10797,1,,0,,In vivo,,,,,Cmax value at the dose of 2.3 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625999
10798,1,,0,,In vivo,,,,,Cmax value at the dose of 5 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626000
10799,1,,0,,In vivo,,,,,Cmax value in the period of 8 hr after dosing. ,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626001
10800,1,,0,,In vivo,,,,,Cmax value at a oral dose of 20 mg/kg; Not tested,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626002
10801,1,,0,,In vivo,,,,,Cmax value at a oral dose of 20 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626003
10802,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626004
10803,1,,1,Cavia porcellus,In vivo,,10141.0,,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,,,,BAO_0000218,50512,N,Intermediate,CHEMBL626005
10804,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626006
10805,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626007
10806,1,,1,Mus musculus,In vivo,,10090.0,1969.0,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626008
10807,1,,1,Canis lupus familiaris,In vivo,,9615.0,2107.0,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,Liver,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626009
10808,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626010
10809,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626011
10810,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626012
10811,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626013
10812,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626014
10813,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL877496
10814,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626015
10815,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626016
10816,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626017
10817,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Bioavailability as maximal plasma concentration in dogs,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626018
10818,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Bioavailability as maximal plasma concentration in dogs,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626692
10819,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Bioavailability as maximal plasma concentration in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626693
10820,1,,0,Rattus norvegicus,In vivo,,10116.0,1969.0,,Bioavailability as maximal plasma concentration in rats,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626694
10821,1,,1,Canis lupus familiaris,In vivo,,9615.0,178.0,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Blood,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626695
10822,1,,1,Canis lupus familiaris,In vivo,,9615.0,178.0,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Blood,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626696
10823,1,,1,Canis lupus familiaris,In vivo,,9615.0,178.0,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Blood,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626697
10824,1,,1,Canis lupus familiaris,In vivo,,9615.0,178.0,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,Blood,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626859
10825,1,,1,Canis lupus familiaris,In vivo,,9615.0,178.0,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Blood,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626860
10826,1,,1,Canis lupus familiaris,In vivo,,9615.0,178.0,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Blood,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626861
10827,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626296
10828,1,,0,,In vivo,,,,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626297
10829,1,,0,,In vivo,,,1969.0,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626298
10830,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626299
10831,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626300
10832,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626301
10833,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626962
10834,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626963
10835,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626964
10836,1,,1,Macaca fascicularis,In vivo,,9541.0,1969.0,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,Plasma,,,,BAO_0000218,100710,N,Intermediate,CHEMBL626965
10837,1,,1,Mus musculus,In vivo,,10090.0,1969.0,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626966
10838,1,,1,Mus musculus,In vivo,,10090.0,1969.0,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626967
10839,1,,1,Macaca fascicularis,In vivo,,9541.0,1969.0,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,Plasma,,,,BAO_0000218,100710,N,Intermediate,CHEMBL626968
10840,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626969
10841,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627126
10842,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631276
10843,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631277
10844,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631278
10845,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874457
10846,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631279
10847,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631280
10848,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631281
10849,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631968
10850,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631969
10851,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631970
10852,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631971
10853,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631972
10854,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630435
10855,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630436
10856,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630437
10857,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630438
10858,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630439
10859,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630440
10860,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630441
10861,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630442
10862,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625234
10863,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625235
10864,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625236
10865,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625237
10866,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626125
10867,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626126
10868,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626127
10869,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626128
10870,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626129
10871,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626130
10872,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626131
10873,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626132
10874,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626752
10875,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626753
10876,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626754
10877,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626755
10878,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626756
10879,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626757
10880,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626758
10881,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626759
10882,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626760
10883,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626394
10884,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626395
10885,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626396
10886,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626397
10887,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626398
10888,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626399
10889,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874653
10890,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626400
10891,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626401
10892,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626402
10893,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626403
10894,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626404
10895,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626405
10896,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625529
10897,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625530
10898,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625531
10899,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625532
10900,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625533
10901,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875474
10902,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625534
10903,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625535
10904,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625536
10905,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625537
10906,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625538
10907,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625539
10908,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625540
10909,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625541
10910,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625542
10911,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625543
10912,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625544
10913,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625545
10914,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625546
10915,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625547
10916,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625548
10917,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625549
10918,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625550
10919,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625551
10920,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL875475
10921,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625552
10922,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625553
10923,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625554
10924,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625555
10925,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625556
10926,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624986
10927,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624987
10928,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624988
10929,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624989
10930,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624990
10931,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL874391
10932,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624991
10933,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624992
10934,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624993
10935,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624994
10936,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624995
10937,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624996
10938,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624997
10939,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624998
10940,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624999
10941,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL882955
10942,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625000
10943,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625001
10944,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625089
10945,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625090
10946,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625091
10947,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625092
10948,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625093
10949,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625094
10950,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625095
10951,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for its bioavailability in the dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625096
10952,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for its bioavailability in the rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625097
10953,1,,0,,In vivo,,,,,Compound was evaluated for oral bioavailability,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL882956
10954,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for percentage of Oral bioavailability in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625098
10955,1,,0,Cavia porcellus,In vivo,,10141.0,,,Bioavailability in guinea pig,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625099
10956,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for the oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625100
10957,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for the oral bioavailability in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625101
10958,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for the oral bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874396
10959,1,,0,Canis lupus familiaris,In vivo,,9615.0,,,Bioavailability in dog (dosed i.v.),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625102
10960,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was tested for in vivo bioavailability in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625103
10961,1,,1,Cricetinae,In vivo,,10026.0,,,Compound was tested for in vivo bioavailability in hamsters,,,,,BAO_0000218,100712,N,Intermediate,CHEMBL625104
10962,1,,0,Simiiformes,In vivo,,314293.0,,,Compound was tested for in vivo bioavailability in monkey,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625105
10963,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was tested for in vivo bioavailability in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625106
10964,1,,0,Mus musculus,In vivo,,10090.0,,,Oral bioavailability in mouse,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625107
10965,1,,1,Mus musculus,In vivo,,10090.0,,,Compound was tested for percent of oral bioavailability in mice; 56-74,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625108
10966,1,,0,Mus musculus,In vivo,,10090.0,,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625109
10967,1,,0,Macaca fascicularis,In vivo,,9541.0,,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625110
10968,1,,0,Macaca fascicularis,In vivo,,9541.0,,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625111
10969,1,,1,Mus musculus,In vivo,,10090.0,,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625112
10970,1,,1,Mus musculus,In vivo,,10090.0,,,Oral bioavailability in nude mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL875334
10971,1,,0,Primates,In vivo,,9443.0,,,Bioavailability in monkey (i.d. dosing),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628617
10972,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628618
10973,1,,0,,In vivo,,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628619
10974,1,,0,,In vivo,,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628620
10975,1,,1,Macaca fascicularis,In vivo,,9541.0,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,,,,BAO_0000218,100710,N,Intermediate,CHEMBL628621
10976,1,,1,Macaca fascicularis,In vivo,,9541.0,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,,,,BAO_0000218,100710,N,Intermediate,CHEMBL628622
10977,1,,1,Macaca fascicularis,In vivo,,9541.0,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,,,,BAO_0000218,100710,N,Intermediate,CHEMBL628623
10978,1,,1,Macaca fascicularis,In vivo,,9541.0,1969.0,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,Plasma,,,,BAO_0000218,100710,N,Intermediate,CHEMBL628624
10979,1,,1,Mus musculus,In vivo,,10090.0,1969.0,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628625
10980,1,,1,Macaca fascicularis,In vivo,,9541.0,1969.0,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,Plasma,,,,BAO_0000218,100710,N,Intermediate,CHEMBL628626
10981,1,,1,Mus musculus,In vivo,,10090.0,1969.0,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627041
10982,1,,1,Mus musculus,In vivo,,10090.0,1969.0,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627042
10983,1,,1,Mus musculus,In vivo,,10090.0,1969.0,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627043
10984,1,,0,,In vivo,,,1969.0,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627044
10985,1,,1,Mus musculus,In vivo,,10090.0,1969.0,,Cmax in mouse plasma,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627045
10986,1,,0,,In vivo,,,1969.0,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627046
10987,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximal plasma concentration in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627047
10988,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627048
10989,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627049
10990,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627050
10991,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627051
10992,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627052
10993,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627053
10994,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627054
10995,1,,1,Mus musculus,In vivo,,10090.0,,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627055
10996,1,,1,Mus musculus,In vivo,,10090.0,,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627056
10997,1,,1,Mus musculus,In vivo,,10090.0,,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627057
10998,1,,1,Mus musculus,In vivo,,10090.0,,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627058
10999,1,,1,Mus musculus,In vivo,,10090.0,,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626211
11000,1,,0,,In vivo,,,,,Maximum Concentration of the compound.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626212
11001,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Maximum Concentration was measured after iv administration into Beagle dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626213
11002,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Maximum Concentration was measured after iv administration into Beagle dog.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626214
11003,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Maximum Concentration was measured after po administration into Beagle dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626215
11004,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Maximum Concentration was measured after po administration into Beagle dog.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626216
11005,1,,0,,In vivo,,,178.0,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626217
11006,1,,0,,In vivo,,,178.0,,Maximum blood level reached after an iv dose of 12.2 uM/kg,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626218
11007,1,,0,,In vivo,,,178.0,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626219
11008,1,,0,,In vivo,,,178.0,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626220
11009,1,,0,,In vivo,,,178.0,,Maximum blood level reached after an oral dose of 5.0 mg/kg,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626221
11010,1,,0,,In vivo,,,178.0,,Maximum blood level reached at dose of 10.6 uM/kg orally,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626222
11011,1,,1,Cavia porcellus,In vivo,,10141.0,,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,,,,BAO_0000218,50512,N,Intermediate,CHEMBL626223
11012,1,,1,Cavia porcellus,In vivo,,10141.0,,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,,,,BAO_0000218,50512,N,Intermediate,CHEMBL626224
11013,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626225
11014,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626226
11015,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626227
11016,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626228
11017,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626229
11018,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626921
11019,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876793
11020,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625309
11021,1,,1,Bacillus subtilis,In vivo,,1423.0,,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,,,,BAO_0000218,50278,N,Intermediate,CHEMBL625310
11022,1,,0,Simiiformes,In vivo,,314293.0,,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625311
11023,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625312
11024,1,,0,,In vivo,,,,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625313
11025,1,,1,Mus musculus,In vivo,,10090.0,,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625314
11026,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration in male rats after iv administration of 20 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625315
11027,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625316
11028,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625317
11029,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625318
11030,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625319
11031,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625320
11032,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625321
11033,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625322
11034,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876801
11035,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625323
11036,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625324
11037,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625325
11038,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625326
11039,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625327
11040,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625328
11041,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625329
11042,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625330
11043,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627774
11044,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627775
11045,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627949
11046,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627950
11047,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627951
11048,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627952
11049,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627953
11050,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627954
11051,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627955
11052,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627956
11053,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876802
11054,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627957
11055,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627958
11056,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627959
11057,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627960
11058,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627961
11059,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627962
11060,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627963
11061,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624759
11062,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624760
11063,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624761
11064,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877607
11065,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624762
11066,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624763
11067,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624764
11068,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624765
11069,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624766
11070,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624767
11071,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624768
11072,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624769
11073,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624770
11074,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624771
11075,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624772
11076,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624773
11077,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624774
11078,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624775
11079,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624776
11080,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624777
11081,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624778
11082,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624779
11083,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624780
11084,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624781
11085,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877608
11086,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624782
11087,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624783
11088,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624784
11089,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624785
11090,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624786
11091,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624787
11092,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628676
11093,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621842
11094,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621843
11095,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623873
11096,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623874
11097,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623875
11098,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623876
11099,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623877
11100,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623878
11101,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623879
11102,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623880
11103,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623881
11104,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623957
11105,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623958
11106,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623959
11107,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623960
11108,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623961
11109,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623962
11110,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624676
11111,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624677
11112,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624678
11113,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624679
11114,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624680
11115,1,,0,,In vivo,,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624849
11116,1,,0,,In vivo,,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624850
11117,1,,0,,In vivo,,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL874399
11118,1,,0,,In vivo,,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624851
11119,1,,0,,In vivo,,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624852
11120,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (dose 10 mg/kg),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624853
11121,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624854
11122,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624855
11123,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rats was determined in vivo,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624856
11124,1,,0,Canis lupus familiaris,In vivo,,9615.0,,,Oral bioavailability in dog,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL882957
11125,1,,0,Simiiformes,In vivo,,314293.0,,,Oral bioavailability of compound in monkey,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624857
11126,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability of compound in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622202
11127,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat of PMEA prodrug,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622203
11128,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625522
11129,1,,0,Macaca mulatta,In vivo,,9544.0,,,Serum conc at 3 hours following 25 mg/kg dose,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622868
11130,1,,0,Macaca mulatta,In vivo,,9544.0,1088.0,,Urine conc 0-5 hours following 25 mg/kg dose,Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622869
11131,1,,0,Macaca mulatta,In vivo,,9544.0,1088.0,,Urine conc 0-24 hours following 25 mg/kg dose,Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622870
11132,1,,0,Chlorocebus aethiops,In vivo,,9534.0,,,Oral bioavailability in African green monkeys; 20-25,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622871
11133,1,,1,Macaca fascicularis,In vivo,,9541.0,,,Oral bioavailability in cynomolgus monkey.,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL620560
11134,1,,0,Canis lupus familiaris,In vivo,,9615.0,,,Oral bioavailability in dog,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL620561
11135,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Oral bioavailability in dog at 10 mg/kg oral dose,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL620562
11136,1,,1,Cricetinae,In vivo,,10026.0,,,Oral bioavailability in hamster at 10 mg/kg oral dose,,,,,BAO_0000218,100712,N,Intermediate,CHEMBL620563
11137,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat at 10 mg/kg oral dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL620564
11138,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL872265
11139,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL620565
11140,1,,0,Eutheria,In vivo,,9347.0,,,Oral bioavailability,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL620566
11141,1,,0,,In vivo,,,,,Oral bioavailability was determined; range 49-102%,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL620567
11142,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Oral bioavailability was determined in dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL620568
11143,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL620569
11144,1,,0,Eutheria,In vivo,,9347.0,,,Oral bioavailability,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL620570
11145,1,,0,,In vivo,,,,,Oral bioavailability was determined; Not orally available,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL620571
11146,1,,1,Mus musculus,In vivo,,10090.0,,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL620572
11147,1,,0,Mus musculus,In vivo,,10090.0,,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL620573
11148,1,,0,Mus musculus,In vivo,,10090.0,,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL620574
11149,1,,0,Macaca mulatta,In vivo,,9544.0,,,Oral bioavailability in Rhesus monkey,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL620575
11150,1,,0,Canis lupus familiaris,In vivo,,9615.0,,,Oral bioavailability in dog (female mongrel),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL620576
11151,1,,0,,In vivo,,,,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL875846
11152,1,,0,Canis lupus familiaris,In vivo,,9615.0,,,Oral bioavailability in dog,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL620577
11153,1,,0,,In vivo,,,,,Percentage Bioavailability was evaluated.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL620578
11154,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat administered i.d.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL620579
11155,1,,0,Eutheria,In vivo,,9347.0,,,Bioavailability,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621248
11156,1,,0,Canis lupus familiaris,In vivo,,9615.0,,,Bioavailability in dog (male Beagle) i.v. administration,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625390
11157,1,,0,Rattus norvegicus,In vivo,,10116.0,,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625391
11158,1,,0,Primates,In vivo,,9443.0,,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL872266
11159,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability in rat (Sprague-Dawley) (male),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625392
11160,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The oral bioavailability was measured on rats after oral administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625393
11161,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625394
11162,1,,1,Macaca mulatta,In vivo,,9544.0,,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,,,,BAO_0000218,50797,N,Intermediate,CHEMBL625395
11163,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 10 mg/kg i.d.),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625396
11164,1,,0,Canis lupus familiaris,In vivo,,9615.0,,,Bioavailability in dog (male Beagle) i.v. administration,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625397
11165,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625398
11166,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625399
11167,1,,1,Mus musculus,In vivo,,10090.0,2037.0,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Cerebellum,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626074
11168,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626075
11169,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626076
11170,1,,1,Macaca mulatta,In vivo,,9544.0,1969.0,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Plasma,,,,BAO_0000218,50797,N,Intermediate,CHEMBL626077
11171,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626078
11172,1,,0,,In vivo,,,178.0,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625846
11173,1,,0,,In vivo,,,178.0,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625847
11174,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,,,,BAO_0000218,50597,N,Expert,CHEMBL625848
11175,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration of compound in plasma administered orally to rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625849
11176,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626023
11177,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626024
11178,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626025
11179,1,,0,,In vivo,,,,,Maximum concentration after 10 mg/kg by oral administration,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626026
11180,1,,0,,In vivo,,,,,Maximum concentration at a dose of 1.5 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626027
11181,1,,0,,In vivo,,,,,Maximum concentration at a dose of 2.0 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626028
11182,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Maximum concentration in dog plasma,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626029
11183,1,,0,,In vivo,,,1969.0,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626030
11184,1,,0,,In vivo,,,1969.0,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626031
11185,1,,0,,In vivo,,,1969.0,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626032
11186,1,,0,,In vivo,,,1969.0,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626033
11187,1,,0,,In vivo,,,1969.0,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626034
11188,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626035
11189,1,,0,,In vivo,,,1969.0,,Maximum concentration in plasma at Tmax,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626036
11190,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,Plasma,,,,BAO_0000218,50588,N,Expert,CHEMBL626037
11191,1,,1,Cricetinae,In vivo,,10026.0,1969.0,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,Plasma,,,,BAO_0000218,100712,N,Intermediate,CHEMBL626038
11192,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626039
11193,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626040
11194,1,,1,Oryctolagus cuniculus,In vivo,,9986.0,1969.0,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,Plasma,,,,BAO_0000218,50592,N,Intermediate,CHEMBL626041
11195,1,,0,,In vivo,,,,,Maximum concentration was calculated,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626042
11196,1,,0,,In vivo,,,,,Maximum concentration was calculated.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626043
11197,1,,0,,In vivo,,,,,Maximum concentration at a peroral dose of 10 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626044
11198,1,,0,,In vivo,,,,,Maximum concentration of the drug at 10 uM/dg administered perorally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626045
11199,1,,0,,In vivo,,,,,Maximum concentration of the drug at 2 uM/dg administered intravenously,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626046
11200,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626047
11201,1,,1,Cricetinae,In vivo,,10026.0,1969.0,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",Plasma,,,,BAO_0000218,100712,N,Intermediate,CHEMBL626048
11202,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626049
11203,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626050
11204,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL874541
11205,1,,1,Cricetinae,In vivo,,10026.0,1969.0,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,Plasma,,,,BAO_0000218,100712,N,Intermediate,CHEMBL622826
11206,1,,1,Cricetinae,In vivo,,10026.0,1969.0,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,Plasma,,,,BAO_0000218,100712,N,Intermediate,CHEMBL622827
11207,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622828
11208,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622829
11209,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration reached following intravenous administration in male rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876806
11210,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622830
11211,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622831
11212,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626794
11213,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626795
11214,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626796
11215,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626797
11216,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum drug concentration is determined after oral dosing in rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626798
11217,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626799
11218,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Maximum observed concentration in oral (5 mg/kg) fed dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626800
11219,1,,0,,In vivo,,,1969.0,,Maximum plasma concentration,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626801
11220,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876816
11221,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626802
11222,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626803
11223,1,,0,,In vivo,,,1969.0,,Maximum plasma concentration following oral administration of 30 umol/kg,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626804
11224,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626805
11225,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626309
11226,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626310
11227,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626311
11228,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626312
11229,1,,1,Rattus norvegicus,,,10116.0,995.0,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626313
11230,1,,1,Rattus norvegicus,,,10116.0,995.0,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626314
11231,1,,1,Rattus norvegicus,,,10116.0,995.0,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626315
11232,1,,1,Rattus norvegicus,,,10116.0,995.0,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626316
11233,1,,1,Rattus norvegicus,,,10116.0,995.0,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626317
11234,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626318
11235,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626319
11236,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626320
11237,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875053
11238,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626321
11239,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626322
11240,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626323
11241,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626324
11242,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626325
11243,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626326
11244,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626327
11245,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626328
11246,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626329
11247,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626330
11248,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626331
11249,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626332
11250,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626333
11251,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626334
11252,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626335
11253,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624798
11254,1,,1,Rattus norvegicus,,,10116.0,955.0,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624799
11255,1,,1,Rattus norvegicus,,,10116.0,955.0,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624800
11256,1,,1,Rattus norvegicus,,,10116.0,955.0,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624801
11257,1,,1,Rattus norvegicus,,,10116.0,955.0,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624802
11258,1,,1,Rattus norvegicus,,,10116.0,955.0,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624803
11259,1,,1,Rattus norvegicus,,,10116.0,955.0,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624804
11260,1,,1,Rattus norvegicus,,,10116.0,955.0,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624805
11261,1,,1,Rattus norvegicus,,,10116.0,955.0,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624806
11262,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624807
11263,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624808
11264,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624809
11265,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624810
11266,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877618
11267,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624811
11268,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624812
11269,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624813
11270,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624814
11271,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624815
11272,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624816
11273,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624817
11274,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624818
11275,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624819
11276,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624820
11277,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624821
11278,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624822
11279,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624823
11280,1,,1,Escherichia coli,,,562.0,,,Observed diffusion coefficient in organic solvent for Escherichia coli,,,,,BAO_0000218,50212,N,Intermediate,CHEMBL624824
11281,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624825
11282,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624826
11283,1,,1,Rattus norvegicus,,,10116.0,2081.0,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Cardiac atrium,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876817
11284,1,,1,Rattus norvegicus,,,10116.0,2081.0,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Cardiac atrium,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624827
11285,1,,1,Rattus norvegicus,,,10116.0,,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624828
11286,1,,1,Rattus norvegicus,,,10116.0,,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624829
11287,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624830
11288,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624831
11289,1,,1,Rattus norvegicus,,,10116.0,2081.0,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Cardiac atrium,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624832
11290,1,,1,Rattus norvegicus,,,10116.0,2081.0,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Cardiac atrium,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624833
11291,1,,1,Rattus norvegicus,,,10116.0,,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624834
11292,1,,1,Rattus norvegicus,,,10116.0,,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624835
11293,1,,1,Rattus norvegicus,,,10116.0,2106.0,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624836
11294,1,,1,Rattus norvegicus,,,10116.0,2106.0,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624837
11295,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624838
11296,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622188
11297,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622189
11298,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622190
11299,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625170
11300,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625171
11301,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625172
11302,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625173
11303,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625174
11304,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625175
11305,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625176
11306,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625177
11307,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625178
11308,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625179
11309,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625180
11310,1,,0,,,,,,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625181
11311,1,,1,Mus musculus,,,10090.0,1088.0,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,Urine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625182
11312,1,,1,Rattus norvegicus,,,10116.0,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625183
11313,1,,1,Rattus norvegicus,,,10116.0,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875848
11314,1,,1,Rattus norvegicus,,,10116.0,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622260
11315,1,,1,Rattus norvegicus,,,10116.0,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622261
11316,1,,1,Rattus norvegicus,,,10116.0,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622262
11317,1,,1,Rattus norvegicus,,,10116.0,2113.0,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622263
11318,1,,1,Rattus norvegicus,,,10116.0,2113.0,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622418
11319,1,,1,Rattus norvegicus,,,10116.0,2107.0,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622419
11320,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623388
11321,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623389
11322,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623390
11323,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623391
11324,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623392
11325,1,,1,Mus musculus,In vivo,,10090.0,2037.0,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Cerebellum,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623393
11326,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623394
11327,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618885
11328,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618886
11329,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618887
11330,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL619535
11331,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL619536
11332,1,,1,Mus musculus,In vivo,,10090.0,2037.0,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),Cerebellum,,,,BAO_0000218,50594,N,Intermediate,CHEMBL619537
11333,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL619705
11334,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL619706
11335,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL619707
11336,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL619708
11337,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625219
11338,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625220
11339,1,,1,Mus musculus,In vivo,,10090.0,2037.0,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Cerebellum,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625221
11340,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625222
11341,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625223
11342,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625224
11343,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625225
11344,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in Rat blood after 24 hours of iv administration,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625226
11345,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625227
11346,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in Rat blood after 30 minutes of iv administration,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625228
11347,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875354
11348,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in Rat blood after 5 minutes of iv administration,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625229
11349,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625230
11350,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in Rat heart after 24 hours of iv administration,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625231
11351,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625900
11352,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in Rat heart after 30 minutes of iv administration,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625901
11353,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625902
11354,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in Rat heart after 5 minutes of iv administration,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625903
11355,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625904
11356,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in Rat liver after 24 hours of iv administration,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625905
11357,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627861
11358,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in Rat liver after 30 minutes of iv administration,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627862
11359,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627863
11360,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in Rat liver after 30 minutes of iv administration,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627769
11361,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627770
11362,1,,1,Macaca fascicularis,In vivo,,9541.0,,,Cmax in cynomolgus monkey (PO dose),,,,,BAO_0000218,100710,N,Intermediate,CHEMBL627771
11363,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rat (PO dose),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627772
11364,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax in rat (PO dose),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627773
11365,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621922
11366,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Cmax in rat plasma after oral dose (10 mg/kg),Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621923
11367,1,,0,,In vivo,,,1969.0,,Cmax in plasma after oral dose (10 mg/kg),Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621924
11368,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL621925
11369,1,,0,Simiiformes,In vivo,,314293.0,1969.0,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621926
11370,1,,1,Oryctolagus cuniculus,In vivo,,9986.0,1969.0,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,Plasma,,,,BAO_0000218,50592,N,Intermediate,CHEMBL621927
11371,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621928
11372,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621929
11373,1,,1,Mus musculus,In vivo,,10090.0,1969.0,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL621930
11374,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration after oral dosing in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621931
11375,1,,0,,In vivo,,,1969.0,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621932
11376,1,,0,,In vivo,,,1969.0,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621933
11377,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL621934
11378,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL621935
11379,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621936
11380,1,,0,,In vivo,,,1969.0,,Maximum plasma concentration was determined,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621937
11381,1,,0,,In vivo,,,1969.0,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621938
11382,1,,0,,In vivo,,,1969.0,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621939
11383,1,,0,,In vivo,,,1969.0,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621940
11384,1,,0,,In vivo,,,1969.0,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621941
11385,1,,0,,In vivo,,,1969.0,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL621942
11386,1,,0,,In vivo,,,1969.0,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626178
11387,1,,0,,In vivo,,,1969.0,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626179
11388,1,,0,,In vivo,,,1969.0,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626180
11389,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Plasma Cmax in rat (PO dose),Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626181
11390,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626182
11391,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626183
11392,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626184
11393,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626185
11394,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626186
11395,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL877589
11396,1,,0,,In vivo,,,,,Maximum concentration of the drug at 1 uM/dg administered intravenously,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626187
11397,1,,0,,In vivo,,,,,Maximum concentration of the drug at 20 uM/dg administered perorally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626188
11398,1,,0,,In vivo,,,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626189
11399,1,,0,,In vivo,,,178.0,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626855
11400,1,,0,,In vivo,,,178.0,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623781
11401,1,,0,,In vivo,,,178.0,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623782
11402,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623783
11403,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Cmax in dog plasma after 1mg/kg oral dose,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623784
11404,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623785
11405,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623786
11406,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral maximum concentration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623787
11407,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral maximum concentration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623788
11408,1,,1,Mus musculus,In vivo,,10090.0,1969.0,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623789
11409,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Peak concentration in blood after intravenous administration to mice,Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623790
11410,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Peak concentration in blood after peroral administration to mice,Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623791
11411,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Peak concentration in rat plasma was determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623792
11412,1,,0,Simiiformes,In vivo,,314293.0,1969.0,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623793
11413,1,,1,Mus musculus,In vivo,,10090.0,1969.0,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623794
11414,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623795
11415,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623796
11416,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623797
11417,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623798
11418,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623799
11419,1,,1,Rattus norvegicus,,,10116.0,160.0,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624490
11420,1,,1,Rattus norvegicus,,,10116.0,160.0,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624491
11421,1,,1,Rattus norvegicus,,,10116.0,160.0,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624492
11422,1,,1,Rattus norvegicus,,,10116.0,160.0,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624493
11423,1,,1,Rattus norvegicus,,,10116.0,160.0,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877595
11424,1,,1,Rattus norvegicus,,,10116.0,160.0,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624494
11425,1,,1,Rattus norvegicus,,,10116.0,160.0,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624495
11426,1,,1,Rattus norvegicus,,,10116.0,160.0,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624681
11427,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624682
11428,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624683
11429,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624684
11430,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624685
11431,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624686
11432,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624687
11433,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624688
11434,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627161
11435,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622127
11436,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622128
11437,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874384
11438,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624898
11439,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624899
11440,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624900
11441,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624901
11442,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624902
11443,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624903
11444,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624904
11445,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624905
11446,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624906
11447,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624907
11448,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624908
11449,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624909
11450,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624910
11451,1,,1,Rattus norvegicus,,,10116.0,2385.0,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624911
11452,1,,1,Rattus norvegicus,,,10116.0,2385.0,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874388
11453,1,,1,Rattus norvegicus,,,10116.0,2385.0,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624912
11454,1,,1,Rattus norvegicus,,,10116.0,2385.0,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622930
11455,1,,1,Rattus norvegicus,,,10116.0,2385.0,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623121
11456,1,,1,Rattus norvegicus,,,10116.0,2385.0,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623122
11457,1,,1,Rattus norvegicus,,,10116.0,2385.0,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623123
11458,1,,1,Rattus norvegicus,,,10116.0,2385.0,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623124
11459,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623125
11460,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623126
11461,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623127
11462,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623128
11463,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623129
11464,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623130
11465,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623131
11466,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623132
11467,1,,1,Rattus norvegicus,,,10116.0,2107.0,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623133
11468,1,,1,Rattus norvegicus,,,10116.0,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623134
11469,1,,1,Rattus norvegicus,,,10116.0,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874389
11470,1,,1,Rattus norvegicus,,,10116.0,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623135
11471,1,,1,Rattus norvegicus,,,10116.0,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623136
11472,1,,1,Rattus norvegicus,,,10116.0,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623137
11473,1,,1,Rattus norvegicus,,,10116.0,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623138
11474,1,,1,Rattus norvegicus,,,10116.0,2113.0,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623139
11475,1,,1,Rattus norvegicus,,,10116.0,2113.0,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623140
11476,1,,1,Rattus norvegicus,,,10116.0,2107.0,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623141
11477,1,,1,Rattus norvegicus,,,10116.0,2107.0,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623142
11478,1,,1,Rattus norvegicus,,,10116.0,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623143
11479,1,,1,Mus musculus,,,10090.0,1088.0,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,Urine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623144
11480,1,,1,Rattus norvegicus,,,10116.0,1088.0,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623405
11481,1,,1,Rattus norvegicus,,,10116.0,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624074
11482,1,,1,Rattus norvegicus,,,10116.0,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624075
11483,1,,1,Rattus norvegicus,,,10116.0,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624076
11484,1,,1,Rattus norvegicus,,,10116.0,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624077
11485,1,,1,Rattus norvegicus,,,10116.0,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624078
11486,1,,1,Rattus norvegicus,,,10116.0,2113.0,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624079
11487,1,,1,Rattus norvegicus,,,10116.0,2113.0,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624261
11488,1,,1,Rattus norvegicus,,,10116.0,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624262
11489,1,,1,Rattus norvegicus,,,10116.0,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624263
11490,1,,1,Rattus norvegicus,,,10116.0,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624264
11491,1,,1,Rattus norvegicus,,,10116.0,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624265
11492,1,,1,Rattus norvegicus,,,10116.0,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624266
11493,1,,1,Rattus norvegicus,,,10116.0,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624267
11494,1,,1,Rattus norvegicus,,,10116.0,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624268
11495,1,,1,Rattus norvegicus,,,10116.0,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875227
11496,1,,1,Rattus norvegicus,,,10116.0,2113.0,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624269
11497,1,,1,Rattus norvegicus,,,10116.0,2113.0,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624270
11498,1,,1,Rattus norvegicus,,,10116.0,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624271
11499,1,,1,Rattus norvegicus,,,10116.0,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624272
11500,1,,1,Rattus norvegicus,,,10116.0,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624273
11501,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624274
11502,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624275
11503,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624276
11504,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624277
11505,1,,0,,,,,,,% dose converted to 2-amino-5-chlorophenyl sulfate,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624278
11506,1,,0,,,,,,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624279
11507,1,,1,Rattus norvegicus,,,10116.0,1988.0,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Feces,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624280
11508,1,,1,Rattus norvegicus,,,10116.0,1988.0,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Feces,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624281
11509,1,,1,Rattus norvegicus,,,10116.0,1988.0,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Feces,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622933
11510,1,,1,Rattus norvegicus,,,10116.0,1988.0,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Feces,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622934
11511,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622935
11512,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in Rat liver after 5 minutes of iv administration,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622936
11513,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875228
11514,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in Rat lung after 24 hours of iv administration,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622937
11515,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622938
11516,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in Rat lung after 30 minutes of iv administration,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL619736
11517,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625117
11518,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in Rat lung after 5 minutes of iv administration,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625118
11519,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625119
11520,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625120
11521,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625121
11522,1,,1,Rattus norvegicus,In vivo,,10116.0,10000006.0,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",Thalamus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625122
11523,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622204
11524,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877503
11525,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627127
11526,1,,0,,In vivo,,,10000000.0,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,Hippocampus,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627128
11527,1,,0,,In vivo,,,10000000.0,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,Hippocampus,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627129
11528,1,,0,,In vivo,,,10000000.0,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,Hippocampus,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627130
11529,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627131
11530,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627132
11531,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627133
11532,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627134
11533,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627135
11534,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627136
11535,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628435
11536,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628436
11537,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628437
11538,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628438
11539,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628439
11540,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628440
11541,1,,1,Rattus norvegicus,In vivo,,10116.0,10000000.0,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628441
11542,1,,1,Rattus norvegicus,In vivo,,10116.0,10000000.0,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628442
11543,1,,1,Rattus norvegicus,In vivo,,10116.0,10000000.0,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628443
11544,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628444
11545,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628445
11546,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877504
11547,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628446
11548,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626874
11549,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626875
11550,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626876
11551,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626877
11552,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626878
11553,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626879
11554,1,,0,Simiiformes,In vivo,,314293.0,1969.0,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626880
11555,1,,1,Mus musculus,In vivo,,10090.0,1969.0,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626881
11556,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626882
11557,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Peak plasma concentration was measured in dogs,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626883
11558,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626884
11559,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626885
11560,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626886
11561,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626887
11562,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626888
11563,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626889
11564,1,,0,Simiiformes,In vivo,,314293.0,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626761
11565,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626762
11566,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626763
11567,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626764
11568,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626765
11569,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626766
11570,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626767
11571,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626768
11572,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626769
11573,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL874463
11574,1,,0,Simiiformes,In vivo,,314293.0,,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626770
11575,1,,0,Simiiformes,In vivo,,314293.0,,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626771
11576,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626772
11577,1,,1,Macaca fascicularis,In vivo,,9541.0,,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL626773
11578,1,,1,Mus musculus,In vivo,,10090.0,,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626774
11579,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626775
11580,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626776
11581,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Maximum concentration (Cmax) in rat when administered orally,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626777
11582,1,,0,Simiiformes,In vivo,,314293.0,1969.0,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626778
11583,1,,0,Rattus norvegicus,In vivo,,10116.0,,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626779
11584,1,,0,Rattus norvegicus,In vivo,,10116.0,,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626780
11585,1,,0,,In vivo,,,1969.0,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626781
11586,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic profile Cmax was evaluated in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632164
11587,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL632165
11588,1,,1,Mus musculus,In vivo,,10090.0,,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL632166
11589,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL632167
11590,1,,1,Mus musculus,In vivo,,10090.0,,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL632168
11591,1,,0,Rattus norvegicus,In vivo,,10116.0,1969.0,,Cmax in rat plasma,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL632169
11592,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Cmax in dog plasma after 30mg/kg oral dose,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL632170
11593,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Cmax in rat plasma after 30mg/kg oral dose,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632171
11594,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Plasma level in rats at 30 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632172
11595,1,,1,Mus musculus,In vivo,,10090.0,1969.0,,Tested for maximum plasma concentration in mice,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL632173
11596,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632174
11597,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The Cmax values in female wistar rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632175
11598,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL632176
11599,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632177
11600,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632178
11601,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632179
11602,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632180
11603,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632181
11604,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632182
11605,1,,0,Mus musculus,In vivo,,10090.0,178.0,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL632183
11606,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL632184
11607,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874470
11608,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631302
11609,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631303
11610,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631304
11611,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631305
11612,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631306
11613,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631307
11614,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631308
11615,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625557
11616,1,,1,Rattus norvegicus,,,10116.0,2106.0,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625558
11617,1,,1,Rattus norvegicus,,,10116.0,2106.0,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625559
11618,1,,1,Rattus norvegicus,,,10116.0,2106.0,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625560
11619,1,,1,Rattus norvegicus,,,10116.0,2106.0,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625561
11620,1,,1,Rattus norvegicus,,,10116.0,2106.0,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625562
11621,1,,1,Rattus norvegicus,,,10116.0,2106.0,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875320
11622,1,,1,Rattus norvegicus,,,10116.0,2106.0,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625563
11623,1,,1,Rattus norvegicus,,,10116.0,2106.0,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625564
11624,1,,1,Rattus norvegicus,,,10116.0,995.0,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625565
11625,1,,1,Rattus norvegicus,,,10116.0,995.0,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625566
11626,1,,1,Rattus norvegicus,,,10116.0,995.0,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625567
11627,1,,1,Rattus norvegicus,,,10116.0,995.0,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625568
11628,1,,1,Rattus norvegicus,,,10116.0,995.0,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628217
11629,1,,1,Rattus norvegicus,,,10116.0,995.0,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628218
11630,1,,1,Rattus norvegicus,,,10116.0,995.0,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628219
11631,1,,1,Rattus norvegicus,,,10116.0,995.0,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628220
11632,1,,0,,,,,,,Distribution in the blood after 120 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628221
11633,1,,0,,,,,,,Distribution in the blood after 15 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628222
11634,1,,0,,,,,,,Distribution in the blood after 30 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628223
11635,1,,0,,,,,,,Distribution in the blood after 5 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628224
11636,1,,0,,,,,,,Distribution in the blood after 60 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628225
11637,1,,0,,,,,,,Distribution in the blood after 90 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628226
11638,1,,0,,,,,,,Distribution in the bone after 120 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628227
11639,1,,0,,,,,,,Distribution in the bone after 15 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL875481
11640,1,,0,,,,,,,Distribution in the bone after 30 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628228
11641,1,,0,,,,,,,Distribution in the bone after 5 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628229
11642,1,,0,,,,,,,Distribution in the bone after 60 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628230
11643,1,,0,,,,,,,Distribution in the bone after 90 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628231
11644,1,,0,,,,,,,Distribution in the heart after 120 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628232
11645,1,,0,,,,,,,Distribution in the heart after 15 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628233
11646,1,,0,,,,,,,Distribution in the heart after 30 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628234
11647,1,,0,,,,,,,Distribution in the heart after 5 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628235
11648,1,,0,,,,,,,Distribution in the heart after 60 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628236
11649,1,,0,,,,,,,Distribution in the heart after 90 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628237
11650,1,,0,,,,,,,Distribution in the kidneys after 120 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628238
11651,1,,0,,,,,,,Distribution in the kidneys after 15 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628239
11652,1,,0,,,,,,,Distribution in the kidneys after 30 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628240
11653,1,,0,,,,,,,Distribution in the kidneys after 5 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628241
11654,1,,0,,,,,,,Distribution in the kidneys after 60 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628242
11655,1,,0,,,,,,,Distribution in the kidneys after 90 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL875482
11656,1,,0,,,,,,,Distribution in the liver after 120 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628243
11657,1,,0,,,,,,,Distribution in the liver after 15 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628244
11658,1,,0,,,,,,,Distribution in the liver after 30 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628245
11659,1,,0,,,,,,,Distribution in the liver after 5 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628246
11660,1,,0,,,,,,,Distribution in the liver after 60 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628247
11661,1,,0,,,,,,,Distribution in the liver after 90 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628248
11662,1,,0,,,,,,,Distribution in the lung after 120 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628249
11663,1,,1,Mus musculus,,,10090.0,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625452
11664,1,,1,Mus musculus,,,10090.0,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625453
11665,1,,1,Mus musculus,,,10090.0,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625454
11666,1,,1,Mus musculus,,,10090.0,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623844
11667,1,,1,Rattus norvegicus,,,10116.0,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623845
11668,1,,1,Rattus norvegicus,,,10116.0,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623846
11669,1,,0,,,,,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623847
11670,1,,1,Macaca fascicularis,,,9541.0,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL623848
11671,1,,1,Macaca fascicularis,,,9541.0,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL623849
11672,1,,1,Macaca fascicularis,,,9541.0,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL623850
11673,1,,1,Macaca fascicularis,,,9541.0,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL623851
11674,1,,0,Simiiformes,,,314293.0,,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623852
11675,1,,1,Mustela putorius furo,,,9669.0,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,,,,BAO_0000218,50506,N,Intermediate,CHEMBL624551
11676,1,,1,Mustela putorius furo,,,9669.0,,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,,,,BAO_0000218,50506,N,Intermediate,CHEMBL624552
11677,1,,0,Simiiformes,,,314293.0,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624553
11678,1,,0,Simiiformes,,,314293.0,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624554
11679,1,,1,Rattus norvegicus,,,10116.0,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624555
11680,1,,1,Rattus norvegicus,,,10116.0,,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624741
11681,1,,1,Canis lupus familiaris,,,9615.0,,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624742
11682,1,,1,Cricetinae,,,10026.0,,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,,,,BAO_0000218,100712,N,Intermediate,CHEMBL624743
11683,1,,1,Rattus norvegicus,,,10116.0,,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877606
11684,1,,0,,,,,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624744
11685,1,,0,,,,,178.0,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624745
11686,1,,0,,,,,178.0,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624746
11687,1,,0,,,,,178.0,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624747
11688,1,,0,,,,,,,Oral absorption expressed as Area under curve was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624748
11689,1,,1,Canis lupus familiaris,,,9615.0,,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622504
11690,1,,1,Canis lupus familiaris,,,9615.0,,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622505
11691,1,,1,Cricetinae,,,10026.0,,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,,,,BAO_0000218,100712,N,Intermediate,CHEMBL622506
11692,1,,1,Cricetinae,,,10026.0,,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,,,,BAO_0000218,100712,N,Intermediate,CHEMBL622507
11693,1,,1,Rattus norvegicus,,,10116.0,,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622508
11694,1,,0,,,,,,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622509
11695,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622510
11696,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622511
11697,1,,1,Macaca fascicularis,,,9541.0,,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL622512
11698,1,,1,Macaca fascicularis,,,9541.0,,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL622513
11699,1,,1,Macaca fascicularis,,,9541.0,,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL622514
11700,1,,1,Canis lupus familiaris,,,9615.0,,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622515
11701,1,,1,Canis lupus familiaris,,,9615.0,,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622516
11702,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622517
11703,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622518
11704,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622519
11705,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622520
11706,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622521
11707,1,,1,Mus musculus,In vivo,,10090.0,14.0,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,Zone of skin,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625113
11708,1,,1,Rattus norvegicus,In vivo,,10116.0,14.0,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,Zone of skin,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625114
11709,1,,1,Rattus norvegicus,In vivo,,10116.0,14.0,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,Zone of skin,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874397
11710,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625115
11711,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625116
11712,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623932
11713,1,,1,Rattus norvegicus,In vivo,,10116.0,2435.0,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623933
11714,1,,1,Rattus norvegicus,In vivo,,10116.0,2435.0,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623934
11715,1,,1,Rattus norvegicus,In vivo,,10116.0,2435.0,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623935
11716,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623936
11717,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623937
11718,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623938
11719,1,,1,Mus musculus,,,10090.0,,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623939
11720,1,,1,Mus musculus,,,10090.0,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623940
11721,1,,1,Mus musculus,,,10090.0,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623941
11722,1,,1,Mus musculus,,,10090.0,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627216
11723,1,,1,Mus musculus,,,10090.0,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623942
11724,1,,1,Mus musculus,,,10090.0,955.0,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618793
11725,1,,1,Mus musculus,,,10090.0,955.0,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618794
11726,1,,1,Mus musculus,,,10090.0,955.0,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618795
11727,1,,1,Mus musculus,,,10090.0,,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618796
11728,1,,1,Mus musculus,,,10090.0,,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618797
11729,1,,1,Mus musculus,,,10090.0,2113.0,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618798
11730,1,,1,Mus musculus,,,10090.0,2113.0,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618799
11731,1,,1,Mus musculus,,,10090.0,2113.0,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618800
11732,1,,1,Mus musculus,,,10090.0,2113.0,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618801
11733,1,,1,Mus musculus,,,10090.0,2113.0,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618802
11734,1,,1,Mus musculus,,,10090.0,2113.0,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618803
11735,1,,1,Mus musculus,,,10090.0,2107.0,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618804
11736,1,,1,Mus musculus,,,10090.0,2107.0,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618805
11737,1,,1,Mus musculus,,,10090.0,2107.0,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618806
11738,1,,1,Mus musculus,,,10090.0,2107.0,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618807
11739,1,,1,Mus musculus,,,10090.0,2107.0,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618808
11740,1,,1,Mus musculus,,,10090.0,2107.0,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618809
11741,1,,1,Mus musculus,,,10090.0,2385.0,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Muscle tissue,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618810
11742,1,,1,Mus musculus,,,10090.0,2385.0,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Muscle tissue,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618811
11743,1,,1,Mus musculus,,,10090.0,2385.0,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Muscle tissue,,,,BAO_0000218,50594,N,Intermediate,CHEMBL875844
11744,1,,1,Mus musculus,,,10090.0,2385.0,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Muscle tissue,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618812
11745,1,,1,Mus musculus,,,10090.0,2385.0,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Muscle tissue,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618813
11746,1,,1,Mus musculus,,,10090.0,,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618814
11747,1,,1,Mus musculus,,,10090.0,,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618815
11748,1,,1,Mus musculus,,,10090.0,,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618816
11749,1,,1,Mus musculus,,,10090.0,,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL618817
11750,1,,1,Mus musculus,,,10090.0,,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL620544
11751,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626230
11752,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626231
11753,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626232
11754,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626233
11755,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626234
11756,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875341
11757,1,,1,Homo sapiens,In vivo,,9606.0,1969.0,,The maximum plasma concentration (100 mg/kg) administered orally in human,Plasma,,,,BAO_0000218,50587,N,Intermediate,CHEMBL626235
11758,1,,0,Callithrix,In vivo,,9481.0,1969.0,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626236
11759,1,,0,Simiiformes,In vivo,,314293.0,1969.0,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626237
11760,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626238
11761,1,,1,Homo sapiens,In vivo,,9606.0,1969.0,,The maximum plasma concentration (200 mg/kg) administered orally in human,Plasma,,,,BAO_0000218,50587,N,Intermediate,CHEMBL622412
11762,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623114
11763,1,,0,Callithrix,In vivo,,9481.0,1969.0,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623115
11764,1,,0,Simiiformes,In vivo,,314293.0,1969.0,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623116
11765,1,,0,Canis lupus familiaris,In vivo,,9615.0,1969.0,,The maximum plasma concentration (30 mg/kg) administered orally in dog,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623117
11766,1,,1,Homo sapiens,In vivo,,9606.0,1969.0,,The maximum plasma concentration (400 mg/kg) administered orally in human,Plasma,,,,BAO_0000218,50587,N,Intermediate,CHEMBL623118
11767,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623119
11768,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,The maximum plasma concentration (50 mg/kg) administered orally in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623120
11769,1,,1,Homo sapiens,In vivo,,9606.0,1969.0,,The maximum plasma concentration (800 mg/kg) administered orally in human,Plasma,,,,BAO_0000218,50587,N,Intermediate,CHEMBL623286
11770,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,The maximum plasma concentration was measured on rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623287
11771,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,The maximum plasma concentration was measured on rats after oral administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623288
11772,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Plasma drug Cmax in rat (PO dose),Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623289
11773,1,,0,,In vivo,,,,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623290
11774,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,maximum Plasma concentration in Dog was determined after Peroral administration,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623291
11775,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,maximum Plasma concentration in Rats was determined after Peroral administration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623292
11776,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623293
11777,1,,0,Simiiformes,In vivo,,314293.0,1969.0,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623294
11778,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623295
11779,1,,1,Mus musculus,In vivo,,10090.0,,,maximum concentration was measured when administered through oral route in mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623296
11780,1,,1,Mus musculus,,,10090.0,,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL875349
11781,1,,0,Simiiformes,,,314293.0,,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623297
11782,1,,0,Simiiformes,,,314293.0,,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623298
11783,1,,0,Simiiformes,,,314293.0,,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623299
11784,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter was evaluated in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623300
11785,1,,1,Mus musculus,,,10090.0,,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623301
11786,1,,1,Mus musculus,,,10090.0,,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623302
11787,1,,1,Mus musculus,,,10090.0,,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623303
11788,1,,1,Mus musculus,,,10090.0,,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623304
11789,1,,1,Mus musculus,,,10090.0,,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623305
11790,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623306
11791,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623307
11792,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623308
11793,1,,1,Mus musculus,,,10090.0,1969.0,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623309
11794,1,,1,Mus musculus,,,10090.0,,,Plasma Concentration after 120 min of oral administration to mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623310
11795,1,,1,Mus musculus,,,10090.0,,,Plasma Concentration after 30 min of oral administration to mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623311
11796,1,,1,Macaca fascicularis,,,9541.0,,,Plasma Concentration after 60 min of oral administration to mice,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL623312
11797,1,,1,Mus musculus,,,10090.0,,,Plasma Concentration after 60 min of oral administration to mice; Not determined,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL875350
11798,1,,1,Mus musculus,,,10090.0,,,Plasma Concentration after 90 min of oral administration to mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628635
11799,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628636
11800,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628637
11801,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628058
11802,1,,1,Rattus norvegicus,,,10116.0,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628059
11803,1,,1,Rattus norvegicus,,,10116.0,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628060
11804,1,,0,,,,,,,Distribution in the lung after 15 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628061
11805,1,,0,,,,,,,Distribution in the lung after 30 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628062
11806,1,,0,,,,,,,Distribution in the lung after 5 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628063
11807,1,,0,,,,,,,Distribution in the lung after 60 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628064
11808,1,,0,,,,,,,Distribution in the lung after 90 min of intravenous administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628065
11809,1,,0,,,,,2385.0,,Distribution in the muscle after 120 min of intravenous administration,Muscle tissue,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628066
11810,1,,0,,,,,2385.0,,Distribution in the muscle after 15 min of intravenous administration,Muscle tissue,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628067
11811,1,,1,Mus musculus,,,10090.0,2385.0,,Distribution in the muscle after 30 min of intravenous administration,Muscle tissue,,,,BAO_0000218,50594,N,Intermediate,CHEMBL874646
11812,1,,0,,,,,2385.0,,Distribution in the muscle after 5 min of intravenous administration,Muscle tissue,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628068
11813,1,,0,,,,,2385.0,,Distribution in the muscle after 60 min of intravenous administration,Muscle tissue,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628069
11814,1,,0,,,,,2385.0,,Distribution in the muscle after 90 min of intravenous administration,Muscle tissue,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628070
11815,1,,0,,,,,2106.0,,Distribution in the spleen after 120 min of intravenous administration,Spleen,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628071
11816,1,,0,,,,,2106.0,,Distribution in the spleen after 15 min of intravenous administration,Spleen,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628072
11817,1,,0,,,,,2106.0,,Distribution in the spleen after 30 min of intravenous administration,Spleen,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628073
11818,1,,0,,,,,2106.0,,Distribution in the spleen after 5 min of intravenous administration,Spleen,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628074
11819,1,,0,,,,,2106.0,,Distribution in the spleen after 60 min of intravenous administration,Spleen,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628075
11820,1,,0,,,,,2106.0,,Distribution in the spleen after 90 min of intravenous administration,Spleen,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628076
11821,1,,1,Rattus norvegicus,,,10116.0,1235.0,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,Adrenal cortex,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628077
11822,1,,1,Rattus norvegicus,,,10116.0,178.0,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628078
11823,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628079
11824,1,,1,Rattus norvegicus,,,10116.0,992.0,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,Female gonad,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628080
11825,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628081
11826,1,,1,Rattus norvegicus,,,10116.0,1235.0,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,Adrenal cortex,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628082
11827,1,,1,Rattus norvegicus,,,10116.0,178.0,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874647
11828,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626406
11829,1,,1,Rattus norvegicus,,,10116.0,992.0,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,Female gonad,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626407
11830,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626408
11831,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626409
11832,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626410
11833,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626411
11834,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626412
11835,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626413
11836,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626414
11837,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626415
11838,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626416
11839,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627062
11840,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627063
11841,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627064
11842,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627227
11843,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627228
11844,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627229
11845,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625792
11846,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625793
11847,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625794
11848,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625795
11849,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625796
11850,1,,1,Canis lupus familiaris,,,9615.0,,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625797
11851,1,,1,Canis lupus familiaris,,,9615.0,,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625798
11852,1,,0,,,,,,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL875613
11853,1,,0,,,,,,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625799
11854,1,,0,,,,,,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625800
11855,1,,0,,,,,,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625801
11856,1,,0,,,,,,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625802
11857,1,,0,,,,,,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625803
11858,1,,0,,,,,,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625804
11859,1,,0,,,,,,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622530
11860,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622531
11861,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622532
11862,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623176
11863,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623177
11864,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623178
11865,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623179
11866,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623180
11867,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623181
11868,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624131
11869,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624132
11870,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624133
11871,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624846
11872,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624847
11873,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL624848
11874,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625012
11875,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625013
11876,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625014
11877,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625015
11878,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625016
11879,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625017
11880,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625018
11881,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625019
11882,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625020
11883,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625021
11884,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625022
11885,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625023
11886,1,,1,Macaca fascicularis,,,9541.0,,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL625024
11887,1,,1,Macaca fascicularis,,,9541.0,,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL627626
11888,1,,0,,,,,955.0,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,Brain,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627627
11889,1,,0,,,,,1977.0,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,Serum,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627628
11890,1,,0,,,,,955.0,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,Brain,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627629
11891,1,,0,,,,,1977.0,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,Serum,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627630
11892,1,,0,,,,,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627631
11893,1,,0,,,,,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629515
11894,1,,1,Mus musculus,,,10090.0,2106.0,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629516
11895,1,,1,Mus musculus,,,10090.0,2106.0,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629517
11896,1,,1,Mus musculus,,,10090.0,2106.0,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629518
11897,1,,1,Mus musculus,,,10090.0,,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL877499
11898,1,,1,Mus musculus,,,10090.0,,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629519
11899,1,,1,Mus musculus,,,10090.0,,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629520
11900,1,,1,Mus musculus,,,10090.0,,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629521
11901,1,,1,Mus musculus,,,10090.0,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629522
11902,1,,1,Mus musculus,,,10090.0,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629523
11903,1,,1,Mus musculus,,,10090.0,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629524
11904,1,,1,Mus musculus,,,10090.0,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629525
11905,1,,1,Mus musculus,,,10090.0,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629526
11906,1,,1,Mus musculus,,,10090.0,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629527
11907,1,,1,Mus musculus,,,10090.0,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629528
11908,1,,1,Mus musculus,,,10090.0,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629529
11909,1,,1,Mus musculus,,,10090.0,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629530
11910,1,,1,Mus musculus,,,10090.0,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629531
11911,1,,1,Mus musculus,,,10090.0,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628656
11912,1,,1,Mus musculus,,,10090.0,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628657
11913,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628658
11914,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628659
11915,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877500
11916,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628660
11917,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628661
11918,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628662
11919,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628663
11920,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628664
11921,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628665
11922,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628666
11923,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628667
11924,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628668
11925,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628669
11926,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628670
11927,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628671
11928,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628672
11929,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630300
11930,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629787
11931,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629788
11932,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629789
11933,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629790
11934,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629791
11935,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629792
11936,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629793
11937,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629794
11938,1,,1,Rattus norvegicus,,,10116.0,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874459
11939,1,,1,Rattus norvegicus,,,10116.0,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629795
11940,1,,1,Rattus norvegicus,,,10116.0,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629796
11941,1,,1,Rattus norvegicus,,,10116.0,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629797
11942,1,,1,Rattus norvegicus,,,10116.0,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629798
11943,1,,1,Rattus norvegicus,In vivo,,10116.0,2369.0,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Adrenal gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629799
11944,1,,1,Rattus norvegicus,In vivo,,10116.0,2369.0,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Adrenal gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629800
11945,1,,1,Rattus norvegicus,In vivo,,10116.0,2369.0,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Adrenal gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629801
11946,1,,1,Rattus norvegicus,In vivo,,10116.0,2369.0,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,Adrenal gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629802
11947,1,,1,Rattus norvegicus,In vivo,,10116.0,2369.0,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Adrenal gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629803
11948,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629804
11949,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629805
11950,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629806
11951,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629807
11952,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629808
11953,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629809
11954,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629810
11955,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629811
11956,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629812
11957,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629813
11958,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874460
11959,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629814
11960,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629815
11961,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629816
11962,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629817
11963,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626643
11964,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626644
11965,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626806
11966,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626807
11967,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627261
11968,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627262
11969,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627263
11970,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627264
11971,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627265
11972,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627266
11973,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627267
11974,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627268
11975,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627269
11976,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627270
11977,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627271
11978,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627946
11979,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875472
11980,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627947
11981,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627948
11982,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628113
11983,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628114
11984,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628115
11985,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628116
11986,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628117
11987,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628118
11988,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628119
11989,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628120
11990,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628121
11991,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628122
11992,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627297
11993,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627298
11994,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627299
11995,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627300
11996,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627301
11997,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627302
11998,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627303
11999,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627304
12000,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627305
12001,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627306
12002,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623982
12003,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623983
12004,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623984
12005,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623985
12006,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623986
12007,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623987
12008,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623988
12009,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623989
12010,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622215
12011,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622216
12012,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877481
12013,1,,0,,,,,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622217
12014,1,,1,Mus musculus,,,10090.0,,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622218
12015,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic profile AUC was evaluated in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622219
12016,1,,0,,,,,,,Pharmacokinetic property (Area under curve),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622220
12017,1,,1,Canis lupus familiaris,,,9615.0,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622221
12018,1,,1,Mus musculus,,,10090.0,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622222
12019,1,,1,Canis lupus familiaris,,,9615.0,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622223
12020,1,,1,Mus musculus,,,10090.0,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622224
12021,1,,0,,,,,,,Plasma concentration (AUC) was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622225
12022,1,,0,,,,,,,Plasma concentration (AUC) was determined; Not detectable,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622226
12023,1,,1,Cavia porcellus,,,10141.0,,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,,,,BAO_0000218,50512,N,Intermediate,CHEMBL624154
12024,1,,1,Rattus norvegicus,,,10116.0,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624155
12025,1,,1,Rattus norvegicus,,,10116.0,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624156
12026,1,,1,Rattus norvegicus,,,10116.0,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624157
12027,1,,1,Rattus norvegicus,,,10116.0,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624158
12028,1,,1,Rattus norvegicus,,,10116.0,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624159
12029,1,,1,Rattus norvegicus,,,10116.0,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624160
12030,1,,1,Rattus norvegicus,,,10116.0,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624161
12031,1,,1,Rattus norvegicus,,,10116.0,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624162
12032,1,,1,Canis lupus familiaris,,,9615.0,,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624163
12033,1,,1,Rattus norvegicus,,,10116.0,,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624164
12034,1,,1,Rattus norvegicus,,,10116.0,,,The AUC(0-infinity) values in female wistar rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624165
12035,1,,1,Rattus norvegicus,,,10116.0,,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624166
12036,1,,1,Rattus norvegicus,,,10116.0,,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624167
12037,1,,1,Rattus norvegicus,,,10116.0,,,The AUC(0-t)values in female wistar rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624168
12038,1,,1,Rattus norvegicus,,,10116.0,,,The Area under the concentration time curve of compound was measured on rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624169
12039,1,,1,Homo sapiens,,,9606.0,,,The area under curve (100 mg/kg) administered orally in humans,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL624170
12040,1,,0,Callithrix,,,9481.0,,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624171
12041,1,,0,Simiiformes,,,314293.0,,,The area under curve (12.5 mg/kg) administered intravenously in monkey,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624172
12042,1,,1,Canis lupus familiaris,,,9615.0,,,The area under curve (15 mg/kg) administered intravenously in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624173
12043,1,,1,Homo sapiens,,,9606.0,,,The area under curve (200 mg/kg) administered orally in humans,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL877488
12044,1,,1,Rattus norvegicus,,,10116.0,,,The area under curve (25 mg/kg) administered intravenously in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624174
12045,1,,0,Callithrix,,,9481.0,,,The area under curve (25 mg/kg) administered orally in marmoset,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624175
12046,1,,0,Simiiformes,,,314293.0,,,The area under curve (25 mg/kg) administered orally in monkey,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624176
12047,1,,1,Canis lupus familiaris,,,9615.0,,,The area under curve (30 mg/kg) administered orally in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624177
12048,1,,1,Homo sapiens,,,9606.0,,,The area under curve (400 mg/kg) administered orally in humans,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL624178
12049,1,,1,Rattus norvegicus,,,10116.0,,,The area under curve (50 mg/kg) administered orally in fasted rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624179
12050,1,,1,Rattus norvegicus,,,10116.0,,,The area under curve (50 mg/kg) administered orally in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627689
12051,1,,1,Homo sapiens,,,9606.0,,,The area under curve (800 mg/kg) administered orally in humans,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL627690
12052,1,,0,,,,,,,The compound was evaluated for area under the curve,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627691
12053,1,,0,Callithrix,,,9481.0,,,The compound was evaluated for area under the curve in marmosets,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627692
12054,1,,0,Callithrix,,,9481.0,,,The compound was evaluated for area under the curve in marmosets,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627693
12055,1,,1,Rattus norvegicus,,,10116.0,,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627694
12056,1,,1,Rattus norvegicus,,,10116.0,,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627695
12057,1,,0,,,,,,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627696
12058,1,,1,Rattus norvegicus,,,10116.0,,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627697
12059,1,,1,Rattus norvegicus,,,10116.0,,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627698
12060,1,,1,Rattus norvegicus,,,10116.0,,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627699
12061,1,,1,Rattus norvegicus,,,10116.0,,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627700
12062,1,,1,Rattus norvegicus,,,10116.0,,,Total drug exposure is determined after oral dosing in rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627701
12063,1,,0,,,,,,,Total drug exposure (5 mg/kg) when administered intravenously,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627702
12064,1,,0,,,,,,,Total drug exposure (5 mg/kg) when administered orally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627703
12065,1,,0,Simiiformes,,,314293.0,,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626873
12066,1,,1,Rattus norvegicus,,,10116.0,,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629583
12067,1,,1,Canis lupus familiaris,,,9615.0,,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629584
12068,1,,1,Canis lupus familiaris,,,9615.0,,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629585
12069,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629586
12070,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629587
12071,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629588
12072,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629589
12073,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629590
12074,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629591
12075,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629592
12076,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629593
12077,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629594
12078,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629595
12079,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630290
12080,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627137
12081,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627138
12082,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627139
12083,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627140
12084,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627141
12085,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627142
12086,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627143
12087,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874449
12088,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627144
12089,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627145
12090,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627146
12091,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627147
12092,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627148
12093,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627149
12094,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632160
12095,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632161
12096,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632162
12097,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632163
12098,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874469
12099,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627182
12100,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627183
12101,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627184
12102,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627185
12103,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627186
12104,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627187
12105,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627188
12106,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627189
12107,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627190
12108,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627191
12109,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627192
12110,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627193
12111,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874590
12112,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627194
12113,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627195
12114,1,,1,Rattus norvegicus,In vivo,,10116.0,992.0,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Female gonad,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627196
12115,1,,1,Rattus norvegicus,In vivo,,10116.0,992.0,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Female gonad,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627197
12116,1,,1,Rattus norvegicus,In vivo,,10116.0,992.0,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Female gonad,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627198
12117,1,,1,Rattus norvegicus,In vivo,,10116.0,992.0,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,Female gonad,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627199
12118,1,,1,Rattus norvegicus,In vivo,,10116.0,992.0,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Female gonad,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627200
12119,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627201
12120,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627202
12121,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627203
12122,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627204
12123,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627205
12124,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627206
12125,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627207
12126,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627208
12127,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627209
12128,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627210
12129,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627211
12130,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627212
12131,1,,1,Rattus norvegicus,In vivo,,10116.0,995.0,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627213
12132,1,,1,Rattus norvegicus,In vivo,,10116.0,995.0,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626599
12133,1,,1,Rattus norvegicus,In vivo,,10116.0,995.0,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626600
12134,1,,1,Rattus norvegicus,In vivo,,10116.0,995.0,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626601
12135,1,,0,,,,,,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627484
12136,1,,1,Macaca fascicularis,,,9541.0,1969.0,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),Plasma,,,,BAO_0000218,100710,N,Intermediate,CHEMBL627485
12137,1,,1,Macaca fascicularis,,,9541.0,1969.0,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,Plasma,,,,BAO_0000218,100710,N,Intermediate,CHEMBL628147
12138,1,,1,Macaca fascicularis,,,9541.0,1969.0,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,Plasma,,,,BAO_0000218,100710,N,Intermediate,CHEMBL628148
12139,1,,1,Canis lupus familiaris,,,9615.0,1969.0,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628149
12140,1,,1,Canis lupus familiaris,,,9615.0,1969.0,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628150
12141,1,,1,Canis lupus familiaris,,,9615.0,1969.0,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628318
12142,1,,1,Canis lupus familiaris,,,9615.0,1969.0,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628319
12143,1,,1,Canis lupus familiaris,,,9615.0,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,,,,BAO_0000218,50588,N,Intermediate,CHEMBL875609
12144,1,,0,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628320
12145,1,,0,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628321
12146,1,,0,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628322
12147,1,,0,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628323
12148,1,,0,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628324
12149,1,,0,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628325
12150,1,,0,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628326
12151,1,,1,Canis lupus familiaris,,,9615.0,1236.0,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",Adrenal medulla,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628327
12152,1,,1,Canis lupus familiaris,,,9615.0,1236.0,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",Adrenal medulla,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628328
12153,1,,1,Canis lupus familiaris,,,9615.0,178.0,,"Concentration of compound in blood of dog 1, after administering intravenously",Blood,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628329
12154,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628330
12155,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628331
12156,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628332
12157,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628333
12158,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628334
12159,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628335
12160,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628336
12161,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628337
12162,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628338
12163,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875610
12164,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628339
12165,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628340
12166,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628341
12167,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622214
12168,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623167
12169,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623168
12170,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623169
12171,1,,1,Rattus norvegicus,,,10116.0,2107.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623170
12172,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627224
12173,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875634
12174,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627225
12175,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627226
12176,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626083
12177,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626084
12178,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626085
12179,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626086
12180,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626087
12181,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626088
12182,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626089
12183,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626090
12184,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626091
12185,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626092
12186,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626093
12187,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626094
12188,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626095
12189,1,,1,Rattus norvegicus,,,10116.0,2048.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626096
12190,1,,0,Simiiformes,,,314293.0,,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626097
12191,1,,1,Rattus norvegicus,,,10116.0,,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626098
12192,1,,0,,,,,1969.0,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626099
12193,1,,0,,,,,1969.0,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626100
12194,1,,1,Canis lupus familiaris,,,9615.0,1969.0,,AUC 0-inf in dog,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626101
12195,1,,1,Cavia porcellus,,,10141.0,1969.0,,AUC 0-inf in guinea pig,Plasma,,,,BAO_0000218,50512,N,Intermediate,CHEMBL626102
12196,1,,1,Canis lupus familiaris,,,9615.0,1969.0,,AUC 0-t in dog,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626103
12197,1,,1,Cavia porcellus,,,10141.0,1969.0,,AUC 0-t in guinea pig,Plasma,,,,BAO_0000218,50512,N,Intermediate,CHEMBL628391
12198,1,,1,Rattus norvegicus,,,10116.0,,,The compound was tested for brain to plasma partition in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628392
12199,1,,1,Rattus norvegicus,,,10116.0,,,The compound was tested for brain to plasma partition in rat.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628393
12200,1,,0,,,,,178.0,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,Blood,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628394
12201,1,,1,Canis lupus familiaris,,,9615.0,,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628395
12202,1,,0,Simiiformes,,,314293.0,,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628396
12203,1,,1,Oryctolagus cuniculus,,,9986.0,,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628397
12204,1,,1,Rattus norvegicus,,,10116.0,,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628398
12205,1,,1,Macaca mulatta,,,9544.0,,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,,,,BAO_0000218,50797,N,Intermediate,CHEMBL628399
12206,1,,1,Canis lupus familiaris,,,9615.0,,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628400
12207,1,,1,Rattus norvegicus,,,10116.0,,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874907
12208,1,,0,,,,,,,Area under curve of the compound was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628401
12209,1,,0,Simiiformes,,,314293.0,1969.0,,AUC in monkeys at a dose of 1 mg/kg,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628402
12210,1,,1,Rattus norvegicus,,,10116.0,1969.0,,AUC in rats at a dose of 1 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628403
12211,1,,0,,,,,,,Compound was evaluated for the overall absorbance loss at pH of 2,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628404
12212,1,,0,,,,,,,Compound was evaluated for the overall absorbance loss at pH of 4,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628405
12213,1,,0,,,,,,,Compound was evaluated for the overall absorbance loss at pH of 7,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628406
12214,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for its absorption in the rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628407
12215,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628408
12216,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629171
12217,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629172
12218,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629173
12219,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629174
12220,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; Range is 10-17,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629175
12221,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; Range is 10-18,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629176
12222,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; Range is 10-19,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629177
12223,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; Range is 12-15,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629178
12224,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; Range is 13-19,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631869
12225,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; Range is 14-17,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631870
12226,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; Range is 15-18,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631871
12227,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; Range is 2-5,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631872
12228,1,,0,,,,,2116.0,,In vitro percent permeability into rat ileum; Range is 23-42,Ileum,,,,BAO_0000221,22224,U,Autocuration,CHEMBL875775
12229,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; Range is 28-36,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631873
12230,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; Range is 29-35,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631874
12231,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; Range is 46-66,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631875
12232,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; Range is 50-68,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631876
12233,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; Range is 78-81,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631877
12234,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631878
12235,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; nd indicates not detected,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631879
12236,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; nt indicates not detected,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631880
12237,1,,1,Rattus norvegicus,,,10116.0,,,In vitro percent permeability into rat ileum; nt indicates not tested,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631881
12238,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for oral absorption in bile-duct cannulated rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631882
12239,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for oral absorption in bile-duct cannulated rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630749
12240,1,,1,Homo sapiens,,,9606.0,,,Oral absorption using Caco-2 cell monolayers.,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL630750
12241,1,,1,Homo sapiens,,,9606.0,,,Percent of the drug absorbed after administration to humans was determined,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL630253
12242,1,,1,Rattus norvegicus,,,10116.0,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630254
12243,1,,1,Rattus norvegicus,,,10116.0,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630255
12244,1,,1,Rattus norvegicus,,,10116.0,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630256
12245,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875781
12246,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630257
12247,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630258
12248,1,,1,Rattus norvegicus,,,10116.0,,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630259
12249,1,,1,Rattus norvegicus,,,10116.0,2435.0,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630260
12250,1,,1,Rattus norvegicus,,,10116.0,2435.0,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630261
12251,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630262
12252,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630263
12253,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630264
12254,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630265
12255,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630266
12256,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630267
12257,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630268
12258,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630269
12259,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630270
12260,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630141
12261,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630142
12262,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630143
12263,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630144
12264,1,,1,Rattus norvegicus,,,10116.0,2367.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,Prostate gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630145
12265,1,,1,Rattus norvegicus,,,10116.0,2367.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,Prostate gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630146
12266,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630147
12267,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630148
12268,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630149
12269,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630150
12270,1,,1,Rattus norvegicus,,,10116.0,2106.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630151
12271,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632031
12272,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632032
12273,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632033
12274,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632034
12275,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632035
12276,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632036
12277,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632037
12278,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632038
12279,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632039
12280,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632040
12281,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632041
12282,1,,1,Canis lupus familiaris,,,9615.0,178.0,,"Concentration of compound in blood of dog 2, after administering intravenously",Blood,,,,BAO_0000218,50588,N,Intermediate,CHEMBL632042
12283,1,,1,Canis lupus familiaris,,,9615.0,,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,,,,BAO_0000218,50588,N,Intermediate,CHEMBL632043
12284,1,,1,Canis lupus familiaris,,,9615.0,,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,,,,BAO_0000218,50588,N,Intermediate,CHEMBL632044
12285,1,,1,Canis lupus familiaris,,,9615.0,2107.0,,"Concentration of compound in liver of dog 1, after administering intravenously",Liver,,,,BAO_0000218,50588,N,Intermediate,CHEMBL632045
12286,1,,1,Canis lupus familiaris,,,9615.0,2107.0,,"Concentration of compound in liver of dog 2, after administering intravenously",Liver,,,,BAO_0000218,50588,N,Intermediate,CHEMBL632046
12287,1,,1,Canis lupus familiaris,,,9615.0,2048.0,,"Concentration of compound in lung of dog 1, after administering intravenously",Lung,,,,BAO_0000218,50588,N,Intermediate,CHEMBL632047
12288,1,,1,Canis lupus familiaris,,,9615.0,2048.0,,"Concentration of compound in lung of dog 2, after administering intravenously",Lung,,,,BAO_0000218,50588,N,Intermediate,CHEMBL632048
12289,1,,1,Canis lupus familiaris,,,9615.0,2385.0,,"Concentration of compound in muscle of dog 1, after administering intravenously",Muscle tissue,,,,BAO_0000218,50588,N,Intermediate,CHEMBL632049
12290,1,,1,Canis lupus familiaris,,,9615.0,2385.0,,"Concentration of compound in muscle of dog 2, after administering intravenously",Muscle tissue,,,,BAO_0000218,50588,N,Intermediate,CHEMBL876418
12291,1,,1,Canis lupus familiaris,,,9615.0,2106.0,,"Concentration of compound in spleen of dog 1,after administering intravenously",Spleen,,,,BAO_0000218,50588,N,Intermediate,CHEMBL632050
12292,1,,1,Canis lupus familiaris,,,9615.0,2106.0,,"Concentration of compound in spleen of dog 2, after administering intravenously",Spleen,,,,BAO_0000218,50588,N,Intermediate,CHEMBL632051
12293,1,,0,,,,,,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL632052
12294,1,,0,,,,,,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL632053
12295,1,,0,,,,,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL632054
12296,1,,0,,,,,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL632055
12297,1,,0,,,,,,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL631181
12298,1,,0,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL631182
12299,1,,0,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL631183
12300,1,,0,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL631184
12301,1,,0,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629774
12302,1,,0,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629775
12303,1,,0,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL876549
12304,1,,0,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628172
12305,1,,0,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628173
12306,1,,0,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628174
12307,1,,0,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628175
12308,1,,0,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628176
12309,1,,0,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628177
12310,1,,0,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628178
12311,1,,0,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628179
12312,1,,0,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628180
12313,1,,0,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628181
12314,1,,0,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628182
12315,1,,0,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628183
12316,1,,0,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628184
12317,1,,0,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628185
12318,1,,0,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL875617
12319,1,,0,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628186
12320,1,,0,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628187
12321,1,,0,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628188
12322,1,,0,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628189
12323,1,,0,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628190
12324,1,,0,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628191
12325,1,,0,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626513
12326,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626514
12327,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626515
12328,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626516
12329,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626517
12330,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626518
12331,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626519
12332,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626520
12333,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626521
12334,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626522
12335,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626523
12336,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626524
12337,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626688
12338,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626689
12339,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626690
12340,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626691
12341,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627319
12342,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624052
12343,1,,1,Rattus norvegicus,,,10116.0,2046.0,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624053
12344,1,,1,Rattus norvegicus,,,10116.0,,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624054
12345,1,,1,Rattus norvegicus,,,10116.0,,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624055
12346,1,,1,Rattus norvegicus,,,10116.0,,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624056
12347,1,,1,Rattus norvegicus,,,10116.0,995.0,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624057
12348,1,,1,Rattus norvegicus,,,10116.0,995.0,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622281
12349,1,,1,Rattus norvegicus,,,10116.0,995.0,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622282
12350,1,,1,Rattus norvegicus,,,10116.0,995.0,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622283
12351,1,,1,Rattus norvegicus,,,10116.0,995.0,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622284
12352,1,,1,Rattus norvegicus,,,10116.0,995.0,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622285
12353,1,,1,Rattus norvegicus,,,10116.0,995.0,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622286
12354,1,,0,,,,,,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL622287
12355,1,,1,Mus musculus,,,10090.0,,,Partition coefficient (logD7.4),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622288
12356,1,,1,Mus musculus,,,10090.0,,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622289
12357,1,,1,Mus musculus,,,10090.0,955.0,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622290
12358,1,,1,Mus musculus,,,10090.0,,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622291
12359,1,,1,Mus musculus,,,10090.0,955.0,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622292
12360,1,,1,Mus musculus,,,10090.0,,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622293
12361,1,,1,Mus musculus,,,10090.0,955.0,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622294
12362,1,,1,Mus musculus,,,10090.0,,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL622295
12363,1,,1,Rattus norvegicus,,,10116.0,955.0,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622296
12364,1,,1,Rattus norvegicus,,,10116.0,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874409
12365,1,,1,Rattus norvegicus,,,10116.0,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622297
12366,1,,1,Rattus norvegicus,,,10116.0,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622298
12367,1,,1,Rattus norvegicus,,,10116.0,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622299
12368,1,,1,Rattus norvegicus,,,10116.0,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622300
12369,1,,1,Rattus norvegicus,,,10116.0,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622301
12370,1,,1,Rattus norvegicus,,,10116.0,1969.0,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622302
12371,1,,1,Rattus norvegicus,,,10116.0,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622303
12372,1,,1,Rattus norvegicus,,,10116.0,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622304
12373,1,,1,Rattus norvegicus,,,10116.0,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622305
12374,1,,1,Rattus norvegicus,,,10116.0,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622306
12375,1,,1,Rattus norvegicus,,,10116.0,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626864
12376,1,,1,Rattus norvegicus,,,10116.0,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626865
12377,1,,1,Rattus norvegicus,,,10116.0,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626866
12378,1,,1,Rattus norvegicus,,,10116.0,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626867
12379,1,,1,Rattus norvegicus,,,10116.0,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626868
12380,1,,1,Rattus norvegicus,,,10116.0,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626869
12381,1,,1,Rattus norvegicus,,,10116.0,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626870
12382,1,,1,Rattus norvegicus,,,10116.0,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626871
12383,1,,1,Rattus norvegicus,,,10116.0,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626872
12384,1,,1,Rattus norvegicus,,,10116.0,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632185
12385,1,,1,Rattus norvegicus,,,10116.0,1969.0,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632186
12386,1,,0,,,,,,,Amount of acetic acid produced by the compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629310
12387,1,,0,,,,,,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629311
12388,1,,1,Rattus norvegicus,,,10116.0,,,Log of (Cbrain/Cblood) in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629312
12389,1,,0,,,,,,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,,,,BAO_0000221,22224,U,Autocuration,CHEMBL629313
12390,1,,0,,,,,,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,,,BAO_0000221,22224,U,Autocuration,CHEMBL629314
12391,1,,0,,,,,,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,,,,BAO_0000221,22224,U,Autocuration,CHEMBL629315
12392,1,,0,,,,,,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,,,,BAO_0000219,22224,U,Autocuration,CHEMBL629316
12393,1,,0,,,,,,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,,,BAO_0000221,22224,U,Autocuration,CHEMBL629317
12394,1,,0,,,,,,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629318
12395,1,,0,,,,,,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL877497
12396,1,,0,,,,,,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629319
12397,1,,0,,,,,,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629320
12398,1,,0,,,,,,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629496
12399,1,,0,,,,,,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629497
12400,1,,0,,,,,,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629498
12401,1,,0,,,,,,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629499
12402,1,,0,,,,,,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629500
12403,1,,0,,,,,,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629501
12404,1,,0,,,,,,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629502
12405,1,,0,,In vivo,,,,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629503
12406,1,,1,Canis lupus familiaris,,,9615.0,,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629504
12407,1,,0,,,,,,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629505
12408,1,,0,,,,,,,Compound was evaluated for total body clearance,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629506
12409,1,,0,,,,,,,Compound was evaluated for volume of distribution at steady state,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629507
12410,1,,0,,,,,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL877498
12411,1,,0,,,,,,,Percentage of the diamine which is monoprotonated at pH 7.4,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629508
12412,1,,0,,,,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629509
12413,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629510
12414,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629511
12415,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629512
12416,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629513
12417,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629514
12418,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628447
12419,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628448
12420,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628449
12421,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631119
12422,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631120
12423,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631121
12424,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874458
12425,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631122
12426,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631123
12427,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631124
12428,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631125
12429,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631290
12430,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631291
12431,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631292
12432,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631293
12433,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631294
12434,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631295
12435,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631296
12436,1,,1,Rattus norvegicus,,,10116.0,178.0,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631297
12437,1,,0,,,,,,,Maximum biodistribution (Bmax) was determined.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL631298
12438,1,,1,Mus musculus,,,10090.0,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631299
12439,1,,1,Mus musculus,,,10090.0,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631300
12440,1,,1,Mus musculus,,,10090.0,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631301
12441,1,,1,Mus musculus,,,10090.0,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630291
12442,1,,0,,,,,,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL630292
12443,1,,0,,,,,,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL630293
12444,1,,0,,,,,,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL630294
12445,1,,0,,,,,,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL630295
12446,1,,0,,,,,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL630296
12447,1,,0,,,,,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626782
12448,1,,0,,,,,,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626783
12449,1,,0,,,,,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626784
12450,1,,0,,,,,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626785
12451,1,,0,,,,,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626786
12452,1,,0,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626787
12453,1,,0,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626788
12454,1,,0,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625927
12455,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625928
12456,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625929
12457,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625930
12458,1,,1,Rattus norvegicus,,,10116.0,178.0,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625931
12459,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627230
12460,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627231
12461,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627232
12462,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627233
12463,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875470
12464,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627234
12465,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627235
12466,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627236
12467,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627237
12468,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627238
12469,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627239
12470,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627240
12471,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627241
12472,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627242
12473,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627243
12474,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627244
12475,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627245
12476,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627246
12477,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627247
12478,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627248
12479,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627249
12480,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625569
12481,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625570
12482,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625571
12483,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625572
12484,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625573
12485,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625574
12486,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626245
12487,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626246
12488,1,,0,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626247
12489,1,,0,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626248
12490,1,,0,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626249
12491,1,,0,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626420
12492,1,,0,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626421
12493,1,,0,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626422
12494,1,,0,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626423
12495,1,,0,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626424
12496,1,,1,Canis lupus familiaris,,,9615.0,,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626425
12497,1,,1,Rattus norvegicus,,,10116.0,,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875476
12498,1,,1,Macaca fascicularis,,,9541.0,,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL626426
12499,1,,0,,,,,,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL626427
12500,1,,0,,,,,,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL626428
12501,1,,0,,,,,,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626429
12502,1,,0,,,,,1088.0,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,Urine,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625025
12503,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625026
12504,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625027
12505,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874410
12506,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625028
12507,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625029
12508,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625030
12509,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625031
12510,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625032
12511,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625033
12512,1,,1,Rattus norvegicus,,,10116.0,178.0,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625034
12513,1,,1,Rattus norvegicus,,,10116.0,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624872
12514,1,,1,Rattus norvegicus,,,10116.0,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624873
12515,1,,1,Rattus norvegicus,,,10116.0,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624874
12516,1,,1,Rattus norvegicus,,,10116.0,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624875
12517,1,,1,Rattus norvegicus,,,10116.0,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624876
12518,1,,1,Rattus norvegicus,,,10116.0,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624877
12519,1,,1,Rattus norvegicus,,,10116.0,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624878
12520,1,,1,Rattus norvegicus,,,10116.0,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624879
12521,1,,1,Rattus norvegicus,,,10116.0,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624880
12522,1,,1,Rattus norvegicus,,,10116.0,948.0,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624881
12523,1,,1,Rattus norvegicus,,,10116.0,948.0,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624882
12524,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624883
12525,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624884
12526,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624885
12527,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624886
12528,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624887
12529,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624888
12530,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624889
12531,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624890
12532,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621964
12533,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621965
12534,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621966
12535,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL621967
12536,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622164
12537,1,,0,,,,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623097
12538,1,,0,,,,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623098
12539,1,,0,,,,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623099
12540,1,,0,,,,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623100
12541,1,,1,Rattus norvegicus,,,10116.0,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628673
12542,1,,1,Rattus norvegicus,,,10116.0,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628674
12543,1,,1,Rattus norvegicus,,,10116.0,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628675
12544,1,,1,Rattus norvegicus,,,10116.0,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627644
12545,1,,1,Rattus norvegicus,,,10116.0,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627645
12546,1,,1,Rattus norvegicus,,,10116.0,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627646
12547,1,,1,Rattus norvegicus,,,10116.0,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627647
12548,1,,1,Rattus norvegicus,,,10116.0,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627648
12549,1,,1,Rattus norvegicus,,,10116.0,,,Free level in rat plasma,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627649
12550,1,,0,,,,,,,Level reaching in blood plasma of rat or human was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628313
12551,1,,1,Rattus norvegicus,,,10116.0,,,Log (Cbrain/Cblood) in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628314
12552,1,,0,,,,,,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628315
12553,1,,0,,,,,,,Mean percentage of compound transport through membrane; expressed as membrane transport,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628316
12554,1,,0,,,,,,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628317
12555,1,,0,,,,,,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628473
12556,1,,0,,,,,,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628474
12557,1,,0,,,,,,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628475
12558,1,,0,,,,,,,Net water uptake by a carrier mediated transport (%cm) mechanism,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628476
12559,1,,0,Simiiformes,,,314293.0,,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628477
12560,1,,1,Mustela putorius furo,,,9669.0,,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,,,,BAO_0000218,50506,N,Intermediate,CHEMBL628478
12561,1,,1,Mustela putorius furo,,,9669.0,,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,,,,BAO_0000218,50506,N,Intermediate,CHEMBL628479
12562,1,,0,Simiiformes,,,314293.0,,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628480
12563,1,,0,Simiiformes,,,314293.0,,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628481
12564,1,,1,Rattus norvegicus,,,10116.0,,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628482
12565,1,,1,Rattus norvegicus,,,10116.0,,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628483
12566,1,,1,Rattus norvegicus,,,10116.0,1969.0,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628484
12567,1,,1,Rattus norvegicus,,,10116.0,1969.0,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628485
12568,1,,1,Macaca fascicularis,,,9541.0,1969.0,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",Plasma,,,,BAO_0000218,100710,N,Intermediate,CHEMBL628486
12569,1,,1,Homo sapiens,,,9606.0,1969.0,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",Plasma,,,,BAO_0000218,50587,N,Intermediate,CHEMBL628487
12570,1,,1,Rattus norvegicus,,,10116.0,1969.0,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628488
12571,1,,1,Rattus norvegicus,,,10116.0,1969.0,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628489
12572,1,,1,Rattus norvegicus,,,10116.0,1969.0,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628490
12573,1,,1,Macaca fascicularis,,,9541.0,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL628491
12574,1,,1,Macaca fascicularis,,,9541.0,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL877507
12575,1,,0,,,,,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628492
12576,1,,0,Simiiformes,,,314293.0,,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628493
12577,1,,0,Simiiformes,,,314293.0,,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628494
12578,1,,0,Simiiformes,,,314293.0,,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628495
12579,1,,1,Homo sapiens,,,9606.0,,,Permeability in Caco-2 assay at 10E-6,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL628496
12580,1,,0,,,,,955.0,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,Brain,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628497
12581,1,,0,,,,,955.0,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,Brain,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628498
12582,1,,0,,,,,,,Plasma protein binding was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628499
12583,1,,0,,,,,,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627656
12584,1,,0,,,,,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627657
12585,1,,0,,,,,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626808
12586,1,,0,,,,,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626809
12587,1,,0,,,,,,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626810
12588,1,,0,,,,,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626811
12589,1,,0,,,,,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL874465
12590,1,,0,,,,,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626812
12591,1,,0,,,,,,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626813
12592,1,,0,,,,,,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626814
12593,1,,0,,,,,,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626815
12594,1,,0,,,,,,,Partition coefficient (logP),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628566
12595,1,,0,,,,,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL628567
12596,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL628568
12597,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,C max in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628569
12598,1,,1,Cavia porcellus,In vivo,,10141.0,,,C max in guinea pig,,,,,BAO_0000218,50512,N,Intermediate,CHEMBL628570
12599,1,,0,,In vivo,,,,,C max value was evaluated,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628571
12600,1,,0,,In vivo,,,,,Cmax value after oral dose of 0.1 mg//kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628572
12601,1,,0,,In vivo,,,,,Cmax value after oral dose of 0.3 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628573
12602,1,,0,,In vivo,,,,,Cmax value after oral dose of 1 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628574
12603,1,,0,,In vivo,,,,,Cmax value after oral dose of 10 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628575
12604,1,,0,,In vivo,,,,,Cmax value after oral dose of 23.4 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628576
12605,1,,0,,In vivo,,,,,Cmax value after oral dose of 3 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628577
12606,1,,0,,In vivo,,,,,Cmax value after oral dose of 3.87 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628578
12607,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Cmax value in female Beagle dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL874466
12608,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax value in male rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628579
12609,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Cmax value in rat plasma when administered 20 mg/kg perorally,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628580
12610,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628581
12611,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628582
12612,1,,1,Canis lupus familiaris,,,9615.0,,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628583
12613,1,,0,Simiiformes,,,314293.0,,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625782
12614,1,,1,Oryctolagus cuniculus,,,9986.0,,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,,,,BAO_0000218,50592,N,Intermediate,CHEMBL625783
12615,1,,1,Rattus norvegicus,,,10116.0,,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625784
12616,1,,1,Macaca mulatta,,,9544.0,1969.0,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,Plasma,,,,BAO_0000218,50797,N,Intermediate,CHEMBL625785
12617,1,,1,Rattus norvegicus,,,10116.0,,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625786
12618,1,,0,,,,,,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL874467
12619,1,,1,Canis lupus familiaris,,,9615.0,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625787
12620,1,,1,Human immunodeficiency virus,,,12721.0,,,cytotoxicity against HIV protease enzyme.,,,,,BAO_0000218,50677,N,Intermediate,CHEMBL625964
12621,1,,1,Mus musculus,,,10090.0,,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625965
12622,1,,1,Mus musculus,,,10090.0,,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625966
12623,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,The plasma clearance in dog.,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625967
12624,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,The plasma clearance in rat.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625968
12625,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Clearance from plasma in male Sprague-Dawley rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625969
12626,1,,1,Macaca fascicularis,In vivo,,9541.0,1969.0,,Clearance from plasma in male cynomolgus monkeys,Plasma,,,,BAO_0000218,100710,N,Intermediate,CHEMBL625970
12627,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625971
12628,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Clearance of compound in dog plasma,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625972
12629,1,,1,Homo sapiens,In vivo,,9606.0,1969.0,,Clearance of compound in human plasma,Plasma,,,,BAO_0000218,50587,N,Intermediate,CHEMBL625973
12630,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625974
12631,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Clearance of compound when administered intravenously as an individual dose to a single dog.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625975
12632,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,"Clearance (10 mg/kg, intravenously) in dog plasma",Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625976
12633,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Clearance value in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625977
12634,1,,1,Cavia porcellus,In vivo,,10141.0,,,Clearance value in guinea pig,,,,,BAO_0000218,50512,N,Intermediate,CHEMBL625978
12635,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance values in rats after iv administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874468
12636,1,,0,,In vivo,,,1969.0,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625421
12637,1,,1,Oryctolagus cuniculus,In vivo,,9986.0,,,In vivo clearance (5 mg/kg) was determined in rabbits,,,,,BAO_0000218,50592,N,Intermediate,CHEMBL625422
12638,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma Clearance rate was determined for the compound in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625423
12639,1,,0,Saimiri,In vivo,,9520.0,,,Plasma Clearance rate was determined for the compound in squirrel monkeys,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625424
12640,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625425
12641,1,,0,,In vivo,,,,,Plasma clearance of the compound,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625426
12642,1,,1,Cavia porcellus,In vivo,,10141.0,,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,,,,BAO_0000218,50512,N,Intermediate,CHEMBL625427
12643,1,,1,Cavia porcellus,In vivo,,10141.0,,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,,,,BAO_0000218,50512,N,Intermediate,CHEMBL625428
12644,1,,0,,In vivo,,,,,Plasma clearance was determined,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625429
12645,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625430
12646,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance rate was determined for the compound in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625431
12647,1,,0,Saimiri,In vivo,,9520.0,,,Plasma clearance rate was determined for the compound in squirrel monkeys,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627307
12648,1,,0,,In vivo,,,,,Slow clearance (CL) was determined,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627308
12649,1,,0,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627309
12650,1,,0,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627310
12651,1,,0,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627311
12652,1,,0,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627312
12653,1,,0,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627313
12654,1,,0,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627314
12655,1,,0,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627315
12656,1,,0,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627316
12657,1,,0,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627317
12658,1,,0,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627318
12659,1,,0,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627999
12660,1,,0,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628000
12661,1,,0,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628001
12662,1,,0,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628002
12663,1,,0,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625610
12664,1,,0,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625611
12665,1,,0,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625612
12666,1,,0,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625613
12667,1,,0,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL875479
12668,1,,0,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625614
12669,1,,0,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625615
12670,1,,0,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626302
12671,1,,1,Rattus norvegicus,,,10116.0,178.0,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626303
12672,1,,1,Rattus norvegicus,,,10116.0,178.0,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627420
12673,1,,1,Rattus norvegicus,,,10116.0,,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627421
12674,1,,1,Rattus norvegicus,,,10116.0,,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625695
12675,1,,1,Rattus norvegicus,,,10116.0,,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625696
12676,1,,1,Mus musculus,,,10090.0,955.0,,Distribution of compound in mice brain was measured after 1 hr,Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL875606
12677,1,,1,Mus musculus,,,10090.0,955.0,,Distribution of compound in mice brain was measured after 24 hr r,Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625697
12678,1,,1,Mus musculus,,,10090.0,955.0,,Distribution of compound in mice brain was measured after 2 hr,Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625698
12679,1,,1,Mus musculus,,,10090.0,955.0,,Distribution of compound in mice brain was measured after 3 hr,Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625699
12680,1,,1,Mus musculus,,,10090.0,955.0,,Distribution of compound in mice brain was measured after 6 hr,Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625700
12681,1,,1,Mus musculus,,,10090.0,,,Distribution of compound in mice liver was measured after 1 hr,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625701
12682,1,,1,Mus musculus,,,10090.0,,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625702
12683,1,,1,Mus musculus,,,10090.0,,,Distribution of compound in mice liver was measured after 2 hr,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625703
12684,1,,1,Mus musculus,,,10090.0,,,Distribution of compound in mice liver was measured after 3 hr,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625704
12685,1,,1,Mus musculus,,,10090.0,,,Distribution of compound in mice liver was measured after 6 hr,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625705
12686,1,,1,Canis lupus familiaris,,,9615.0,1236.0,,Distribution in dog adrenal medulla 30 min after administration.,Adrenal medulla,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625706
12687,1,,1,Canis lupus familiaris,,,9615.0,1236.0,,Distribution in dog adrenal medulla 72 hours after administration.,Adrenal medulla,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625707
12688,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog Ovary 24 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625708
12689,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog Ovary 72 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625709
12690,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog adipose 24 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624180
12691,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog adipose 72 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624181
12692,1,,1,Canis lupus familiaris,,,9615.0,1235.0,,Distribution in female dog adrenal cortex 72 hours after administration.,Adrenal cortex,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624182
12693,1,,1,Canis lupus familiaris,,,9615.0,1235.0,,Distribution in female dog adrenal cortex 72 hours after administration.,Adrenal cortex,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624183
12694,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624184
12695,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877489
12696,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624185
12697,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624186
12698,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624187
12699,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624188
12700,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624189
12701,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624190
12702,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624191
12703,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624192
12704,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624193
12705,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624194
12706,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624891
12707,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624892
12708,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624893
12709,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627632
12710,1,,1,Rattus norvegicus,,,10116.0,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627633
12711,1,,1,Rattus norvegicus,,,10116.0,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627634
12712,1,,1,Rattus norvegicus,,,10116.0,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627635
12713,1,,1,Rattus norvegicus,,,10116.0,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627636
12714,1,,1,Rattus norvegicus,,,10116.0,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626816
12715,1,,1,Rattus norvegicus,,,10116.0,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626817
12716,1,,1,Rattus norvegicus,,,10116.0,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626818
12717,1,,1,Rattus norvegicus,,,10116.0,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626819
12718,1,,1,Rattus norvegicus,,,10116.0,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626820
12719,1,,1,Rattus norvegicus,,,10116.0,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626821
12720,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626822
12721,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626823
12722,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626824
12723,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626825
12724,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626826
12725,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626827
12726,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626828
12727,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626829
12728,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626830
12729,1,,1,Rattus norvegicus,,,10116.0,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627150
12730,1,,1,Rattus norvegicus,,,10116.0,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627151
12731,1,,1,Rattus norvegicus,,,10116.0,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627152
12732,1,,1,Rattus norvegicus,,,10116.0,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627153
12733,1,,0,,,,,,,Rate of acetate production by the compound was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627154
12734,1,,0,,,,,,,Rate of acetate production by the compound was determined; Not determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627155
12735,1,,0,,,,,,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627156
12736,1,,0,,,,,,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627157
12737,1,,1,Oryctolagus cuniculus,,,9986.0,,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,,,,BAO_0000218,50592,N,Intermediate,CHEMBL627158
12738,1,,1,Oryctolagus cuniculus,,,9986.0,1969.0,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Plasma,,,,BAO_0000218,50592,N,Intermediate,CHEMBL627159
12739,1,,1,Mus musculus,,,10090.0,,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627160
12740,1,,1,Rattus norvegicus,,,10116.0,,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628540
12741,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628541
12742,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628542
12743,1,,0,,,,,,,Solubility after at a pH 1.2,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL628543
12744,1,,0,,,,,,,Solubility after at pH 1.2,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL628544
12745,1,,0,,,,,,,Solubility after injection of water,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL628545
12746,1,,0,,,,,,,Statistical significance of IC 50 values; Expressed as R value,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628546
12747,1,,0,,,,,,,Systemic availability with respect to methyldopa was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL874455
12748,1,,1,Rattus norvegicus,,,10116.0,,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628547
12749,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628548
12750,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628549
12751,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628550
12752,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628551
12753,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628552
12754,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628553
12755,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628554
12756,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628555
12757,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628556
12758,1,,1,Oryctolagus cuniculus,,,9986.0,2113.0,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",Kidney,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628557
12759,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628558
12760,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628559
12761,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628560
12762,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL874456
12763,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628561
12764,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628562
12765,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628563
12766,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628564
12767,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628565
12768,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL631248
12769,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL631249
12770,1,,1,Oryctolagus cuniculus,,,9986.0,2113.0,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",Kidney,,,,BAO_0000218,50592,N,Intermediate,CHEMBL627214
12771,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL874591
12772,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL627215
12773,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL625471
12774,1,,1,Oryctolagus cuniculus,,,9986.0,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,,,,BAO_0000218,50592,N,Intermediate,CHEMBL625472
12775,1,,1,Oryctolagus cuniculus,,,9986.0,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,,,,BAO_0000218,50592,N,Intermediate,CHEMBL625473
12776,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625474
12777,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625475
12778,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625476
12779,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625477
12780,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625478
12781,1,,1,Rattus norvegicus,In vitro,,10116.0,,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,esophageal tunica muscularis mucosae,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625479
12782,1,,1,Rattus norvegicus,In vitro,,10116.0,,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,esophageal tunica muscularis mucosae,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625480
12783,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625481
12784,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625482
12785,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625483
12786,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625484
12787,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625485
12788,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625486
12789,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625487
12790,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625488
12791,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625489
12792,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625490
12793,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625491
12794,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625492
12795,1,,1,Homo sapiens,In vivo,,9606.0,1969.0,,plasma clearance in human,Plasma,,,,BAO_0000218,50587,N,Intermediate,CHEMBL625493
12796,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625494
12797,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625495
12798,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625496
12799,1,,0,,,,,,,1-Octanol/water partition coefficient measured at 7.4,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625497
12800,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625498
12801,1,,0,,,,,,,Partition coefficient (logP),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625499
12802,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625500
12803,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625501
12804,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625502
12805,1,,0,,,,,,,Calculated partition coefficient (clogP) (relative to BAY K 8644),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625503
12806,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625504
12807,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625505
12808,1,,0,,,,,,,Calculated partition coefficient of the compound,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625506
12809,1,,0,,,,,,,Partition coefficient (logP),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625507
12810,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625508
12811,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625509
12812,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625510
12813,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL883125
12814,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625511
12815,1,,0,,,,,,,Partition coefficient of the compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL874650
12816,1,,0,,,,,,,Partition coefficient of the compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625512
12817,1,,0,,,,,,,Partition coefficient of compound was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625513
12818,1,,0,,,,,,,Partition coefficient was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625514
12819,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625515
12820,1,,0,,,,,,,partition coefficient of compound was determined,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625516
12821,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,The total body administered intravenously in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625517
12822,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The total body administered intravenously in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625518
12823,1,,1,Mus musculus,,,10090.0,,,Time taken for the administration to female NIH mice weighing 25-30 g.,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625519
12824,1,,0,,,,,,,Time taken for the administration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625520
12825,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL874651
12826,1,,0,Simiiformes,In vivo,,314293.0,,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625521
12827,1,,1,Oryctolagus cuniculus,In vivo,,9986.0,,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,,,,BAO_0000218,50592,N,Intermediate,CHEMBL623171
12828,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623853
12829,1,,0,,,,,,,Plasma clearance for the compound was determined.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623854
12830,1,,0,,,,,,,CLog P value of the compound,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL874405
12831,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL623855
12832,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL623856
12833,1,,0,,,,,,,ClogP value of the compound; nd ='no data',,,,,BAO_0000100,22224,U,Autocuration,CHEMBL623857
12834,1,,0,,,,,,,ClogP value of the compound; nd ='not determined',,,,,BAO_0000100,22224,U,Autocuration,CHEMBL623858
12835,1,,0,,,,,,,CLog P was determined,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL623859
12836,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL839829
12837,1,,0,,,,,,,CLogP was calculated,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623860
12838,1,,0,,,,,,,CLogP value was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623861
12839,1,,0,,,,,,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623862
12840,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL874406
12841,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL623863
12842,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL624021
12843,1,,1,Canis lupus familiaris,,,9615.0,1236.0,,Distribution in female dog adrenal medulla 24 hours after administration.,Adrenal medulla,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624022
12844,1,,1,Canis lupus familiaris,,,9615.0,1236.0,,Distribution in female dog adrenal medulla 72 hours after administration.,Adrenal medulla,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624023
12845,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog bile 24 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624024
12846,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog bile 72 hr after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624025
12847,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog blood 24 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624026
12848,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog blood 72 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624027
12849,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog heart 24 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624028
12850,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog heart 72 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624029
12851,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog kidney 24 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624030
12852,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog kidney 72 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624031
12853,1,,1,Canis lupus familiaris,,,9615.0,160.0,,Distribution in female dog large intestine 24 hours after administration.,Intestine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624032
12854,1,,1,Canis lupus familiaris,,,9615.0,160.0,,Distribution in female dog large intestine 72 hours after administration.,Intestine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL874407
12855,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog liver 24 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624033
12856,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog liver 72 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624034
12857,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog lung 24 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624035
12858,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog lung 72 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624036
12859,1,,1,Canis lupus familiaris,,,9615.0,2385.0,,Distribution in female dog muscle 24 hours after administration.,Muscle tissue,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624037
12860,1,,1,Canis lupus familiaris,,,9615.0,2385.0,,Distribution in female dog muscle 72 hours after administration.,Muscle tissue,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624038
12861,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog pancreas 24 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624039
12862,1,,1,Canis lupus familiaris,,,9615.0,,,Distribution in female dog pancreas 72 hours after administration.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624040
12863,1,,1,Canis lupus familiaris,,,9615.0,160.0,,Distribution in female dog small intestine 24 hours after administration.,Intestine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624041
12864,1,,1,Canis lupus familiaris,,,9615.0,160.0,,Distribution in female dog small intestine 72 hours after administration.,Intestine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624042
12865,1,,1,Canis lupus familiaris,,,9615.0,2106.0,,Distribution in female dog spleen 24 hours after administration.,Spleen,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624043
12866,1,,1,Canis lupus familiaris,,,9615.0,2106.0,,Distribution in female dog spleen 72 hours after administration.,Spleen,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624044
12867,1,,1,Canis lupus familiaris,,,9615.0,945.0,,Distribution in female dog stomach 24 hours after administration.,Stomach,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624045
12868,1,,1,Canis lupus familiaris,,,9615.0,945.0,,Distribution in female dog stomach 72 hours after administration.,Stomach,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624046
12869,1,,1,Canis lupus familiaris,,,9615.0,2046.0,,Distribution in female dog thyroid 24 hours after administration.,Thyroid gland,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624047
12870,1,,1,Canis lupus familiaris,,,9615.0,2046.0,,Distribution in female dog thyroid 72 hours after administration.,Thyroid gland,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624048
12871,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Distribution in female dog urine 24 hours after administration.,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL874408
12872,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Distribution in female dog urine 72 hr after administration.,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624049
12873,1,,0,,,,,1969.0,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL624050
12874,1,,0,,,,,,,Plasma concentration at 7 hr after intravenous dosing,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624051
12875,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623278
12876,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623279
12877,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623280
12878,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623963
12879,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623964
12880,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623965
12881,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623966
12882,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874415
12883,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623967
12884,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623968
12885,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623969
12886,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628409
12887,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628410
12888,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628411
12889,1,,1,Rattus norvegicus,,,10116.0,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628412
12890,1,,0,,,,,,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628413
12891,1,,0,,,,,1969.0,,The concentration in plasmat; Not determined,Plasma,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628414
12892,1,,1,Rattus norvegicus,,,10116.0,,,Tissue level at 10 mg/kg/po in wistar rats in blood,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628415
12893,1,,1,Rattus norvegicus,,,10116.0,,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628416
12894,1,,1,Rattus norvegicus,,,10116.0,,,Tissue level at 10 mg/kg/po in wistar rats in heart,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628417
12895,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Tissue level at 10 mg/kg/po in wistar rats in liver,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874908
12896,1,,1,Rattus norvegicus,,,10116.0,,,Tissue level at 10 mg/kg/po in wistar rats in plasma,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628418
12897,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628419
12898,1,,1,Rattus norvegicus,,,10116.0,,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628420
12899,1,,0,,,,,,,Water solubility at 37 degree C.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628421
12900,1,,0,,,,,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL626726
12901,1,,0,,,,,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL626727
12902,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626728
12903,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626729
12904,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626730
12905,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626731
12906,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626732
12907,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626733
12908,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626734
12909,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626735
12910,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874909
12911,1,,1,Rattus norvegicus,,,10116.0,948.0,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626736
12912,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626737
12913,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630999
12914,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631000
12915,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631001
12916,1,,1,Rattus norvegicus,,,10116.0,2113.0,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631002
12917,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631003
12918,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631004
12919,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631005
12920,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631006
12921,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631007
12922,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631008
12923,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631009
12924,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631010
12925,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631011
12926,1,,1,Rattus norvegicus,,,10116.0,2048.0,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631012
12927,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630271
12928,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630272
12929,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630273
12930,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630274
12931,1,,1,Rattus norvegicus,,,10116.0,2046.0,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630275
12932,1,,1,Rattus norvegicus,,,10116.0,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875782
12933,1,,1,Rattus norvegicus,,,10116.0,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630276
12934,1,,1,Rattus norvegicus,,,10116.0,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630277
12935,1,,1,Rattus norvegicus,,,10116.0,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630278
12936,1,,1,Rattus norvegicus,,,10116.0,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630279
12937,1,,0,,,,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630280
12938,1,,0,,,,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630281
12939,1,,1,Oryctolagus cuniculus,,,9986.0,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,,,,BAO_0000218,50592,N,Intermediate,CHEMBL630282
12940,1,,1,Oryctolagus cuniculus,,,9986.0,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,,,,BAO_0000218,50592,N,Intermediate,CHEMBL630283
12941,1,,0,,,,,,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630284
12942,1,,0,,,,,,,Alkylating activity was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630285
12943,1,,0,,,,,,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,,,Microsomes,BAO_0000251,22224,U,Autocuration,CHEMBL630286
12944,1,,1,Oryctolagus cuniculus,,,9986.0,,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,,,,BAO_0000218,50592,N,Intermediate,CHEMBL630069
12945,1,,1,Oryctolagus cuniculus,,,9986.0,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,,,,BAO_0000218,50592,N,Intermediate,CHEMBL630070
12946,1,,1,Oryctolagus cuniculus,,,9986.0,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,,,,BAO_0000218,50592,N,Intermediate,CHEMBL630071
12947,1,,1,Oryctolagus cuniculus,,,9986.0,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,,,,BAO_0000218,50592,N,Intermediate,CHEMBL630072
12948,1,,1,Oryctolagus cuniculus,,,9986.0,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,,,,BAO_0000218,50592,N,Intermediate,CHEMBL875110
12949,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for antidiuretic activity in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630073
12950,1,,0,,,,,,,Compound was tested for inactivation kinetic values,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630074
12951,1,,0,,In vivo,,,,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL630075
12952,1,,0,,,,,,,Dissociation rate calculated from the first-order equation using the t1/2 value,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630076
12953,1,,0,,,,,,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL630077
12954,1,,0,,,,,,,Aqueous solubility was measured,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL630078
12955,1,,0,,,,,,,Aqueous solubility was measured at a pH 4,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL630079
12956,1,,0,,,,,,,Aqueous solubility (pH 7),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL630080
12957,1,,0,,,,,,,Aqueous solubility was measured at a pH 9,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL630081
12958,1,,0,,,,,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630082
12959,1,,0,,,,,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630083
12960,1,,0,,,,,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630084
12961,1,,0,,,,,,,Aqueous solubility of the compound,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL629198
12962,1,,0,,,,,,,Aqueous solubility at 37 degree Celsius at pH 7.38,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL629199
12963,1,,0,,,,,,,Aqueous solubility in pH 7.4 phosphate buffer,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL629200
12964,1,,1,Canis lupus familiaris,,,9615.0,,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629201
12965,1,,1,Canis lupus familiaris,,,9615.0,,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629202
12966,1,,1,Homo sapiens,,,9606.0,,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL875111
12967,1,,1,Homo sapiens,,,9606.0,,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL629203
12968,1,,1,Homo sapiens,,,9606.0,,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL629204
12969,1,,1,Homo sapiens,,,9606.0,,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL629205
12970,1,,1,Homo sapiens,,,9606.0,,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL629206
12971,1,,0,,,,,,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631185
12972,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for the average bile flow rat in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631186
12973,1,,1,Oryctolagus cuniculus,,,9986.0,,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,,,,BAO_0000218,50592,N,Intermediate,CHEMBL631187
12974,1,,1,Oryctolagus cuniculus,,,9986.0,,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,,,,BAO_0000218,50592,N,Intermediate,CHEMBL631188
12975,1,,0,,,,,,,Average half life period was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL876419
12976,1,,0,,,,,,,Average half life period was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631189
12977,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL631190
12978,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL631191
12979,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL631192
12980,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL632400
12981,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL630564
12982,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL630565
12983,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL630566
12984,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL631229
12985,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL631230
12986,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL876428
12987,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL631231
12988,1,,0,,,,,,,Calculated partition coefficient (clogP) (MacLogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL631232
12989,1,,0,,,,,,,Hydrophilicity was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631233
12990,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL631234
12991,1,,0,,,,,,,Increased absorption was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL883126
12992,1,,0,,,,,,,Lipophilicity value was evaluated,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL631235
12993,1,,0,,,,,,,Log P value of the compound.,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL631236
12994,1,,0,,,,,,,Partition coefficient of compound was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631237
12995,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL631238
12996,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL876429
12997,1,,0,,,,,,,Partition coefficient was measured by medchem software; Not calculated,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631414
12998,1,,0,,,,,,,Partition coefficient was measured by octanol-water using standard shake-flask method,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL631415
12999,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL631416
13000,1,,0,,,,,,,Partition coefficient (logP),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631417
13001,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL631418
13002,1,,0,,,,,,,The Octanol/Water partition coefficient CLogP,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL631419
13003,1,,0,,,,,,,The pharmacokinetic parameter C Log p was reported,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631420
13004,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL631421
13005,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL631422
13006,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL631423
13007,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876430
13008,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631424
13009,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Compound was administered intravenously in dog to evaluate plasma clearance values,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631425
13010,1,,0,Simiiformes,In vivo,,314293.0,1969.0,,Compound was administered intravenously in monkey to evaluate plasma clearance values,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL631426
13011,1,,1,Mus musculus,In vivo,,10090.0,1969.0,,Compound was administered intravenously in mouse to evaluate plasma clearance values,Plasma,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631427
13012,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631428
13013,1,,1,Macaca mulatta,In vitro,,9544.0,2107.0,,Intrinsic clearance in Rhesus liver microsome,Liver,,,Microsomes,BAO_0000218,50797,N,Intermediate,CHEMBL631429
13014,1,,1,Canis lupus familiaris,In vitro,,9615.0,2107.0,,Intrinsic clearance in dog liver microsome,Liver,,,Microsomes,BAO_0000218,50588,N,Intermediate,CHEMBL631430
13015,1,,1,Rattus norvegicus,In vitro,,10116.0,2107.0,,Intrinsic clearance in rat liver microsome,Liver,,,Microsomes,BAO_0000218,50597,N,Intermediate,CHEMBL631431
13016,1,,1,Macaca mulatta,In vivo,,9544.0,1969.0,,Low plasma clearance was calculated in rhesus monkey,Plasma,,,,BAO_0000218,50797,N,Intermediate,CHEMBL631432
13017,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631433
13018,1,,0,,In vivo,,,,,Plasma clearance after intravenous dose of 0.3 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL631434
13019,1,,0,,In vivo,,,,,Plasma clearance after intravenous dose of 1 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL631435
13020,1,,0,,In vivo,,,,,Plasma clearance after intravenous dose of 3 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL631436
13021,1,,0,,In vivo,,,,,Plasma clearance after intravenous dose of 3.87 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL631437
13022,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance after peroral administration at 10 mpk in Rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631438
13023,1,,1,Macaca mulatta,In vivo,,9544.0,,,Plasma clearance after peroral administration at 10 mpk in Rhesus,,,,,BAO_0000218,50797,N,Intermediate,CHEMBL876431
13024,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Plasma clearance after peroral administration at 10 mpk in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631439
13025,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631440
13026,1,,0,,,,,,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631441
13027,1,,0,,,,,,,Critical Micellar concentration was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631442
13028,1,,0,,,,,,,Critical Micellar concentration of the compound. was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626525
13029,1,,0,,,,,,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627168
13030,1,,0,,,,,,,Critical micellar concentration was measured in water by the dye solubilization method,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL875618
13031,1,,0,,,,,,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626612
13032,1,,0,,,,,,,CMR value (relative to BAY K 8644),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626613
13033,1,,0,,,,,,,Carbamoylating activity was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626614
13034,1,,0,Simiiformes,,,314293.0,,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626615
13035,1,,0,,,,,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626616
13036,1,,0,,,,,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626617
13037,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626618
13038,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626619
13039,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,"Clearance rate at 0.46 mg/kg, iv, in dogs",,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626620
13040,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Clearance rate at 5.5 mg/kg, iv, in rat",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626621
13041,1,,1,Macaca fascicularis,In vivo,,9541.0,,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL626622
13042,1,,1,Macaca fascicularis,In vivo,,9541.0,,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL626623
13043,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626624
13044,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626625
13045,1,,1,Rattus norvegicus,Ex vivo,,10116.0,2107.0,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626626
13046,1,,0,,In vivo,,,,,Tested for the total clearance of the compound,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626627
13047,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626628
13048,1,,0,,In vivo,,,,,Total body clearance was determined,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626629
13049,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626630
13050,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626631
13051,1,,0,,,,,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL626632
13052,1,,0,,,,,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL626633
13053,1,,0,,,,,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL626634
13054,1,,0,,,,,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL626635
13055,1,,0,,,,,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL626636
13056,1,,0,,,,,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL626637
13057,1,,1,Pneumocystis carinii,,,4754.0,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,,,,BAO_0000218,50339,N,Intermediate,CHEMBL626638
13058,1,,1,Pneumocystis carinii,,,4754.0,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,,,,BAO_0000218,50339,N,Intermediate,CHEMBL626639
13059,1,,1,Pneumocystis carinii,,,4754.0,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,,,,BAO_0000218,50339,N,Intermediate,CHEMBL626640
13060,1,,1,Pneumocystis carinii,,,4754.0,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,,,,BAO_0000218,50339,N,Intermediate,CHEMBL626641
13061,1,,1,Pneumocystis carinii,,,4754.0,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,,,,BAO_0000218,50339,N,Intermediate,CHEMBL627272
13062,1,,1,Pneumocystis carinii,,,4754.0,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,,,,BAO_0000218,50339,N,Intermediate,CHEMBL627273
13063,1,,1,Pneumocystis carinii,,,4754.0,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,,,,BAO_0000218,50339,N,Intermediate,CHEMBL627441
13064,1,,1,Pneumocystis carinii,,,4754.0,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,,,,BAO_0000218,50339,N,Intermediate,CHEMBL628355
13065,1,,1,Pneumocystis carinii,,,4754.0,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,,,,BAO_0000218,50339,N,Intermediate,CHEMBL628356
13066,1,,1,Pneumocystis carinii,,,4754.0,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,,,,BAO_0000218,50339,N,Intermediate,CHEMBL628357
13067,1,,1,Pneumocystis carinii,,,4754.0,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,,,,BAO_0000218,50339,N,Intermediate,CHEMBL628358
13068,1,,1,Pneumocystis carinii,,,4754.0,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,,,,BAO_0000218,50339,N,Intermediate,CHEMBL622307
13069,1,,0,,,,,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622527
13070,1,,0,,,,,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622528
13071,1,,0,,,,,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622529
13072,1,,0,,,,,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622992
13073,1,,0,,,,,,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622993
13074,1,,0,,,,,,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622994
13075,1,,1,Rattus norvegicus,,,10116.0,,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622995
13076,1,,1,Rattus norvegicus,,,10116.0,,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622996
13077,1,,1,Rattus norvegicus,,,10116.0,,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622997
13078,1,,1,Rattus norvegicus,,,10116.0,,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622998
13079,1,,0,,,,,,,Cp max following ip administration at 1 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622999
13080,1,,0,,In vivo,,,1969.0,,Maximum concentration in plasma was reported at 0.5 hour,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623000
13081,1,,0,,In vivo,,,1969.0,,Maximum concentration in plasma was reported at 2 hour,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623001
13082,1,,1,Mus musculus,,,10090.0,,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL623002
13083,1,,0,,,,,,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL623003
13084,1,,0,,,,,,,Steady state concentration was evaluated,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623004
13085,1,,0,,,,,,,Partition coefficient (logP),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623005
13086,1,,0,,,,,,,Partition coefficient (logD7.4),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623006
13087,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623007
13088,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623008
13089,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876654
13090,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623009
13091,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623010
13092,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623011
13093,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623012
13094,1,,0,,,,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623013
13095,1,,0,,,,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623014
13096,1,,0,,,,,1088.0,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,Urine,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623015
13097,1,,0,,,,,1088.0,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Urine,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623016
13098,1,,0,,,,,1088.0,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,Urine,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624858
13099,1,,1,Rattus norvegicus,,,10116.0,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624859
13100,1,,1,Rattus norvegicus,,,10116.0,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624860
13101,1,,1,Rattus norvegicus,,,10116.0,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624861
13102,1,,1,Rattus norvegicus,,,10116.0,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624862
13103,1,,1,Rattus norvegicus,,,10116.0,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624863
13104,1,,1,Rattus norvegicus,,,10116.0,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876655
13105,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624864
13106,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624865
13107,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624866
13108,1,,1,Canis lupus familiaris,,,9615.0,,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,,,,BAO_0000218,50588,N,Expert,CHEMBL624867
13109,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624868
13110,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628450
13111,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628451
13112,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628452
13113,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628453
13114,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628454
13115,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628455
13116,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628456
13117,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628457
13118,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL877505
13119,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628458
13120,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628459
13121,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628460
13122,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628461
13123,1,,0,,,,,,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628462
13124,1,,1,Canis lupus familiaris,,,9615.0,,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628463
13125,1,,1,Rattus norvegicus,,,10116.0,,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,,,,BAO_0000218,50597,N,Expert,CHEMBL625666
13126,1,,0,,,,,,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625667
13127,1,,1,Rattus norvegicus,,,10116.0,,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,,,BAO_0000218,50597,N,Expert,CHEMBL625668
13128,1,,1,Rattus norvegicus,,,10116.0,,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625669
13129,1,,0,,,,,,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625670
13130,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625671
13131,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL625672
13132,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL625673
13133,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL625674
13134,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL625675
13135,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL627637
13136,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL627638
13137,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL627639
13138,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL627640
13139,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL627641
13140,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL627642
13141,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL877506
13142,1,,1,Mus musculus,,,10090.0,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627275
13143,1,,1,Mustela putorius furo,,,9669.0,,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,,,,BAO_0000218,50506,N,Intermediate,CHEMBL627643
13144,1,,1,Mustela putorius furo,,,9669.0,,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,,,,BAO_0000218,50506,N,Intermediate,CHEMBL631246
13145,1,,1,Mustela putorius furo,,,9669.0,,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,,,,BAO_0000218,50506,N,Intermediate,CHEMBL631247
13146,1,,1,Mustela putorius furo,,,9669.0,,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,,,,BAO_0000218,50506,N,Intermediate,CHEMBL629532
13147,1,,1,Mustela putorius furo,,,9669.0,,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,,,,BAO_0000218,50506,N,Intermediate,CHEMBL629533
13148,1,,1,Mustela putorius furo,,,9669.0,,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,,,,BAO_0000218,50506,N,Intermediate,CHEMBL629534
13149,1,,1,Mustela putorius furo,,,9669.0,,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,,,,BAO_0000218,50506,N,Intermediate,CHEMBL629535
13150,1,,0,,,,,,,Pharmacokinetic parameter :drug bound to plasma was reported,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625932
13151,1,,0,,,,,,,compound was evaluated for drug bound in plasma,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625933
13152,1,,1,Rattus norvegicus,,,10116.0,,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625934
13153,1,,0,Eutheria,,,9347.0,,,Bioavailability,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625935
13154,1,,1,Rattus norvegicus,,,10116.0,,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625936
13155,1,,1,Rattus norvegicus,,,10116.0,,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625937
13156,1,,1,Canis lupus familiaris,,,9615.0,,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625938
13157,1,,1,Rattus norvegicus,,,10116.0,1970.0,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,Bile,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625939
13158,1,,1,Rattus norvegicus,,,10116.0,1970.0,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,Bile,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625940
13159,1,,1,Rattus norvegicus,,,10116.0,1970.0,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,Bile,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874464
13160,1,,1,Rattus norvegicus,,,10116.0,1970.0,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,Bile,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625941
13161,1,,1,Rattus norvegicus,,,10116.0,1970.0,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,Bile,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625942
13162,1,,1,Rattus norvegicus,,,10116.0,1970.0,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,Bile,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625943
13163,1,,1,Homo sapiens,,,9606.0,1977.0,,In vitro protein binding in human serum at 5 ug/ml,Serum,,,,BAO_0000218,50587,N,Intermediate,CHEMBL625944
13164,1,,0,,,,,,,Serum protein binding ability was measured,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625945
13165,1,,0,,,,,,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625946
13166,1,,0,Canis lupus familiaris,In vivo,,9615.0,,,Oral bioavailability in dog,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625947
13167,1,,1,Rattus norvegicus,In vivo,,10116.0,,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625948
13168,1,,0,,In vivo,,,,,Absolute oral bioavailability at an iv dose of 14 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625949
13169,1,,0,,In vivo,,,,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625950
13170,1,,0,Eutheria,In vivo,,9347.0,,,Oral bioavailability (dose 15 mg/kg i.v.),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625951
13171,1,,0,,In vivo,,,,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625952
13172,1,,0,,In vivo,,,,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625953
13173,1,,0,,In vivo,,,,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625954
13174,1,,0,,In vivo,,,,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL882959
13175,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625955
13176,1,,0,Mustela putorius furo,In vivo,,9669.0,,,Bioavailability in ferret,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625956
13177,1,,1,Macaca fascicularis,In vivo,,9541.0,,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL625957
13178,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625958
13179,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625959
13180,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626642
13181,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631330
13182,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631331
13183,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631332
13184,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631333
13185,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632018
13186,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632019
13187,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632020
13188,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632021
13189,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632022
13190,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632023
13191,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632024
13192,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874472
13193,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632025
13194,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632026
13195,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632027
13196,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632028
13197,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626430
13198,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626431
13199,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626432
13200,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626433
13201,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626434
13202,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627280
13203,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627281
13204,1,,1,Rattus norvegicus,,,10116.0,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627282
13205,1,,0,,,,,,,Total body clearance was measured at given dose,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627283
13206,1,,0,,,,,,,Total body clearance was measured at given dose.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627284
13207,1,,1,Rattus norvegicus,,,10116.0,,,Metabolic clearance from the body in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627285
13208,1,,0,,In vivo,,,,,Renal clearance from the body,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627286
13209,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Renal clearance from the body in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875477
13210,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627287
13211,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627288
13212,1,,1,Rattus norvegicus,,,10116.0,,,Total clearance from the body in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627289
13213,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Clearance into cortex from rat plasma or PBS,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627290
13214,1,,0,,In vivo,,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627291
13215,1,,0,,In vivo,,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627292
13216,1,,0,,In vivo,,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627293
13217,1,,0,,In vivo,,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627294
13218,1,,0,,In vivo,,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL875478
13219,1,,0,,In vivo,,,,,Clearance was determined,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627295
13220,1,,1,Mus musculus,In vivo,,10090.0,,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627296
13221,1,,1,Oryctolagus cuniculus,In vivo,,9986.0,,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,,,,BAO_0000218,50592,N,Intermediate,CHEMBL626119
13222,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626120
13223,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance in rat after iv dose (100 ug/kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626121
13224,1,,0,Cavia porcellus,In vivo,,10141.0,,,Clearance in guinea pig,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626122
13225,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for clearance in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626123
13226,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for the clearance in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623456
13227,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for the clearance in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623457
13228,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was tested in vivo for clearance after iv administration in the rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623458
13229,1,,0,,In vivo,,,,,IV clearance determined at an iv dose of 14 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623459
13230,1,,0,,In vivo,,,,,IV clearance determined at an iv dose of 15.2 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL875484
13231,1,,0,,In vivo,,,,,IV clearance determined at an iv dose of 15 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623460
13232,1,,0,,In vivo,,,,,IV clearance determined at an peroral dose of 30 mg/kg.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623461
13233,1,,0,,In vivo,,,,,IV clearance determined at an peroral dose of 30.2 mg/kg.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL623462
13234,1,,0,,In vivo,,,,,IV clearance determined at an peroral dose of 30.3 mg/kg.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627386
13235,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627387
13236,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627388
13237,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627389
13238,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627390
13239,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627391
13240,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627392
13241,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627393
13242,1,,1,Rattus norvegicus,In vivo,,10116.0,3126.0,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,Trachea,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627394
13243,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627395
13244,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875485
13245,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627396
13246,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627397
13247,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627398
13248,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627399
13249,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627400
13250,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627401
13251,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627402
13252,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627403
13253,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627404
13254,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623101
13255,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877480
13256,1,,1,Rattus norvegicus,In vivo,,10116.0,3126.0,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,Trachea,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623102
13257,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623103
13258,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623104
13259,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623105
13260,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623106
13261,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623107
13262,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623108
13263,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623109
13264,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623110
13265,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623111
13266,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625060
13267,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625061
13268,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625062
13269,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625063
13270,1,,1,Rattus norvegicus,In vivo,,10116.0,3126.0,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,Trachea,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625064
13271,1,,1,Rattus norvegicus,In vivo,,10116.0,10000001.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,Bone,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625065
13272,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625066
13273,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625067
13274,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625068
13275,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622159
13276,1,,1,Rattus norvegicus,In vivo,,10116.0,160.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,Intestine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622160
13277,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622161
13278,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622162
13279,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622163
13280,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622313
13281,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622314
13282,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622315
13283,1,,1,Rattus norvegicus,In vivo,,10116.0,3126.0,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,Trachea,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622316
13284,1,,1,Escherichia coli,,,562.0,,,Normal diffusion coefficient in water for Escherichia coli,,,,,BAO_0000218,50212,N,Intermediate,CHEMBL877486
13285,1,,0,,,,,,,Average max percent decrease in RVR (renal vascular resistance) was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622317
13286,1,,0,,,,,,,Average max percent decrease in RVR (renal vascular resistance) was determined.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622318
13287,1,,0,,,,,,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622319
13288,1,,0,,,,,,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622320
13289,1,,0,,,,,,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622321
13290,1,,0,,,,,,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622322
13291,1,,0,,,,,,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622323
13292,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622324
13293,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622325
13294,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622326
13295,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL877487
13296,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622327
13297,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622328
13298,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622329
13299,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622330
13300,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622331
13301,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622332
13302,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622333
13303,1,,0,Simiiformes,,,314293.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627658
13304,1,,0,Simiiformes,,,314293.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL630428
13305,1,,0,Simiiformes,,,314293.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL630429
13306,1,,0,Simiiformes,,,314293.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL630430
13307,1,,0,Simiiformes,,,314293.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL630431
13308,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630432
13309,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630433
13310,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630434
13311,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629372
13312,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629553
13313,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629554
13314,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874447
13315,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629555
13316,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629556
13317,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629557
13318,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629558
13319,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629559
13320,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629560
13321,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629561
13322,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629562
13323,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629563
13324,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629564
13325,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629565
13326,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629566
13327,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629567
13328,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629568
13329,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629569
13330,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629570
13331,1,,0,Simiiformes,,,314293.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629571
13332,1,,0,Rattus norvegicus,In vivo,,10116.0,,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629572
13333,1,,0,Rattus norvegicus,In vivo,,10116.0,,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629573
13334,1,,0,Eutheria,In vivo,,9347.0,,,Bioavailability (dose 20 mg/kg),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629574
13335,1,,0,Canis lupus familiaris,In vivo,,9615.0,,,Bioavailability in dog,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629575
13336,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (Sprague-Dawley) (male),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL874448
13337,1,,0,Primates,In vivo,,9443.0,,,Bioavailability in monkey (dose 10 mg/kg i.d.),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629576
13338,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629577
13339,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629578
13340,1,,0,Canis lupus familiaris,In vivo,,9615.0,,,Bioavailability in dog (dose 3.0 mg/kg p.o.),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629579
13341,1,,0,Canis lupus familiaris,In vivo,,9615.0,,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL882958
13342,1,,1,Pan troglodytes,In vivo,,9598.0,,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,,,,BAO_0000218,50505,N,Intermediate,CHEMBL629580
13343,1,,0,Eutheria,In vivo,,9347.0,,,Bioavailability,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629581
13344,1,,0,Saimiri,In vivo,,9520.0,,,Bioavailability in squirrel monkey,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629582
13345,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Bioavailability was evaluated in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628522
13346,1,,1,Cricetinae,In vivo,,10026.0,,,Bioavailability was evaluated in hamster,,,,,BAO_0000218,100712,N,Intermediate,CHEMBL625432
13347,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625433
13348,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625434
13349,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625435
13350,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 10 mg/kg p.o.),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625436
13351,1,,1,Macaca fascicularis,In vivo,,9541.0,,,Bioavailability was measured in cynomolgus monkeys.,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL874588
13352,1,,1,Mus musculus,In vivo,,10090.0,,,Bioavailability was measured in nude mice.,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625437
13353,1,,0,Mustela putorius furo,In vivo,,9669.0,,,Bioavailability in ferret (dose 10 mg/kg i.d.),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625438
13354,1,,0,Simiiformes,In vivo,,314293.0,,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625439
13355,1,,0,Simiiformes,In vivo,,314293.0,,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625440
13356,1,,0,Simiiformes,In vivo,,314293.0,,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625441
13357,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Bioavailability in rat (dose 10 mg/kg i.d.),,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625442
13358,1,,1,Rattus norvegicus,In vivo,,10116.0,,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625443
13359,1,,0,,In vivo,,,,,Bioavailability was determined; extremely poor,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625444
13360,1,,1,Mus musculus,In vivo,,10090.0,,,% bioavailability in mice after oral administration of prodrug,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625445
13361,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625446
13362,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL882960
13363,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625447
13364,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625448
13365,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625449
13366,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL874589
13367,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625450
13368,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625451
13369,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626584
13370,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626585
13371,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626586
13372,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626587
13373,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626588
13374,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626589
13375,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626590
13376,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626591
13377,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627181
13378,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628083
13379,1,,0,,In vivo,,,,,IV clearance determined at an peroral dose of 15 mg/kg.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628084
13380,1,,1,Hymenolepis nana,In vivo,,102285.0,,,Mouse oral clearance was measured against Hymenolepiasis nana.,,,,,BAO_0000218,50064,N,Expert,CHEMBL628085
13381,1,,1,Heligmosomoides polygyrus,In vivo,,6339.0,,,Mouse oral clearance was measured against Nematospiroides dubius,,,,,BAO_0000218,50545,N,Expert,CHEMBL628086
13382,1,,0,,In vivo,,,,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628087
13383,1,,1,Mus musculus,In vivo,,10090.0,,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628088
13384,1,,0,,In vivo,,,,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628089
13385,1,,0,,In vivo,,,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628090
13386,1,,0,,In vivo,,,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628091
13387,1,,0,,In vivo,,,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628092
13388,1,,0,,In vivo,,,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628093
13389,1,,0,,In vivo,,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL875607
13390,1,,0,,In vivo,,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625710
13391,1,,0,,In vivo,,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625711
13392,1,,0,,In vivo,,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625712
13393,1,,0,,In vivo,,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625713
13394,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625714
13395,1,,1,Macaca mulatta,In vivo,,9544.0,,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,,,,BAO_0000218,50797,N,Intermediate,CHEMBL625715
13396,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625716
13397,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625717
13398,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance was determined for the compound in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625718
13399,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625719
13400,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625720
13401,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625721
13402,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625722
13403,1,,1,Rattus norvegicus,In vivo,,10116.0,,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625723
13404,1,,1,Heligmosomoides polygyrus,In vivo,,6339.0,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,,,,BAO_0000218,50545,N,Intermediate,CHEMBL625724
13405,1,,1,Heligmosomoides polygyrus,In vivo,,6339.0,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,,,,BAO_0000218,50545,N,Intermediate,CHEMBL625725
13406,1,,1,Heligmosomoides polygyrus,In vivo,,6339.0,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,,,,BAO_0000218,50545,N,Intermediate,CHEMBL625726
13407,1,,1,Heligmosomoides polygyrus,In vivo,,6339.0,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,,,,BAO_0000218,50545,N,Intermediate,CHEMBL875608
13408,1,,1,Heligmosomoides polygyrus,In vivo,,6339.0,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,,,,BAO_0000218,50545,N,Intermediate,CHEMBL625727
13409,1,,0,Rattus norvegicus,In vivo,,10116.0,1088.0,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625728
13410,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625729
13411,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625730
13412,1,,0,Rattus norvegicus,In vivo,,10116.0,1088.0,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625731
13413,1,,0,Rattus norvegicus,In vivo,,10116.0,1088.0,,Urinary clearance was determined in rat at 25 mg/kg os dosage,Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626417
13414,1,,1,Homo sapiens,In vivo,,9606.0,1088.0,,Urinary clearance was determined at 100 mg/kg oral dosage in human,Urine,,,,BAO_0000218,50587,N,Intermediate,CHEMBL626418
13415,1,,1,Canis lupus familiaris,In vivo,,9615.0,1088.0,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626419
13416,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626592
13417,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626593
13418,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626594
13419,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Clearance rate in dogs,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625035
13420,1,,0,,In vitro,,,,,Compound was measured for intrinsic clearance,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625036
13421,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625037
13422,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625038
13423,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625039
13424,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625040
13425,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625041
13426,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625042
13427,1,,0,,,,,,,Partition coefficient of the compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL874411
13428,1,,0,,,,,,,Permeability,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625043
13429,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625044
13430,1,,0,,,,,,,Partition coefficient (logD),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625045
13431,1,,0,,,,,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625046
13432,1,,0,,,,,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625047
13433,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625048
13434,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625049
13435,1,,0,,,,,,,Calculated logarithm of partition coefficient (P) was determined,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625050
13436,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625051
13437,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL874412
13438,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625052
13439,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL625053
13440,1,,0,,,,,,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623250
13441,1,,0,,,,,,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623251
13442,1,,0,,,,,,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623252
13443,1,,0,,,,,,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623253
13444,1,,0,,,,,,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623254
13445,1,,0,,,,,,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623255
13446,1,,0,,,,,,,Percent degradation of compound at a pH of 1 over a 18 hr period,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626831
13447,1,,0,,,,,,,Percent degradation of compound at pH of 1 over an 18 hr period,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL877494
13448,1,,0,,,,,,,Delta Logarithm of Partition Coefficient value was determined.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626832
13449,1,,0,,,,,,,Delta logPoct-cyc,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626833
13450,1,,0,,,,,,,Lipophilicity estimated on reversed phase TLC,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL626834
13451,1,,0,,,,,,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626835
13452,1,,0,,,,,,,Delta logPoct-cyc,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626836
13453,1,,0,,,,,,,Change in logarithm of partition coefficient of the compound,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL626837
13454,1,,0,,,,,,,Delta logD (pH 6.5),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626838
13455,1,,0,,,,,,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,,,,BAO_0000100,22224,U,Autocuration,CHEMBL626839
13456,1,,0,,,,,,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626840
13457,1,,0,,,,,,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626841
13458,1,,0,,,,,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,,,,BAO_0000219,22224,U,Autocuration,CHEMBL626842
13459,1,,0,,,,,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,,,,BAO_0000219,22224,U,Autocuration,CHEMBL626843
13460,1,,1,Rattus norvegicus,,,10116.0,,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626844
13461,1,,1,Rattus norvegicus,,,10116.0,,,Amount of deuterium retained was reported after normal workup in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877495
13462,1,,1,Rattus norvegicus,,,10116.0,,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626845
13463,1,,1,Rattus norvegicus,,,10116.0,,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626846
13464,1,,1,Rattus norvegicus,,,10116.0,,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626847
13465,1,,1,Rattus norvegicus,,,10116.0,,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628677
13466,1,,1,Rattus norvegicus,,,10116.0,,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628678
13467,1,,0,,,,,,,Compound was subjected to electrochemical oxidation,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628679
13468,1,,0,,,,,,,Compound was subjected to photochemical oxidation,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628680
13469,1,,0,,,,,,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628681
13470,1,,0,,,,,,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628682
13471,1,,0,,,,,,,Oxidation of compound by methemoglobin in presence of hydroperoxide,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628683
13472,1,,1,Rattus norvegicus,,,10116.0,,,Percent diffusion through fuzzy rat skin after 48 h of incubation,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628684
13473,1,,0,,,,,,,Dissociation constant (pKa),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL877501
13474,1,,0,,,,,,,Dissociation constant value of the compound; ND means not determined.,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL628685
13475,1,,1,Rattus norvegicus,,,10116.0,178.0,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628686
13476,1,,1,Rattus norvegicus,,,10116.0,178.0,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628687
13477,1,,1,Rattus norvegicus,,,10116.0,,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628688
13478,1,,1,Rattus norvegicus,,,10116.0,,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628689
13479,1,,1,Rattus norvegicus,,,10116.0,2107.0,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628690
13480,1,,1,Rattus norvegicus,,,10116.0,2107.0,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629363
13481,1,,1,Rattus norvegicus,,,10116.0,2106.0,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629364
13482,1,,1,Rattus norvegicus,,,10116.0,2106.0,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629365
13483,1,,1,Rattus norvegicus,,,10116.0,,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629366
13484,1,,1,Rattus norvegicus,,,10116.0,1088.0,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629367
13485,1,,1,Rattus norvegicus,,,10116.0,1988.0,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Feces,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629368
13486,1,,1,Rattus norvegicus,,,10116.0,1088.0,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877502
13487,1,,1,Mus musculus,,,10090.0,2037.0,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,Cerebellum,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629369
13488,1,,1,Mus musculus,,,10090.0,955.0,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629370
13489,1,,0,Simiiformes,,,314293.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629371
13490,1,,0,Simiiformes,,,314293.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626276
13491,1,,0,Simiiformes,,,314293.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626277
13492,1,,0,Simiiformes,,,314293.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL631250
13493,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631251
13494,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631252
13495,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631253
13496,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631254
13497,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631255
13498,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631256
13499,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631257
13500,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628009
13501,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628010
13502,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628011
13503,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628012
13504,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628013
13505,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628014
13506,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628015
13507,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628016
13508,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL874461
13509,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628017
13510,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628018
13511,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628019
13512,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628020
13513,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628021
13514,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628022
13515,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628023
13516,1,,0,Simiiformes,,,314293.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628024
13517,1,,0,Simiiformes,,,314293.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628025
13518,1,,0,Simiiformes,,,314293.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628026
13519,1,,0,Simiiformes,,,314293.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628027
13520,1,,0,Simiiformes,,,314293.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628028
13521,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628029
13522,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628030
13523,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628031
13524,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628032
13525,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628033
13526,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628034
13527,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628035
13528,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628036
13529,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874462
13530,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628037
13531,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628123
13532,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628124
13533,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628125
13534,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628126
13535,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628127
13536,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628128
13537,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628129
13538,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628130
13539,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628131
13540,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628132
13541,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628133
13542,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628134
13543,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628135
13544,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628136
13545,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628137
13546,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628138
13547,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628139
13548,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628140
13549,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628141
13550,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628142
13551,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628143
13552,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628144
13553,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628145
13554,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL628146
13555,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625355
13556,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625356
13557,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625357
13558,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625527
13559,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL875473
13560,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625528
13561,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626304
13562,1,,1,Canis lupus familiaris,In vivo,,9615.0,1637.0,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,Artery,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624138
13563,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL624139
13564,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL624140
13565,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL624141
13566,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL624142
13567,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL624143
13568,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL624144
13569,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL624145
13570,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL624146
13571,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL624147
13572,1,,0,,,,,,,Calculated partition coefficient (clogP) (MacLogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL883123
13573,1,,0,,,,,,,Partition coefficient (logP),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624148
13574,1,,0,,,,,,,Kinetic parameter was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL874416
13575,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL624149
13576,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL624150
13577,1,,0,,,,,,,Lipophilicity was determined,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL624151
13578,1,,0,,,,,,,Lipophilicity was determined,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL624152
13579,1,,0,,,,,,,Lipophilicity was determined,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL622139
13580,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL622140
13581,1,,0,,,,,,,Lipophilicity was determined,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL622141
13582,1,,0,,,,,,,Lipophilicity in octanol-water,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL622142
13583,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL622143
13584,1,,0,,,,,,,Octanol-water partition coefficient was determined,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL622144
13585,1,,0,,,,,,,Partition coefficient (logP),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL877473
13586,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL622145
13587,1,,0,,,,,,,Partition coefficient was determined; ND means not determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622146
13588,1,,0,,,,,,,Calculated partition coefficient (clogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL622147
13589,1,,0,,,,,,,Partition coefficient of the compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622148
13590,1,,0,,,,,,,Permeability was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL883124
13591,1,,0,,,,,,,The compound was evaluated for the partition coefficient,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL622149
13592,1,,0,,,,,,,Partition coefficient (logP),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622150
13593,1,,0,,,,,,,The lipophilicity was reported,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL622151
13594,1,,0,,,,,,,logarithm of the octanol-water partition coefficient for the compound,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL622152
13595,1,,0,,,,,,,Clogp value was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL622153
13596,1,,0,,In vivo,,,,,Clp at a dose of 1.5 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL877474
13597,1,,0,,In vivo,,,,,Clp at a dose of 2.0 mg/kg,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622154
13598,1,,0,,In vivo,,,1969.0,,"Clp, plasma clearance at a dose of 10 mg/kg",Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622155
13599,1,,0,,In vivo,,,1969.0,,"Clp, plasma clearance at a dose of 50 mg/kg",Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622156
13600,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was tested for plasma clearance in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622157
13601,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Compound was tested for plasma clearance in rat; Not determined,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622158
13602,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622807
13603,1,,1,Macaca mulatta,In vivo,,9544.0,,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,,,,BAO_0000218,50797,N,Intermediate,CHEMBL622808
13604,1,,0,,In vivo,,,,,Plasma clearance by iv administration at a dose 0.003 ug/mL,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622809
13605,1,,0,,In vivo,,,,,Plasma clearance determined,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622810
13606,1,,1,Cricetinae,In vivo,,10026.0,,,Plasma clearance after iv administration at 3 mg/kg in hamster,,,,,BAO_0000218,100712,N,Intermediate,CHEMBL876653
13607,1,,1,Cricetinae,In vivo,,10026.0,,,Plasma clearance after iv administration at 4 mg/kg in hamster,,,,,BAO_0000218,100712,N,Intermediate,CHEMBL622811
13608,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Rate of clearance in rat was determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622986
13609,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622987
13610,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622988
13611,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622989
13612,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622990
13613,1,,0,Simiiformes,In vivo,,314293.0,1969.0,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Plasma,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622991
13614,1,,1,Rattus norvegicus,In vivo,,10116.0,1969.0,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622227
13615,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622228
13616,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Clpl value in rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622229
13617,1,,1,Cavia porcellus,In vivo,,10141.0,,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,,,,BAO_0000218,50512,N,Intermediate,CHEMBL622230
13618,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622231
13619,1,,1,Macaca fascicularis,In vivo,,9541.0,,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,,,,BAO_0000218,100710,N,Intermediate,CHEMBL622232
13620,1,,0,,In vivo,,,,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622233
13621,1,,0,,In vivo,,,,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622234
13622,1,,0,,In vivo,,,,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622235
13623,1,,0,,In vivo,,,,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622236
13624,1,,0,,In vivo,,,,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622237
13625,1,,0,,In vivo,,,,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL877482
13626,1,,0,,In vivo,,,,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622238
13627,1,,0,,In vivo,,,,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622239
13628,1,,0,,In vivo,,,178.0,,Cmax was calculated as maximum concentration reached in the blood,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622240
13629,1,,0,,In vivo,,,178.0,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL622241
13630,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax was determine after peroral administration at 10 mpk in Rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631013
13631,1,,1,Macaca mulatta,In vivo,,9544.0,,,Cmax was determine after peroral administration at 10 mpk in Rhesus,,,,,BAO_0000218,50797,N,Intermediate,CHEMBL631014
13632,1,,1,Canis lupus familiaris,In vivo,,9615.0,,,Cmax was determine after peroral administration at 10 mpk in dog,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631015
13633,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax was determine after peroral administration at 160 mpk in Rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631016
13634,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax was determine after peroral administration at 20 mpk in Rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631017
13635,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Cmax was determine after peroral administration at 50 mpk in Rat,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631018
13636,1,,0,,In vivo,,,,,Cmax was determined,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL631019
13637,1,,1,Mus musculus,,,10090.0,955.0,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL875761
13638,1,,1,Mus musculus,,,10090.0,955.0,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631020
13639,1,,1,Mus musculus,,,10090.0,955.0,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631669
13640,1,,1,Mus musculus,,,10090.0,955.0,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631670
13641,1,,1,Mus musculus,,,10090.0,2435.0,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,Striatum,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631671
13642,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631672
13643,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631673
13644,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631856
13645,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631857
13646,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631858
13647,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631859
13648,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631860
13649,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631861
13650,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631862
13651,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631863
13652,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631864
13653,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631865
13654,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631866
13655,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629360
13656,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629361
13657,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629362
13658,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630740
13659,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630741
13660,1,,1,Rattus norvegicus,,,10116.0,178.0,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630742
13661,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630743
13662,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630744
13663,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630745
13664,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630746
13665,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630747
13666,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630748
13667,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632056
13668,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632057
13669,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632058
13670,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632059
13671,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632060
13672,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632061
13673,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629207
13674,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629208
13675,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629209
13676,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629210
13677,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629211
13678,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629212
13679,1,,1,Rattus norvegicus,,,10116.0,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629213
13680,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629214
13681,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629215
13682,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL635154
13683,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629216
13684,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629217
13685,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629218
13686,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629219
13687,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629220
13688,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629221
13689,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631127
13690,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631128
13691,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631129
13692,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631130
13693,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631131
13694,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631132
13695,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631133
13696,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631134
13697,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875120
13698,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631135
13699,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631136
13700,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631137
13701,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631138
13702,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631139
13703,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631140
13704,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631141
13705,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631142
13706,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631143
13707,1,,1,Rattus norvegicus,,,10116.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631144
13708,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631145
13709,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631146
13710,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631147
13711,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631148
13712,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631149
13713,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631150
13714,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631151
13715,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631152
13716,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631443
13717,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631444
13718,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631445
13719,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631446
13720,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631447
13721,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631448
13722,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631449
13723,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL631450
13724,1,,1,Canis lupus familiaris,,,9615.0,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629724
13725,1,,1,Mus musculus,In vivo,,10090.0,14.0,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Zone of skin,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629725
13726,1,,1,Mus musculus,In vivo,,10090.0,14.0,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Zone of skin,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629726
13727,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629727
13728,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630404
13729,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630405
13730,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630406
13731,1,,1,Mus musculus,In vivo,,10090.0,945.0,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Stomach,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630407
13732,1,,1,Mus musculus,In vivo,,10090.0,945.0,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Stomach,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630573
13733,1,,1,Mus musculus,In vivo,,10090.0,945.0,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Stomach,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630574
13734,1,,1,Mus musculus,In vivo,,10090.0,945.0,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Stomach,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630575
13735,1,,1,Mus musculus,In vivo,,10090.0,,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630576
13736,1,,1,Mus musculus,In vivo,,10090.0,,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630577
13737,1,,1,Mus musculus,In vivo,,10090.0,,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630578
13738,1,,1,Mus musculus,In vivo,,10090.0,,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630579
13739,1,,1,Mus musculus,,,10090.0,2113.0,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630580
13740,1,,1,Mus musculus,,,10090.0,2113.0,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630581
13741,1,,1,Mus musculus,,,10090.0,2113.0,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630582
13742,1,,1,Mus musculus,,,10090.0,,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630583
13743,1,,1,Mus musculus,,,10090.0,,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630584
13744,1,,1,Mus musculus,,,10090.0,,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630585
13745,1,,1,Mus musculus,,,10090.0,,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630586
13746,1,,1,Mus musculus,,,10090.0,,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630587
13747,1,,1,Mus musculus,,,10090.0,,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630588
13748,1,,1,Mus musculus,,,10090.0,,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630589
13749,1,,1,Mus musculus,,,10090.0,,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630590
13750,1,,0,,,,,1988.0,,Removal of 238-Plutonium(IV) in feces at 24 h,Feces,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630591
13751,1,,0,,,,,1988.0,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),Feces,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630592
13752,1,,0,,,,,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630593
13753,1,,0,,,,,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630594
13754,1,,0,,,,,1088.0,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),Urine,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630595
13755,1,,0,,,,,1088.0,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),Urine,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630596
13756,1,,0,,,,,1088.0,,Removal of 238-Plutonium(IV) in urine after 0-24 h,Urine,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630597
13757,1,,0,,,,,1088.0,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),Urine,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630598
13758,1,,0,,,,,1088.0,,Removal of 238-Plutonium(IV) in urine after 0-4 h,Urine,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630599
13759,1,,0,,,,,1088.0,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),Urine,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630600
13760,1,,0,,,,,1088.0,,Removal of 238-Plutonium(IV) in urine after 4-24 h,Urine,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630601
13761,1,,0,,,,,1088.0,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),Urine,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630602
13762,1,,0,,,,,1088.0,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),Urine,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630603
13763,1,,0,,,,,1088.0,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),Urine,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630604
13764,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624869
13765,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624870
13766,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623189
13767,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623190
13768,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623191
13769,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623192
13770,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623193
13771,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623194
13772,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623195
13773,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623196
13774,1,,1,Rattus norvegicus,,,10116.0,,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623197
13775,1,,1,Rattus norvegicus,,,10116.0,,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623198
13776,1,,1,Rattus norvegicus,,,10116.0,,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623199
13777,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623200
13778,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623201
13779,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623202
13780,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623203
13781,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623204
13782,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623205
13783,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623206
13784,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623207
13785,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623208
13786,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623209
13787,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623210
13788,1,,1,Rattus norvegicus,,,10116.0,,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623211
13789,1,,1,Rattus norvegicus,,,10116.0,995.0,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623212
13790,1,,0,,,,,,,Tested in vitro for intrinsic activity relative to quinpirole,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623213
13791,1,,0,,,,,,,"Relative ion enhancement, determined in pulsed ultrafiltration",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623214
13792,1,,0,,,,,,,% ionization at the pH 7.4 at 37 degree Centigrade,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623215
13793,1,,0,,,,,,,Percentage ionization was measured,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623216
13794,1,,1,Bos taurus,,,9913.0,,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,,,,BAO_0000218,50591,N,Intermediate,CHEMBL623217
13795,1,,0,,,,,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623218
13796,1,,0,,,,,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623913
13797,1,,0,,,,,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL623914
13798,1,,0,,,,,,,Compound was evaluated for the partition coefficient in octanol/water,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL623915
13799,1,,0,,,,,,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL624080
13800,1,,0,,,,,,,Equilibrium constant measured by the pulse radiolysis at pH 7,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL624081
13801,1,,1,Homo sapiens,,,9606.0,,,In vitro hydrolytic rate constant determined in human blood,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL624082
13802,1,,1,Homo sapiens,,,9606.0,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL625054
13803,1,,0,,,,,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL877485
13804,1,,1,Mus musculus,,,10090.0,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625055
13805,1,,1,Mus musculus,,,10090.0,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625056
13806,1,,1,Homo sapiens,,,9606.0,,,In vitro oxidation of compound in presence of human plasma,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL625057
13807,1,,0,,,,,,,In vitro oxidation of compound in presence of hydrogen peroxide,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625058
13808,1,,1,Mus musculus,,,10090.0,,,In vitro oxidation of compound in presence of mouse brain homogenate,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625059
13809,1,,1,Mus musculus,,,10090.0,,,In vitro oxidation of compound in presence of mouse liver homogenate,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629536
13810,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629537
13811,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629538
13812,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629539
13813,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874445
13814,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629540
13815,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629541
13816,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629542
13817,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630243
13818,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630244
13819,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630245
13820,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630246
13821,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630247
13822,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630248
13823,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood at 240 minutes after dose administration.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630249
13824,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood at 30 minutes after dose administration.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630250
13825,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood at 360 minutes after dose administration.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630251
13826,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood at 3 hr after dose administration.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630252
13827,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood at 60 minutes after dose administration.,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630408
13828,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630409
13829,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874446
13830,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630410
13831,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630411
13832,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630412
13833,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630413
13834,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution in rat cerebellum at 3 hr after dose administration.,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630414
13835,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630415
13836,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in rat cortex at 120 minutes after dose administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630416
13837,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in rat cortex at 1440 minutes after dose administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630417
13838,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in rat cortex at 15 minutes after dose administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630418
13839,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in rat cortex at 240 minutes after dose administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630419
13840,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in rat cortex at 30 minutes after dose administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630420
13841,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in rat cortex at 360 minutes after dose administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630421
13842,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in rat cortex at 3 hr after dose administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630422
13843,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in rat cortex at 60 minutes after dose administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630423
13844,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart at 120 minutes after dose administration.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630424
13845,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart at 15 minutes after dose administration.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630425
13846,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart at 240 minutes after dose administration.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629462
13847,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart at 30 minutes after dose administration.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630426
13848,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart at 360 minutes after dose administration.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630427
13849,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart at 3 hr after dose administration.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625877
13850,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart at 60 minutes after dose administration.,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625878
13851,1,,1,Rattus norvegicus,In vivo,,10116.0,10000000.0,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625879
13852,1,,1,Rattus norvegicus,In vivo,,10116.0,10000000.0,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625880
13853,1,,1,Rattus norvegicus,In vivo,,10116.0,10000000.0,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625881
13854,1,,1,Rattus norvegicus,In vivo,,10116.0,10000000.0,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625882
13855,1,,1,Rattus norvegicus,In vivo,,10116.0,10000000.0,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625883
13856,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney at 120 minutes after dose administration.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625884
13857,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney at 1440 minutes after dose administration.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625885
13858,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney at 15 minutes after dose administration.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628649
13859,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney at 240 minutes after dose administration.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628650
13860,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney at 30 minutes after dose administration.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628651
13861,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney at 360 minutes after dose administration.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628652
13862,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney at 60 minutes after dose administration.,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628653
13863,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver at 120 minutes after dose administration.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628654
13864,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver at 1440 minutes after dose administration.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628655
13865,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver at 15 minutes after dose administration.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625238
13866,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver at 240 minutes after dose administration.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625239
13867,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver at 30 minutes after dose administration.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625240
13868,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver at 360 minutes after dose administration.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625241
13869,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver at 60 minutes after dose administration.,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625242
13870,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in rat lung at 120 minutes after dose administration.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874587
13871,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in rat lung at 1440 minutes after dose administration.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625405
13872,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in rat lung at 15 minutes after dose administration.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625406
13873,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in rat lung at 240 minutes after dose administration.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625407
13874,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in rat lung at 30 minutes after dose administration.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625408
13875,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in rat lung at 360 minutes after dose administration.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625409
13876,1,,1,Rattus norvegicus,,,10116.0,1515.0,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,Thoracic aorta,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625410
13877,1,,1,Rattus norvegicus,,,10116.0,1515.0,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,Thoracic aorta,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625411
13878,1,,1,Rattus norvegicus,,,10116.0,1515.0,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,Thoracic aorta,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625412
13879,1,,1,Rattus norvegicus,,,10116.0,1515.0,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,Thoracic aorta,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625413
13880,1,,1,Rattus norvegicus,,,10116.0,1515.0,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,Thoracic aorta,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625414
13881,1,,1,Rattus norvegicus,,,10116.0,1515.0,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,Thoracic aorta,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625415
13882,1,,1,Rattus norvegicus,,,10116.0,1515.0,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,Thoracic aorta,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625416
13883,1,,1,Rattus norvegicus,,,10116.0,1088.0,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625417
13884,1,,1,Rattus norvegicus,,,10116.0,1988.0,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,Feces,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625418
13885,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625419
13886,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625420
13887,1,,1,Rattus norvegicus,,,10116.0,,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626996
13888,1,,1,Rattus norvegicus,,,10116.0,1988.0,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",Feces,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626997
13889,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626998
13890,1,,1,Rattus norvegicus,,,10116.0,,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626999
13891,1,,1,Mus musculus,,,10090.0,,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627000
13892,1,,1,Mus musculus,,,10090.0,,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627001
13893,1,,1,Mus musculus,,,10090.0,,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627002
13894,1,,1,Mus musculus,,,10090.0,,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627003
13895,1,,1,Mus musculus,,,10090.0,1088.0,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,Urine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627004
13896,1,,1,Mus musculus,,,10090.0,1088.0,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,Urine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627005
13897,1,,1,Mus musculus,,,10090.0,1088.0,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,Urine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL874594
13898,1,,1,Mus musculus,,,10090.0,1088.0,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,Urine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627006
13899,1,,1,Mus musculus,,,10090.0,1088.0,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,Urine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627007
13900,1,,1,Mus musculus,,,10090.0,1088.0,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,Urine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627884
13901,1,,1,Mus musculus,,,10090.0,1088.0,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,Urine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627885
13902,1,,1,Mus musculus,,,10090.0,1088.0,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,Urine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627886
13903,1,,1,Mus musculus,,,10090.0,1088.0,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,Urine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627887
13904,1,,1,Mus musculus,,,10090.0,1088.0,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,Urine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627888
13905,1,,1,Mus musculus,,,10090.0,1088.0,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,Urine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628057
13906,1,,1,Mus musculus,,,10090.0,1088.0,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,Urine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627405
13907,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627406
13908,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627407
13909,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627408
13910,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627409
13911,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL875486
13912,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627410
13913,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627411
13914,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627412
13915,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627413
13916,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627414
13917,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627415
13918,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627416
13919,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627417
13920,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627418
13921,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627419
13922,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627320
13923,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627321
13924,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627322
13925,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627323
13926,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627491
13927,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627492
13928,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627493
13929,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627494
13930,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627495
13931,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627496
13932,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627497
13933,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627498
13934,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627499
13935,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627500
13936,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627501
13937,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625616
13938,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625617
13939,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625618
13940,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625619
13941,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625620
13942,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625621
13943,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625622
13944,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625788
13945,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625789
13946,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625790
13947,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625791
13948,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622334
13949,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622335
13950,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622336
13951,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622337
13952,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622338
13953,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622339
13954,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624153
13955,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628430
13956,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628431
13957,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628432
13958,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628433
13959,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628434
13960,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626789
13961,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626790
13962,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626791
13963,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626792
13964,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626793
13965,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627436
13966,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627437
13967,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627438
13968,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627439
13969,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627440
13970,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627602
13971,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627603
13972,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627604
13973,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627605
13974,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627606
13975,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627607
13976,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627608
13977,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627609
13978,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627610
13979,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627611
13980,1,,1,Rattus norvegicus,,,10116.0,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627612
13981,1,,0,,,,,,,Octanol:water partition coefficient is evaluated,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL627613
13982,1,,0,,,,,,,Partition coefficient in 1-octanol/water system,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL627614
13983,1,,0,,,,,,,Partition coefficient in 1-octanol/water system measured using radio active compounds,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL627615
13984,1,,0,,,,,,,Partition coefficient in octanol/water system was determined,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL627616
13985,1,,0,,,,,,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL627617
13986,1,,0,,,,,,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627618
13987,1,,0,,,,,,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627619
13988,1,,0,,,,,,,Pseudo-first-order rate constant of the compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627620
13989,1,,0,,,,,,,Pseudo-first-order rate constant with 1-min time point,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627621
13990,1,,0,,,,,,,Pseudo-first-order rate constant without 1-min time point,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627622
13991,1,,0,,,,,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627623
13992,1,,0,,,,,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627624
13993,1,,0,,,,,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627625
13994,1,,0,,,,,,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628523
13995,1,,0,,,,,,,The alkaline hydrolysis second order rate constant(K OH) of the compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628524
13996,1,,0,,,,,,,The efflux rate constant of the compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628525
13997,1,,0,,,,,,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625732
13998,1,,0,,,,,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625733
13999,1,,0,,,,,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625734
14000,1,,0,,,,,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625913
14001,1,,0,,,,,,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625914
14002,1,,0,,,,,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625915
14003,1,,0,,,,,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625916
14004,1,,0,,,,,,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625917
14005,1,,0,,,,,,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625918
14006,1,,0,,,,,,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625919
14007,1,,0,,,,,,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625920
14008,1,,0,,,,,,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL874453
14009,1,,0,,,,,,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625921
14010,1,,0,,,,,,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625922
14011,1,,0,,,,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625923
14012,1,,0,,,,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625924
14013,1,,0,,,,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625925
14014,1,,0,,,,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625926
14015,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in rat lung at 60 minutes after dose administration.,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627704
14016,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627705
14017,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627706
14018,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627707
14019,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627708
14020,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628361
14021,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628362
14022,1,,1,Rattus norvegicus,In vivo,,10116.0,2435.0,,Biodistribution in rat striatum at 120 minutes after dose administration.,Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628363
14023,1,,1,Rattus norvegicus,In vivo,,10116.0,2435.0,,Biodistribution in rat striatum at 1440 minutes after dose administration.,Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628364
14024,1,,1,Rattus norvegicus,In vivo,,10116.0,2435.0,,Biodistribution in rat striatum at 15 minutes after dose administration.,Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628365
14025,1,,1,Rattus norvegicus,In vivo,,10116.0,2435.0,,Biodistribution in rat striatum at 240 minutes after dose administration.,Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874454
14026,1,,1,Rattus norvegicus,In vivo,,10116.0,2435.0,,Biodistribution in rat striatum at 30 minutes after dose administration.,Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628531
14027,1,,1,Rattus norvegicus,In vivo,,10116.0,2435.0,,Biodistribution in rat striatum at 360 minutes after dose administration.,Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628532
14028,1,,1,Rattus norvegicus,In vivo,,10116.0,2435.0,,Biodistribution in rat striatum at 3 hr after dose administration.,Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628533
14029,1,,1,Rattus norvegicus,In vivo,,10116.0,2435.0,,Biodistribution in rat striatum at 60 minutes after dose administration.,Striatum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628534
14030,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution in rat thyroid at 120 minutes after dose administration.,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628535
14031,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628536
14032,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution in rat thyroid at 15 minutes after dose administration.,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628537
14033,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution in rat thyroid at 240 minutes after dose administration.,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628538
14034,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution in rat thyroid at 30 minutes after dose administration.,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628539
14035,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution in rat thyroid at 360 minutes after dose administration.,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630297
14036,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution in rat thyroid at 60 minutes after dose administration.,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630298
14037,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630299
14038,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628094
14039,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628095
14040,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874648
14041,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628096
14042,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628097
14043,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628098
14044,1,,0,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628099
14045,1,,0,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628100
14046,1,,0,,,,,,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628101
14047,1,,0,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628102
14048,1,,0,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628103
14049,1,,0,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628104
14050,1,,0,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628105
14051,1,,0,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628106
14052,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628107
14053,1,,0,,,,,1088.0,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628108
14054,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628109
14055,1,,0,,,,,1088.0,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Urine,,,,BAO_0000218,22224,U,Autocuration,CHEMBL625299
14056,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625300
14057,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625301
14058,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625302
14059,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874649
14060,1,,1,Rattus norvegicus,,,10116.0,,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625303
14061,1,,1,Rattus norvegicus,,,10116.0,,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625463
14062,1,,1,Homo sapiens,,,9606.0,2107.0,,In vitro metabolism in human liver microsomes,Liver,,,,BAO_0000218,50587,N,Intermediate,CHEMBL625464
14063,1,,1,Homo sapiens,,,9606.0,,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL625465
14064,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625466
14065,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625467
14066,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625468
14067,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625469
14068,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625470
14069,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632418
14070,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627250
14071,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627251
14072,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627252
14073,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627253
14074,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627254
14075,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875471
14076,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627255
14077,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627256
14078,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627257
14079,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627258
14080,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627259
14081,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627260
14082,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623256
14083,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874413
14084,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623257
14085,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623258
14086,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623259
14087,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623260
14088,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623261
14089,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623262
14090,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623263
14091,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623264
14092,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623265
14093,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623266
14094,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623267
14095,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623268
14096,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623269
14097,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623270
14098,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623271
14099,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623272
14100,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623273
14101,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623274
14102,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874414
14103,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623275
14104,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629150
14105,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623276
14106,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623277
14107,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623112
14108,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623113
14109,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623800
14110,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623801
14111,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623802
14112,1,,1,Rattus norvegicus,In vivo,,10116.0,995.0,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623803
14113,1,,1,Rattus norvegicus,In vivo,,10116.0,995.0,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623970
14114,1,,1,Rattus norvegicus,In vivo,,10116.0,995.0,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Uterus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623971
14115,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623972
14116,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623973
14117,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623974
14118,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623975
14119,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623976
14120,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623977
14121,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623978
14122,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623979
14123,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623980
14124,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623981
14125,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626278
14126,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626279
14127,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in mice bladder plus excreted urine was determined,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626280
14128,1,,1,Mus musculus,,,10090.0,,,"Percentage biodistribution in mouse blood, 10 minutes post injection",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626281
14129,1,,1,Mus musculus,,,10090.0,,,"Percentage biodistribution in mouse blood, 30 minutes post injection",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626282
14130,1,,1,Mus musculus,,,10090.0,,,"Percentage biodistribution in mouse blood, 5 minutes post injection",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626283
14131,1,,1,Mus musculus,,,10090.0,,,"Percentage biodistribution in mouse blood, 60 minutes post injection",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626284
14132,1,,1,Mus musculus,,,10090.0,955.0,,"Percentage biodistribution in mouse brain, 10 minutes post injection",Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626285
14133,1,,1,Mus musculus,,,10090.0,955.0,,"Percentage biodistribution in mouse brain, 30 minutes post injection",Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626286
14134,1,,1,Mus musculus,,,10090.0,955.0,,"Percentage biodistribution in mouse brain, 5 minutes post injection",Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626287
14135,1,,1,Mus musculus,,,10090.0,955.0,,"Percentage biodistribution in mouse brain, 60 minutes post injection",Brain,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626288
14136,1,,1,Mus musculus,,,10090.0,,,"Percentage biodistribution in mouse heart, 10 minutes post injection",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626289
14137,1,,1,Mus musculus,,,10090.0,,,"Percentage biodistribution in mouse heart, 30 minutes post injection",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626290
14138,1,,1,Mus musculus,,,10090.0,,,"Percentage biodistribution in mouse heart, 5 minutes post injection",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626291
14139,1,,1,Mus musculus,,,10090.0,,,"Percentage biodistribution in mouse heart, 60 minutes post injection",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL839888
14140,1,,1,Mus musculus,,,10090.0,160.0,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",Intestine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626292
14141,1,,1,Mus musculus,,,10090.0,160.0,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",Intestine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626293
14142,1,,1,Mus musculus,,,10090.0,160.0,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",Intestine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626294
14143,1,,1,Mus musculus,,,10090.0,160.0,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",Intestine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL626295
14144,1,,1,Mus musculus,,,10090.0,2107.0,,"Percentage biodistribution in mouse liver, 10 minutes post injection",Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627659
14145,1,,1,Mus musculus,,,10090.0,2107.0,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627660
14146,1,,1,Mus musculus,,,10090.0,2107.0,,"Percentage biodistribution in mouse liver, 5 minutes post injection",Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627661
14147,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,Biodistribution in mice liver at 60 minutes of post injection,Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627662
14148,1,,1,Mus musculus,In vivo,,10090.0,2048.0,,Biodistribution in mice lungs at 10 min of post injection,Lung,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627663
14149,1,,1,Mus musculus,,,10090.0,,,"Percentage biodistribution in mouse lung, 30 minutes post injection",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627664
14150,1,,1,Mus musculus,,,10090.0,,,"Percentage biodistribution in mousee lung, 5 minutes post injection",,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627665
14151,1,,1,Mus musculus,In vivo,,10090.0,2048.0,,Biodistribution in mice lungs at 60 min of post injection,Lung,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627666
14152,1,,1,Mus musculus,,,10090.0,2106.0,,Percentage biodistribution in mouse spleen,Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627667
14153,1,,1,Mus musculus,,,10090.0,945.0,,Percentage biodistribution in mouse stomach,Stomach,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627668
14154,1,,1,Mus musculus,,,10090.0,1088.0,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,Urine,,,,BAO_0000218,50594,N,Intermediate,CHEMBL627669
14155,1,,0,,In vivo,,,1255.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,Urinary bladder,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627670
14156,1,,0,,In vivo,,,178.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627671
14157,1,,0,,In vivo,,,1474.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,Bone element,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627672
14158,1,,0,,In vivo,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627673
14159,1,,0,,In vivo,,,2113.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,Kidney,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627674
14160,1,,0,,In vivo,,,2107.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,Liver,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627675
14161,1,,0,,In vivo,,,2048.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,Lung,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627676
14162,1,,0,,In vivo,,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627677
14163,1,,0,,,,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627678
14164,1,,1,Rattus norvegicus,,,10116.0,1977.0,,Affinity for protein binding expressed as association constant in fresh rat serum,Serum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627679
14165,1,,0,,,,,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627680
14166,1,,0,,,,,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627681
14167,1,,0,,,,,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627682
14168,1,,0,,,,,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627683
14169,1,,0,,,,,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627684
14170,1,,0,,,,,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL874441
14171,1,,0,,,,,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627685
14172,1,,0,,,,,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627686
14173,1,,0,,,,,,,Apparent rate constant Koff for inactivation of dTMP synthase.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627687
14174,1,,0,,,,,,,The irreversible inhibitor activity by second order rate equation.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627688
14175,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628038
14176,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628039
14177,1,,1,Rattus norvegicus,,,10116.0,,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628040
14178,1,,0,,,,,,,Dissociation rate calculated from the first-order equation using t1/2 value,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628041
14179,1,,0,,,,,,,The compound was tested for Binding constant against DNA,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630226
14180,1,,0,,,,,,,First order rate constant for cyclization of the compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628042
14181,1,,0,,,,,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625232
14182,1,,0,,,,,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625233
14183,1,,0,,,,,,,Hydrolysis rate constant was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625979
14184,1,,0,,,,,,,Observed first order rate constant,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625980
14185,1,,0,,,,,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625981
14186,1,,0,,,,,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625982
14187,1,,0,,,,,,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625983
14188,1,,0,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625984
14189,1,,0,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625985
14190,1,,0,,,,,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625986
14191,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625987
14192,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625988
14193,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625989
14194,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625990
14195,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625991
14196,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625992
14197,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625993
14198,1,,0,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631973
14199,1,,0,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632143
14200,1,,0,,,,,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632144
14201,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632145
14202,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632146
14203,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632147
14204,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632148
14205,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632149
14206,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632150
14207,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632151
14208,1,,1,Homo sapiens,,,9606.0,,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL632152
14209,1,,1,Homo sapiens,,,9606.0,,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL632153
14210,1,,1,Homo sapiens,,,9606.0,,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL632154
14211,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL632155
14212,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL632156
14213,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL632157
14214,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL632158
14215,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL632159
14216,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL626305
14217,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL626306
14218,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL626307
14219,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL626308
14220,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL626479
14221,1,,1,Human herpesvirus 1,,,10298.0,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,,,,BAO_0000218,50602,N,Intermediate,CHEMBL626480
14222,1,,0,,,,,,,Calculated partition coefficient (clogP) (MlogP),,,,,BAO_0000100,22229,U,Autocuration,CHEMBL626481
14223,1,,0,,,,,,,Equipotent potent ratio relative to carbachol (nicotinic activity),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626482
14224,1,,1,Canis lupus familiaris,,,9615.0,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626483
14225,1,,1,Canis lupus familiaris,,,9615.0,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626484
14226,1,,0,,,,,,,Solubility at pH 7.4 in micro g/mL;NA denotes available,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL626485
14227,1,,0,,,,,,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL626486
14228,1,,0,,,,,,,Solubility at pH 7.4 in ug/mL;NA denotes not available,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL626487
14229,1,,1,Canis lupus familiaris,In vivo,,9615.0,1969.0,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Plasma,,,,BAO_0000218,50588,N,Intermediate,CHEMBL626488
14230,1,,1,Rattus norvegicus,,,10116.0,1977.0,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,Serum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626489
14231,1,,0,,,,,,,Area under the MAP curve measured over 5 min; ND means Not determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626490
14232,1,,0,,,,,,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL626491
14233,1,,0,,,,,,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL626492
14234,1,,0,,,,,,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626493
14235,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626494
14236,1,,0,,In vivo,,,,,Half life after oral tested,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626495
14237,1,,1,Rattus norvegicus,,,10116.0,1969.0,,Half life was determined in plasma of rat; NT indicates not tested,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626496
14238,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626497
14239,1,,0,,In vivo,,,,,Oral bioavailability after oral tested,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL626498
14240,1,,1,Rattus norvegicus,,,10116.0,,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626499
14241,1,,1,Rattus norvegicus,,,10116.0,,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626500
14242,1,,1,Rattus norvegicus,,,10116.0,1969.0,,half life was determined in plasma of rat; NT indicates not tested,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626501
14243,1,,1,Rattus norvegicus,,,10116.0,1969.0,,half life was determined in plasma of rat; NT means not tested,Plasma,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626502
14244,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626503
14245,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626504
14246,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626505
14247,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626506
14248,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626507
14249,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626508
14250,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626509
14251,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875480
14252,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626510
14253,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626511
14254,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626512
14255,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628208
14256,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628209
14257,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628210
14258,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628211
14259,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628212
14260,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628213
14261,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628214
14262,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628215
14263,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628216
14264,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626595
14265,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626596
14266,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626597
14267,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626598
14268,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622242
14269,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622243
14270,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622244
14271,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622245
14272,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622246
14273,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622247
14274,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622248
14275,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877483
14276,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL622249
14277,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622250
14278,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622251
14279,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622252
14280,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622253
14281,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622254
14282,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622255
14283,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622256
14284,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622257
14285,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622258
14286,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622259
14287,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622927
14288,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622928
14289,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL622929
14290,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623182
14291,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL623183
14292,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623184
14293,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623185
14294,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877484
14295,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627274
14296,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623186
14297,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623187
14298,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL623188
14299,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628055
14300,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628056
14301,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628200
14302,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628201
14303,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628202
14304,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628203
14305,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628204
14306,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628205
14307,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628206
14308,1,,0,,In vivo,,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),Prostate gland,,,,BAO_0000218,22224,U,Autocuration,CHEMBL628207
14309,1,,0,,In vivo,,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,Prostate gland,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627220
14310,1,,0,,In vivo,,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627221
14311,1,,0,,In vivo,,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),Prostate gland,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627222
14312,1,,0,,In vivo,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627223
14313,1,,0,,In vivo,,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL632062
14314,1,,0,,In vivo,,,2106.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,Spleen,,,,BAO_0000218,22224,U,Autocuration,CHEMBL632063
14315,1,,0,,In vivo,,,1255.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,Urinary bladder,,,,BAO_0000218,22224,U,Autocuration,CHEMBL632064
14316,1,,0,,In vivo,,,178.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL632065
14317,1,,0,,In vivo,,,1474.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,Bone element,,,,BAO_0000218,22224,U,Autocuration,CHEMBL632066
14318,1,,0,,In vivo,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL632067
14319,1,,0,,In vivo,,,2113.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,Kidney,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629188
14320,1,,0,,In vivo,,,2107.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,Liver,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629189
14321,1,,0,,In vivo,,,2048.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,Lung,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629190
14322,1,,0,,In vivo,,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629191
14323,1,,0,,In vivo,,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),Prostate gland,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629192
14324,1,,0,,In vivo,,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629193
14325,1,,0,,In vivo,,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),Prostate gland,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629194
14326,1,,0,,In vivo,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629195
14327,1,,0,,In vivo,,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629373
14328,1,,0,,In vivo,,,2106.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,Spleen,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629374
14329,1,,0,,In vivo,,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,Prostate gland,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629375
14330,1,,0,,In vivo,,,1255.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,Urinary bladder,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629376
14331,1,,0,,In vivo,,,178.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629377
14332,1,,0,,In vivo,,,1474.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,Bone element,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629378
14333,1,,0,,In vivo,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629379
14334,1,,0,,In vivo,,,2113.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,Kidney,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629151
14335,1,,0,,In vivo,,,2107.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,Liver,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629152
14336,1,,0,,In vivo,,,2048.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,Lung,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629153
14337,1,,0,,In vivo,,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629154
14338,1,,0,,In vivo,,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),Prostate gland,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629155
14339,1,,0,,In vivo,,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,Prostate gland,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629156
14340,1,,0,,In vivo,,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629157
14341,1,,0,,In vivo,,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),Prostate gland,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629158
14342,1,,0,,In vivo,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629159
14343,1,,0,,In vivo,,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629160
14344,1,,0,,In vivo,,,2106.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,Spleen,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629161
14345,1,,0,,In vivo,,,1255.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,Urinary bladder,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629162
14346,1,,0,,In vivo,,,178.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629163
14347,1,,0,,In vivo,,,1474.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,Bone element,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629164
14348,1,,0,,In vivo,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629165
14349,1,,0,,In vivo,,,2107.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,Liver,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629166
14350,1,,0,,In vivo,,,2048.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,Lung,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629167
14351,1,,0,,In vivo,,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629168
14352,1,,0,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629169
14353,1,,0,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629170
14354,1,,0,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631153
14355,1,,0,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL875121
14356,1,,0,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631154
14357,1,,0,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631155
14358,1,,0,,,,,,,Hydrolysis rate constant was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631156
14359,1,,0,,,,,,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631157
14360,1,,0,,,,,,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631158
14361,1,,0,,,,,,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631159
14362,1,,0,,,,,,,Observed second order rate constant,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631160
14363,1,,0,,,,,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631161
14364,1,,0,,,,,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631162
14365,1,,0,,,,,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630313
14366,1,,0,,,,,,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630314
14367,1,,0,,,,,,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630315
14368,1,,0,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630316
14369,1,,0,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630986
14370,1,,0,,,,,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630987
14371,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630988
14372,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630989
14373,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630990
14374,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630991
14375,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630992
14376,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630993
14377,1,,0,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630994
14378,1,,1,Rattus norvegicus,,,10116.0,,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630995
14379,1,,0,,,,,,,Association constant for compound at 31 degree C was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629252
14380,1,,0,,,,,,,Calculated antagonist equilibrium dissociation constant of the compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629253
14381,1,,0,,,,,,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629944
14382,1,,1,Cavia porcellus,,,10141.0,3126.0,,Dissociation constants vs LTE4 on guinea pig trachea,Trachea,,,,BAO_0000218,50512,N,Intermediate,CHEMBL629945
14383,1,,0,,,,,,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629946
14384,1,,0,,,,,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629947
14385,1,,0,,,,,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629948
14386,1,,0,,,,,,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL856024
14387,1,,0,,,,,,,Affinity constant KD value was derived from TMP,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629949
14388,1,,0,,,,,,,Apparent dissociation (binding) rate constant was evaluated,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629950
14389,1,,0,,,,,,,Dissociation constant (KD) of the compound,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL630127
14390,1,,0,,,,,,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL630128
14391,1,,0,,,,,,,Dissociation constant from ESR titration experiments,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL630129
14392,1,,0,,,,,,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630130
14393,1,,0,,,,,,,Dissociation constant was evaluated.,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL875234
14394,1,,0,,,,,,,Dissociation constant was reported,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL630131
14395,1,,1,Rattus norvegicus,,,10116.0,,,Dissociation constant was determined in rat pituitary cells.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630132
14396,1,,0,,,,,,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630133
14397,1,,0,,,,,,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630134
14398,1,,0,,,,,,,Equilibrium dissociation constant of the compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630135
14399,1,,0,,,,,,,Equilibrium dissociation constant was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630136
14400,1,,0,,,,,,,Kinetic constant KD was evaluated,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630137
14401,1,,0,,,,,,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630138
14402,1,,0,,,,,,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630139
14403,1,,0,,,,,,,Rate constant for hydrolysis in aqueous acetone.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630140
14404,1,,0,,,,,,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL875235
14405,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876439
14406,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630605
14407,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630606
14408,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630607
14409,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630608
14410,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630609
14411,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630610
14412,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630611
14413,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629552
14414,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629733
14415,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629734
14416,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629735
14417,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629736
14418,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629737
14419,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629738
14420,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629739
14421,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629740
14422,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629741
14423,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629742
14424,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629743
14425,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629744
14426,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629745
14427,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629746
14428,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629747
14429,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629748
14430,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629749
14431,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629750
14432,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629751
14433,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629752
14434,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629753
14435,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629754
14436,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629755
14437,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629756
14438,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629757
14439,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629758
14440,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629759
14441,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629760
14442,1,,1,Rattus norvegicus,,,10116.0,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876443
14443,1,,1,Canis lupus familiaris,,,9615.0,,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629761
14444,1,,1,Canis lupus familiaris,,,9615.0,,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629762
14445,1,,1,Mus musculus,,,10090.0,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629763
14446,1,,1,Mus musculus,,,10090.0,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629764
14447,1,,1,Mus musculus,,,10090.0,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629765
14448,1,,1,Mus musculus,,,10090.0,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629766
14449,1,,1,Mus musculus,,,10090.0,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629767
14450,1,,1,Canis lupus familiaris,,,9615.0,,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629768
14451,1,,1,Mus musculus,,,10090.0,,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629769
14452,1,,1,Canis lupus familiaris,,,9615.0,,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629770
14453,1,,1,Canis lupus familiaris,,,9615.0,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,,,,BAO_0000218,50588,N,Intermediate,CHEMBL629771
14454,1,,1,Mus musculus,,,10090.0,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629772
14455,1,,1,Mus musculus,,,10090.0,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL629773
14456,1,,1,Mus musculus,,,10090.0,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625455
14457,1,,1,Mus musculus,,,10090.0,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625456
14458,1,,1,Mus musculus,,,10090.0,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL625457
14459,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625458
14460,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625459
14461,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875483
14462,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL634779
14463,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625460
14464,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626117
14465,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626118
14466,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628342
14467,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628343
14468,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628344
14469,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628345
14470,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628346
14471,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628347
14472,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628348
14473,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628349
14474,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875611
14475,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628350
14476,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628351
14477,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628352
14478,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628353
14479,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628354
14480,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626667
14481,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626668
14482,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626669
14483,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626670
14484,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626671
14485,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626672
14486,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626673
14487,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626674
14488,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626675
14489,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626676
14490,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626677
14491,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626678
14492,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626679
14493,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875612
14494,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626680
14495,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626681
14496,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626682
14497,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626683
14498,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626684
14499,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626685
14500,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626686
14501,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626687
14502,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624978
14503,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624979
14504,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624980
14505,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL624981
14506,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL624982
14507,1,,0,,In vivo,,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),Prostate gland,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627564
14508,1,,0,,In vivo,,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),Prostate gland,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627565
14509,1,,0,,In vivo,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627566
14510,1,,0,,In vivo,,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627567
14511,1,,0,,In vivo,,,2106.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,Spleen,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627568
14512,1,,0,,In vivo,,,2113.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,Kidney,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627569
14513,1,,0,,In vivo,,,1255.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,Urinary bladder,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627570
14514,1,,0,,In vivo,,,178.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,Blood,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627571
14515,1,,0,,In vivo,,,1474.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,Bone element,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627572
14516,1,,0,,In vivo,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627573
14517,1,,0,,In vivo,,,2113.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,Kidney,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627574
14518,1,,0,,In vivo,,,2107.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,Liver,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627575
14519,1,,0,,In vivo,,,2048.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,Lung,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627576
14520,1,,0,,In vivo,,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627577
14521,1,,0,,In vivo,,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),Prostate gland,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627578
14522,1,,0,,In vivo,,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,Prostate gland,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627579
14523,1,,0,,In vivo,,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627580
14524,1,,0,,In vivo,,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),Prostate gland,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627581
14525,1,,0,,In vivo,,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627582
14526,1,,0,,In vivo,,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627583
14527,1,,0,,In vivo,,,2106.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,Spleen,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627584
14528,1,,0,,In vivo,,,2367.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,Prostate gland,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627585
14529,1,,0,,In vivo,,,2385.0,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,Muscle tissue,,,,BAO_0000218,22224,U,Autocuration,CHEMBL627586
14530,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627587
14531,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627588
14532,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628250
14533,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628251
14534,1,,1,Rattus norvegicus,In vivo,,10116.0,10000000.0,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628252
14535,1,,1,Rattus norvegicus,In vivo,,10116.0,10000000.0,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628253
14536,1,,1,Rattus norvegicus,In vivo,,10116.0,1898.0,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,Hypothalamus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628254
14537,1,,1,Rattus norvegicus,In vivo,,10116.0,1898.0,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Hypothalamus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL877493
14538,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628255
14539,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628256
14540,1,,1,Rattus norvegicus,In vivo,,10116.0,10000000.0,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628257
14541,1,,1,Rattus norvegicus,In vivo,,10116.0,1898.0,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Hypothalamus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628258
14542,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628259
14543,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628429
14544,1,,1,Rattus norvegicus,In vivo,,10116.0,10000000.0,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626862
14545,1,,1,Rattus norvegicus,In vivo,,10116.0,1898.0,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,Hypothalamus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626863
14546,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625886
14547,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625887
14548,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625888
14549,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625889
14550,1,,1,Rattus norvegicus,In vivo,,10116.0,10000000.0,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625890
14551,1,,1,Rattus norvegicus,In vivo,,10116.0,10000000.0,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625891
14552,1,,1,Rattus norvegicus,In vivo,,10116.0,1898.0,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,Hypothalamus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625892
14553,1,,1,Rattus norvegicus,In vivo,,10116.0,1898.0,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,Hypothalamus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625893
14554,1,,1,Rattus norvegicus,In vivo,,10116.0,2037.0,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,Cerebellum,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625894
14555,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625895
14556,1,,0,,,,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625896
14557,1,,0,,,,,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625897
14558,1,,0,,,,,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625898
14559,1,,0,,,,,,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL625899
14560,1,,0,,,,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL626124
14561,1,,1,Escherichia coli,,,562.0,,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,,,,BAO_0000218,50212,N,Intermediate,CHEMBL628500
14562,1,,1,Rattus norvegicus,,,10116.0,,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL857856
14563,1,,1,Rattus norvegicus,,,10116.0,,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628501
14564,1,,0,,,,,,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628502
14565,1,,0,,,,,,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628503
14566,1,,0,,,,,,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628504
14567,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628505
14568,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL874452
14569,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628506
14570,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628507
14571,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628508
14572,1,,0,,,,,,,Michaelis constant (KM) was evaluated,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628509
14573,1,,0,,,,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628510
14574,1,,0,,,,,,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628511
14575,1,,0,,,,,,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628512
14576,1,,0,,,,,,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628513
14577,1,,0,,,,,,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628514
14578,1,,0,,,,,,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628515
14579,1,,0,,,,,,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628516
14580,1,,0,,,,,,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628517
14581,1,,0,,,,,,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628518
14582,1,,0,,,,,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628519
14583,1,,0,,,,,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628520
14584,1,,0,,,,,,,Binding constant was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628521
14585,1,,0,,,,,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630443
14586,1,,0,,,,,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630444
14587,1,,0,,,,,,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL857732
14588,1,,0,,,,,,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL630445
14589,1,,0,,,,,,,Catalytic rate constant of the compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630446
14590,1,,0,,,,,,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630447
14591,1,,0,,,,,,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630448
14592,1,,0,,,,,,,Catalytic rate constant against phospholipase A2 was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630449
14593,1,,0,,,,,,,"Compound was evaluated for catalytic constant, Kcat",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630450
14594,1,,0,,,,,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630451
14595,1,,0,,,,,,,Kcat calculated from 0.693/T1/2,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630452
14596,1,,0,,,,,,,Kcat was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630453
14597,1,,0,,,,,,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630454
14598,1,,0,,,,,,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630455
14599,1,,0,,,,,,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631487
14600,1,,0,,,,,,,Kcat value was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631488
14601,1,,0,,,,,,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL876440
14602,1,,0,,,,,,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631489
14603,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL857742
14604,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631490
14605,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631491
14606,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631492
14607,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631493
14608,1,,0,,,,,,,Kinetic parameter for rate of conversion to PABA was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631494
14609,1,,0,,,,,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631495
14610,1,,1,Rattus norvegicus,,,10116.0,1988.0,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Feces,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631496
14611,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631497
14612,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631498
14613,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629776
14614,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629777
14615,1,,1,Rattus norvegicus,,,10116.0,1088.0,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629778
14616,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630456
14617,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630457
14618,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630458
14619,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630459
14620,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630460
14621,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876550
14622,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630461
14623,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630462
14624,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630463
14625,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630464
14626,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630465
14627,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630466
14628,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630467
14629,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630633
14630,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630634
14631,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630635
14632,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630636
14633,1,,1,Rattus norvegicus,,,10116.0,,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630637
14634,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL630638
14635,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL630639
14636,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL630640
14637,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL876551
14638,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL630641
14639,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL630642
14640,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL630643
14641,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL630644
14642,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL630645
14643,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL625599
14644,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL625600
14645,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL625601
14646,1,,1,Oryctolagus cuniculus,,,9986.0,1988.0,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Feces,,,,BAO_0000218,50592,N,Intermediate,CHEMBL625602
14647,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL627470
14648,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL627471
14649,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL627472
14650,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL627473
14651,1,,1,Oryctolagus cuniculus,,,9986.0,1088.0,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Urine,,,,BAO_0000218,50592,N,Intermediate,CHEMBL627474
14652,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627475
14653,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL627476
14654,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627477
14655,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627478
14656,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627479
14657,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627480
14658,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627481
14659,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627482
14660,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL627483
14661,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL875636
14662,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625764
14663,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625765
14664,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625766
14665,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625767
14666,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625768
14667,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625769
14668,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625770
14669,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625771
14670,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625772
14671,1,,1,Canis lupus familiaris,,,9615.0,1088.0,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Urine,,,,BAO_0000218,50588,N,Intermediate,CHEMBL625773
14672,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625774
14673,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625775
14674,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625776
14675,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625777
14676,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625778
14677,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625779
14678,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625780
14679,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625781
14680,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875637
14681,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626473
14682,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626474
14683,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626475
14684,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626476
14685,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL634397
14686,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL626477
14687,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631069
14688,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631070
14689,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631071
14690,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631072
14691,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631073
14692,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631074
14693,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631075
14694,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631725
14695,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631726
14696,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631727
14697,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631728
14698,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631729
14699,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631730
14700,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631731
14701,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631910
14702,1,,1,Rattus norvegicus,In vivo,,10116.0,10000000.0,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,Hippocampus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631911
14703,1,,1,Rattus norvegicus,In vivo,,10116.0,1898.0,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,Hypothalamus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631912
14704,1,,1,Rattus norvegicus,In vivo,,10116.0,1898.0,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,Hypothalamus,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631913
14705,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631914
14706,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631915
14707,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875778
14708,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631916
14709,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631917
14710,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631918
14711,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631919
14712,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631920
14713,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631921
14714,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631922
14715,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631923
14716,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631924
14717,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630234
14718,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630235
14719,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630236
14720,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630237
14721,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630238
14722,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630239
14723,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630303
14724,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630304
14725,1,,1,Rattus norvegicus,In vivo,,10116.0,,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630305
14726,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630306
14727,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630307
14728,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630308
14729,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630309
14730,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629309
14731,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629993
14732,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629994
14733,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629995
14734,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631993
14735,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631994
14736,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631995
14737,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631996
14738,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631997
14739,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631998
14740,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631999
14741,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632000
14742,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632001
14743,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL874424
14744,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632002
14745,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632003
14746,1,,0,,,,,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632004
14747,1,,0,,,,,,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632005
14748,1,,0,,,,,,,Compound was tested for amidase rate in the presence of N62C screen enzyme,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632006
14749,1,,0,,,,,,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632007
14750,1,,0,,,,,,,Compound was tested for amidase rate in the presence of S166C screen enzyme,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632008
14751,1,,0,,,,,,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632009
14752,1,,0,,,,,,,Compound was tested for esterase rate in the presence of N62C screen enzyme,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632010
14753,1,,0,,,,,,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL857750
14754,1,,0,,,,,,,Compound was tested for esterase rate in the presence of S166C screen enzyme,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632011
14755,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632012
14756,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632013
14757,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL632014
14758,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629622
14759,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629623
14760,1,,0,,,,,,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629624
14761,1,,0,,,,,,,Ratio of Kcat to that of Km was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629625
14762,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629626
14763,1,,0,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629627
14764,1,,0,,,,,,,"Compound was evaluated for constant, Kd",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629628
14765,1,,0,,,,,,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629629
14766,1,,0,,,,,,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629630
14767,1,,0,,,,,,,Dissociation Constant of compound determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL856030
14768,1,,0,,,,,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629631
14769,1,,0,,,,,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629632
14770,1,,0,,,,,,,Dissociation constant of compound with Fructose was determined,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL629633
14771,1,,0,,,,,,,Dissociation constant of compound with Fructose was determined; Not determined,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL629634
14772,1,,0,,,,,,,Dissociation constant of compound with Lactulose was determined,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL629635
14773,1,,0,,,,,,,Dissociation constant of compound with Lactulose was determined; Not determined,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL629636
14774,1,,0,,,,,,,Dissociation constant of the Compound,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL629637
14775,1,,0,,,,,,,Dissociation constant by non-linear regression analysis,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL629638
14776,1,,0,,,,,,,Dissociation constant was determined,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL629639
14777,1,,0,,,,,,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL629640
14778,1,,0,,,,,,,Dissociation constant was determined,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL629641
14779,1,,0,,,,,,,Dissociation constant was determined,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL631344
14780,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631345
14781,1,,0,,,,,,,The dissociation constant determined by fluorescence displacement assay,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631346
14782,1,,0,,,,,,,kd value surface plasmon resonance (SPR) method,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631524
14783,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631525
14784,1,,0,,,,,,,First dissociation constant of the binding of compound to V30M TTR,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631526
14785,1,,0,,,,,,,Second dissociation constant of the binding of compound to V30M TTR,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631527
14786,1,,0,,,,,,,"Compound was evaluated for equilibrium constant, Ke",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631528
14787,1,,0,,,,,1898.0,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,Hypothalamus,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631529
14788,1,,0,,,,,1898.0,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,Hypothalamus,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631530
14789,1,,0,,,,,,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631531
14790,1,,0,,,,,,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631532
14791,1,,0,,,,,,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL631533
14792,1,,1,Mus musculus,,,10090.0,,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL876552
14793,1,,1,Mus musculus,,,10090.0,,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631534
14794,1,,1,Mus musculus,,,10090.0,,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631535
14795,1,,1,Mus musculus,,,10090.0,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631536
14796,1,,1,Mus musculus,,,10090.0,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631537
14797,1,,1,Mus musculus,,,10090.0,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631538
14798,1,,1,Mus musculus,,,10090.0,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631539
14799,1,,1,Mus musculus,,,10090.0,,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631540
14800,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625637
14801,1,,1,Rattus norvegicus,,,10116.0,,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625638
14802,1,,1,Rattus norvegicus,,,10116.0,,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625639
14803,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625640
14804,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625641
14805,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625642
14806,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625643
14807,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625644
14808,1,,1,Rattus norvegicus,In vivo,,10116.0,2113.0,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Kidney,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625645
14809,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625646
14810,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625647
14811,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625648
14812,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625649
14813,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625650
14814,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625651
14815,1,,1,Rattus norvegicus,In vivo,,10116.0,14.0,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Zone of skin,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625652
14816,1,,1,Rattus norvegicus,In vivo,,10116.0,14.0,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Zone of skin,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625653
14817,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625654
14818,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625655
14819,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of Compound in rat blood after 15 minutes of administration,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625656
14820,1,,1,Rattus norvegicus,In vivo,,10116.0,178.0,,Biodistribution of Compound in rat blood after 2 minutes of administration,Blood,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625657
14821,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of Compound in rat brain after 15 minutes of administration,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625658
14822,1,,1,Rattus norvegicus,In vivo,,10116.0,955.0,,Biodistribution of Compound in rat brain after 2 minutes of administration,Brain,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625659
14823,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of Compound in rat heart after 15 minutes of administration,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625660
14824,1,,1,Rattus norvegicus,In vivo,,10116.0,948.0,,Biodistribution of Compound in rat heart after 2 minutes of administration,Heart,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625661
14825,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of Compound in rat liver after 15 minutes of administration,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625662
14826,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution of Compound in rat liver after 2 minutes of administration,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL625663
14827,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of Compound in rat lung after 15 minutes of administration,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875621
14828,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution of Compound in rat lung after 2 minutes of administration,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628382
14829,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of Compound in rat muscle after 15 minutes of administration,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628383
14830,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution of Compound in rat muscle after 2 minutes of administration,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628384
14831,1,,1,Rattus norvegicus,,,10116.0,,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628385
14832,1,,1,Rattus norvegicus,,,10116.0,,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875753
14833,1,,1,Rattus norvegicus,,,10116.0,,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628386
14834,1,,1,Rattus norvegicus,,,10116.0,,,Organ distribution in rat blood 2 minutes after intravenous injection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628387
14835,1,,1,Rattus norvegicus,,,10116.0,,,Organ distribution in rat blood 2 hr after intravenous injection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628388
14836,1,,1,Rattus norvegicus,,,10116.0,,,Organ distribution in rat blood 30 minutes after intravenous injection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628389
14837,1,,1,Rattus norvegicus,,,10116.0,,,Organ distribution in rat blood 30 min after intravenous injection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632756
14838,1,,1,Rattus norvegicus,,,10116.0,,,Organ distribution in rat brain 2 minutes after intravenous injection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628390
14839,1,,1,Rattus norvegicus,,,10116.0,,,Organ distribution in rat brain 2 hr after intravenous injection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631811
14840,1,,1,Rattus norvegicus,,,10116.0,,,Organ distribution in rat brain 30 minutes after intravenous injection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631812
14841,1,,1,Rattus norvegicus,,,10116.0,,,Organ distribution in rat heart 2 minutes after intravenous injection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631813
14842,1,,1,Rattus norvegicus,,,10116.0,,,Organ distribution in rat heart 2 hr after intravenous injection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631814
14843,1,,1,Rattus norvegicus,,,10116.0,,,Organ distribution in rat heart 30 minutes after intravenous injection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631815
14844,1,,1,Rattus norvegicus,,,10116.0,,,Organ distribution in rat kidney 2 minutes after intravenous injection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631816
14845,1,,1,Rattus norvegicus,,,10116.0,,,Organ distribution in rat kidney 2 hr after intravenous injection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875758
14846,1,,1,Rattus norvegicus,,,10116.0,,,Organ distribution in rat kidney 30 minutes after intravenous injection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631817
14847,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Organ distribution in rat liver 2 minutes after intravenous injection,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631818
14848,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Organ distribution in rat liver 2 hr after intravenous injection,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631819
14849,1,,1,Rattus norvegicus,,,10116.0,2107.0,,Organ distribution in rat liver 30 minutes after intravenous injection,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631820
14850,1,,1,Rattus norvegicus,,,10116.0,,,Organ distribution in rat lung 2 minutes after intravenous injection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631821
14851,1,,1,Rattus norvegicus,,,10116.0,,,Organ distribution in rat lung 2 hr after intravenous injection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631822
14852,1,,1,Rattus norvegicus,,,10116.0,,,Organ distribution in rat lung 30 minutes after intravenous injection,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631823
14853,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Organ distribution in rat muscle 2 minutes after intravenous injection,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631824
14854,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Organ distribution in rat muscle 2 hr after intravenous injection,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631825
14855,1,,1,Rattus norvegicus,,,10116.0,2385.0,,Organ distribution in rat muscle 30 minutes after intravenous injection,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631826
14856,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631827
14857,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631828
14858,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL631829
14859,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875759
14860,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631830
14861,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631831
14862,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631832
14863,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631833
14864,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631834
14865,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631835
14866,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631836
14867,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631837
14868,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631838
14869,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631839
14870,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631840
14871,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631841
14872,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631842
14873,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631843
14874,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631844
14875,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631845
14876,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631846
14877,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL875760
14878,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL632199
14879,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631847
14880,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631848
14881,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628707
14882,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628708
14883,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628709
14884,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628710
14885,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628711
14886,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628712
14887,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628713
14888,1,,1,Rattus norvegicus,,,10116.0,1088.0,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Urine,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628714
14889,1,,1,Rattus norvegicus,,,10116.0,,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,,,,BAO_0000218,50597,N,Intermediate,CHEMBL628715
14890,1,,0,,,,,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629179
14891,1,,0,,,,,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629180
14892,1,,0,,,,,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL875108
14893,1,,0,,,,,1235.0,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,Adrenal cortex,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629181
14894,1,,0,,,,,1235.0,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,Adrenal cortex,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629182
14895,1,,0,,,,,,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629183
14896,1,,0,,,,,,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629184
14897,1,,0,,,,,1235.0,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,Adrenal cortex,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629185
14898,1,,0,,,,,1235.0,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,Adrenal cortex,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629186
14899,1,,0,,,,,,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629187
14900,1,,0,,,,,,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629887
14901,1,,0,,,,,,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629888
14902,1,,0,,,,,,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629889
14903,1,,0,,,,,1235.0,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,Adrenal cortex,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629890
14904,1,,0,,,,,,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629891
14905,1,,0,,,,,,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629892
14906,1,,0,,,,,1235.0,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,Adrenal cortex,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629893
14907,1,,0,,,,,,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629894
14908,1,,0,,,,,,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629895
14909,1,,0,Canis lupus familiaris,In vivo,,9615.0,,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,,,,BAO_0000218,22224,U,Autocuration,CHEMBL875109
14910,1,,0,Macaca fascicularis,In vivo,,9541.0,,,Absolute bioavailability in male cynomolgus monkeys,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629896
14911,1,,0,Rattus norvegicus,In vivo,,10116.0,,,Absolute bioavailability in maleSprague-Dawley rats,,,,,BAO_0000218,22224,U,Autocuration,CHEMBL629897
14912,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL629898
14913,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630057
14914,1,,1,Rattus norvegicus,In vivo,,10116.0,2107.0,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Liver,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630058
14915,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630059
14916,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630060
14917,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630061
14918,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630062
14919,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630063
14920,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630064
14921,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630065
14922,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630066
14923,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630067
14924,1,,1,Rattus norvegicus,In vivo,,10116.0,2048.0,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Lung,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630068
14925,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631113
14926,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631114
14927,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631115
14928,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL631116
14929,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630528
14930,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630529
14931,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630530
14932,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630531
14933,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630532
14934,1,,1,Rattus norvegicus,In vivo,,10116.0,2385.0,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Muscle tissue,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630533
14935,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Biodistribution in normal mice blood after 120 hr,Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630534
14936,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Biodistribution in normal mice blood after 24 hr,Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630535
14937,1,,1,Mus musculus,In vivo,,10090.0,178.0,,Biodistribution in normal mice blood after 4 hr,Blood,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630536
14938,1,,1,Mus musculus,In vivo,,10090.0,10000001.0,,Biodistribution in normal mice bone after 120 hr,Bone,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630537
14939,1,,1,Mus musculus,In vivo,,10090.0,10000001.0,,Biodistribution in normal mice bone after 24 hr,Bone,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630538
14940,1,,1,Mus musculus,In vivo,,10090.0,10000001.0,,Biodistribution in normal mice bone after 4 hr,Bone,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630539
14941,1,,1,Mus musculus,In vivo,,10090.0,948.0,,Biodistribution in normal mice heart after 120 hr,Heart,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630540
14942,1,,1,Mus musculus,In vivo,,10090.0,948.0,,Biodistribution in normal mice heart after 24 hr,Heart,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630541
14943,1,,1,Mus musculus,In vivo,,10090.0,948.0,,Biodistribution in normal mice heart after 4 hr,Heart,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630542
14944,1,,1,Mus musculus,In vivo,,10090.0,2113.0,,Biodistribution in normal mice kidney after 120 hr,Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630543
14945,1,,1,Mus musculus,In vivo,,10090.0,2113.0,,Biodistribution in normal mice kidney after 24 hr,Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630544
14946,1,,1,Mus musculus,In vivo,,10090.0,2113.0,,Biodistribution in normal mice kidney after 4 hr,Kidney,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630545
14947,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,Biodistribution in normal mice liver after 120 hr,Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630546
14948,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,Biodistribution in normal mice liver after 24 hr,Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630547
14949,1,,1,Mus musculus,In vivo,,10090.0,2107.0,,Biodistribution in normal mice liver after 4 hr,Liver,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630548
14950,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,Biodistribution in normal mice spleen after 120 hr,Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630549
14951,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,Biodistribution in normal mice spleen after 24 hr,Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL630550
14952,1,,1,Mus musculus,In vivo,,10090.0,2106.0,,Biodistribution in normal mice spleen after 4 hr,Spleen,,,,BAO_0000218,50594,N,Intermediate,CHEMBL876426
14953,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630551
14954,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630552
14955,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630553
14956,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630554
14957,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630555
14958,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630556
14959,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630557
14960,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630558
14961,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630559
14962,1,,1,Rattus norvegicus,In vivo,,10116.0,2106.0,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Spleen,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630560
14963,1,,1,Rattus norvegicus,In vivo,,10116.0,2046.0,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Thyroid gland,,,,BAO_0000218,50597,N,Intermediate,CHEMBL876427
14964,1,,1,Rattus norvegicus,,,10116.0,,,The Kel values in female wistar rats.,,,,,BAO_0000218,50597,N,Intermediate,CHEMBL630561
14965,1,,0,,,,,,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630562
14966,1,,0,,,,,,,Hydrolysis rate constant of the compound,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL630563
14967,1,,0,,,,,,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,,,,BAO_0000100,22229,U,Autocuration,CHEMBL629673
14968,1,,0,,,,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629674
14969,1,,0,,,,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629675
14970,1,,0,,,,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629676
14971,1,,0,,,,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629677
14972,1,,0,,,,,,,Apparent inactivation rate constant was evaluated,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629678
14973,1,,0,,,,,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629679
14974,1,,0,,,,,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629680
14975,1,,0,,,,,,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629681
14976,1,,0,,,,,,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629682
14977,1,,0,,,,,,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629683
14978,1,,0,,,,,,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL629684
14979,1,,0,,,,,,,Dissociation constant was determined,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL629685
14980,1,,0,,,,,,,Dissociation constant was determined,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL629686
14981,1,,0,,,,,,,Dissociation constant at pH 7.4,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL872932
14982,1,,0,,,,,,,Dissociation constant in presence of 1 mM dithiothreitol,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL629687
14983,1,,0,,,,,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL872931
14984,1,,0,,,,,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628151
14985,1,,0,,,,,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628152
14986,1,,0,,,,,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628153
14987,1,,0,,,,,,,Kinetic constant for aromatization of androstenedione,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628154
14988,1,,0,,,,,,,Kinetic constant for aromatization of testosterone,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628155
14989,1,,0,,,,,,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628156
14990,1,,0,,,,,,,Local inhibition constant was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628157
14991,1,,1,Saccharomyces cerevisiae,,,4932.0,,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,,,,BAO_0000218,50347,N,Intermediate,CHEMBL857533
14992,1,,0,,,,,,,Dissociation constant value of the compound,,,,,BAO_0000100,22224,U,Autocuration,CHEMBL628158
14993,1,,0,,,,,964.0,,In vitro permeability through cornea without epithelium,Cornea,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628159
14994,1,,0,,,,,964.0,,In vitro permeability through intact cornea,Cornea,,,,BAO_0000019,22224,U,Autocuration,CHEMBL875616
14995,1,,1,Oryctolagus cuniculus,,,9986.0,964.0,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,Cornea,,,,BAO_0000218,50592,N,Intermediate,CHEMBL628160
14996,1,,0,,,,,,,Rate of enzyme inactivation for the compound was determined,,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628161
14997,1,,0,,,,,964.0,,In vitro permeability through cornea without epithelium,Cornea,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628162
14998,1,,0,,,,,964.0,,In vitro permeability through intact cornea,Cornea,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628163
14999,1,,0,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628164
15000,1,,0,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628165
15001,1,,0,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628166
15002,1,,0,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628167
15003,1,,0,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628168
15004,1,,0,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628169
15005,1,,0,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628170
15006,1,,0,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628171
15007,1,,0,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627434
15008,1,,0,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL627435
15009,1,,0,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628110
15010,1,,0,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628111
15011,1,,0,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628112
15012,1,,0,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628260
15013,1,,0,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,,,BAO_0000019,22224,U,Autocuration,CHEMBL628261
15014,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628262
15015,1,,1,Homo sapiens,In vivo,,9606.0,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,,,,BAO_0000218,50587,N,Intermediate,CHEMBL628263
15016,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628264
15017,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628265
15018,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628266
15019,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628267
15020,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628268
15021,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628269
15022,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628270
15023,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628271
15024,1,,1,Mus musculus,In vivo,,10090.0,,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,,,,BAO_0000218,50594,N,Intermediate,CHEMBL628272
